NEW Sep.2023 Japanese Study by Ogasawara shows:
67% lower risk of death
78% lower disease progression
75% lower O2 need
10 recent studies reviewed in this article:
Vitamin D as a TREATMENT for HOSPITALIZED and ICU COVID-19 patients works, which is probably why it was NOT recommended or used by Canadian and US Public Health authorities and healthcare leaderships, whose goal seems to have been to drive up COVID-19 deaths and not to save lives.
What Vitamin D does for patients hospitalized with COVID-19:
decrease risk of death
decrease risk of disease progression
decrease risk of oxygen therapy
decrease risk of ICU admission
decrease length of hospital stay
decrease inflammatory markers
What Vitamin D does for ICU COVID-19 Patients:
decrease risk of death
decrease length of ICU stay
Even works for pediatric hospitalizations!
Vitamin D formulations:
Regimens would include D3 50,000 IU daily or weekly (25,000 to 100,000 IU in literature)
High doses went as high as D3 600,000 IU single dose !!
Recent research is moving towards Vitamin D analogs (more rapid onset):
Calcitriol, paricalcitol, and alfacalcidol are active vitamin D analogs that do not require conversion (Vitamin D3 or Cholecalciferol can take up to 7 days to covert to active calcitriol).
This allows them to have more rapid onset of action compared to cholecalciferol (D3).
Public Health, Hospital CEOs and Healthcare Directors are not using Vitamin D as part of Hospital or ICU treatment, which is leading to unnecessary deaths.
Ask yourselves why they’re driving up COVID-19 deaths on purpose!
Article Link in photo to avoid shadowban, just re-type URL into your browser
#DiedSuddenly #cdnpoli #ableg
The Following list of Studies is via: https://c19early.org/d
|
Sep 13
|
et al., Virology Journal, doi:10.1186/s12985-023-02165-1 | Vitamin D status in hospitalized COVID‑19 patients is associated with disease severity and IL-5 production |
| Retrospective 399 hospitalized patients in China, showing that lower vitamin D levels and higher IL-5 levels were independent risk factors for COVID-19 severity. | ||
|
Sep 8
|
Vitamin D for COVID-19: real-time meta analysis of 299 studies (115 treatment studies and 184 sufficiency studies) | |
| 115 treatment studies show statistically significant lower risk for mortality, ICU admission, hospitalization, and cases. 58 studies from 54 independent teams in 20 countries show statistically significant lower risk. • Random effects m.. | ||
|
Sep 1
|
et al., Clinical Nutrition, doi:10.1016/j.clnu.2023.08.021 | The effect of 1-hydroxy-vitamin D treatment in hospitalized patients with COVID-19: A retrospective study |
| 78% lower progression (p=0.05) and 75% lower need for oxygen therapy (p=0.09). PSM retrospective 312 hospitalized patients in Japan, showing lower progression with vitamin D (alfacalcidol) treatment, statistically significant via KM log-rank. | ||
|
Aug 25
|
et al., Journal of Clinical Medicine, doi:10.3390/jcm12175520 | Is Serum 25-Hydroxyvitamin D Level Associated with Severity of COVID-19? A Retrospective Study |
| Retrospective 763 hospitalized COVID-19 patients showing no significant difference in outcomes based on serum levels. Unadjusted results show non-significantly lower risk of critical severity, death, and complications with vitamin D suffi.. | ||
|
Aug 14
|
et al., Frontiers in Medicine, doi:10.3389/fmed.2023.1237903 | Survival implications vs. complications: unraveling the impact of vitamin D adjunctive use in critically ill patients with COVID-19—A multicenter cohort study |
| 22% higher mortality (p=0.25), 27% higher ventilation (p=0.05), 17% higher ICU admission (p=0.07), and no change in hospitalization (p=1). Retrospective 1,435 ICU patients in Saudi Arabia, showing no significant difference in mortality, and longer mechanical ventilation with treatment. Vitamin D patients had higher Q1, median, and Q3 SOFA scores after propensity score matchi.. | ||
|
Aug 11
|
et al., Mucosal Immunology, doi:10.1016/j.mucimm.2023.08.002 | Age differential CD13 and interferon expression in airway epithelia affect SARS-CoV-2 infection – effects of vitamin D |
| In Vitro study showing that vitamin D reduced SARS-CoV-2 replication in adult nasal epithelial cells via increased type I interferon expression. Administration of vitamin D by systemic supplementation or direct nasal delivery may be benef.. | ||
|
Aug 9
|
et al., Cellular and Molecular Biology, doi:10.14715/cmb/2023.69.5.5 | The vitamin D binding protein gene polymorphism association with Covid-19-infected Iraqi patients |
| Case control study of 150 COVID-19 patients and 150 healthy controls showing that COVID-19 patients had significantly lower vitamin D levels, and that the DBP gene polymorphism rs12785878 TG genotype was associated with higher risk of COV.. | ||
|
Aug 9
|
et al., Neuroimmunomodulation, doi:10.1159/000533286 | Understanding the immune-endocrine effects of vitamin D in SARS-CoV-2 infection: a role in protecting against neurodamage? |
| Review of the potential benefits of vitamin D for COVID-19 in relation to neuroprotection. Authors note that neurological symptoms are common in COVID-19, likely related to disruption of the blood-brain barrier, inflammation, and immunoth.. | ||
|
Aug 8
|
et al., Asian Journal of Internal Medicine, 2:2 | Association of vitamin D levels with severity and outcome of COVID-19 infection among inward patients at a tertiary care unit in Sri Lanka |
| 98% higher mortality (p=0.69) and 67% higher severe cases (p=0.32). Retrospective 141 hospitalized patients in Sri Lanka, showing lower mortality and severity with vitamin D deficiency, without statistical significance. Authors state that “studies regarding the correlation between vitamin D and CO.. | ||
|
Aug 3
|
et al., Nucleosides, Nucleotides & Nucleic Acids, doi:10.1080/15257770.2023.2253281 | Effect of vitamin D receptor gene BsmI polymorphism on hospitalization of SARS-CoV-2 positive patients |
| Analysis of 80 COVID-19 hospitalized patients and 110 healthy controls, showing lower vitamin D levels in COVID-19 patients. The vitamin D receptor gene BsmI b allele and bb genotype were associated with hospitalization. Authors note this.. | ||
|
Jul 30
|
et al., Nutrients, doi:10.3390/nu15153392 | Vitamin D Deficiency in COVID-19 Patients and Role of Calcifediol Supplementation |
| 39% lower mortality (p=0.04), 23% lower need for oxygen therapy (p=0.22), and 35% shorter hospitalization (p=0.01). Retrospective 288 hospitalized COVID-19 patients in Italy, showing lower mortality and shorter hospitalization with calcifediol. Results may underestimate the benefits because only higher risk patients with vitamin D deficiency received.. | ||
|
Jul 26
|
et al., Journal of Contemporary Medicine, doi:10.16899/jcm.1319088 | Comparison of Length of Hospital Stay and Routine Laboratory Parameters in Covid-19 Patients With and Without Serum Vitamin D Deficiency |
| 13% shorter hospitalization (p=0.33). Retrospective 413 hospitalized COVID-19 patients in Turkey showing vitamin D deficiency associated with higher CRP, fibrinogen, neutrophils, and hematocrit. There was no significant difference for length of stay. | ||
|
Jul 26
|
et al., Gaceta Médica de México, doi:10.24875/gmm.m23000770 | 25(OH)D levels during the COVID-19 pandemic: impact of lockdown and ultraviolet radiation |
| Analysis of the impact of COVID-19 lockdown policies on vitamin D levels in Argentina. Vitamin D levels were lower in 2020 compared to 2019, especially during the first wave of COVID-19 from September-November 2020. Levels decreased after.. | ||
|
Jul 25
|
et al., Journal of Health, Population and Nutrition, doi:10.1186/s41043-023-00409-y | High-dose vitamin D supplementation is related to an improvement in serum alkaline phosphatase in COVID-19 patients; a randomized double-blinded clinical trial |
| RCT 140 hospitalized patients in Iran, showing patients treated with high dose vitamin D had a significant decrease in serum alkaline phosphatase compared to the control group receiving lower dose vitamin D. No significant differences wer.. | ||
|
Jul 17
|
et al., Canadian Journal of Infectious Diseases and Medical Microbiology, doi:10.1155/2023/5205188 | Survival and Mortality in Hospitalized Children with COVID-19: A Referral Center Experience in Yazd, Iran |
| 58% lower mortality (p=0.7). Retrospective 183 hospitalized pediatric COVID-19 patients in Iran, showing no significant difference in mortality with in unadjusted results. | ||
|
Jul 15
|
et al., Current Research in Immunology, doi:10.1016/j.crimmu.2023.100064 | High baseline frequencies of natural killer cells are associated with asymptomatic SARS-CoV-2 infection |
| Analysis of 88 COVID+ patients in the USA showing that a higher frequency of natural killer (NK) cells was associated with asymptomatic infection. Improved NK cell numbers and functioning has been shown for exercise [Oh], better sleep [Ir.. | ||
|
Jul 11
|
et al., Annals of Medicine & Surgery, doi:10.1097/MS9.0000000000000955 | Vitamin D status and blood group among severe COVID19 patients |
| Retrospective 305 COVID-19 ICU patients in Iran, showing vitamin D deficiency associated with mortality. | ||
|
Jul 11
|
et al., Current Developments in Nutrition, doi:10.1016/j.cdnut.2023.101971 | Vitamin D and zinc supplementation to improve treatment outcomes among COVID-19 patients in India: results from a double-blind randomized placebo-controlled trial |
| 3% higher ventilation (p=0.91), 14% higher hospital discharge (p=0.53), and 11% improved recovery (p=0.65). Early terminated factorial RCT with 46 vitamin D, 48 zinc, 44 vitamin D + zinc, and 43 placebo patients in India. The most serious outcome (ventilation) numbers do not seem realistic. Authors do not specify outcomes per group, but with on.. | ||
|
Jul 6
|
et al., Frontiers in Nutrition, doi:10.3389/fnut.2023.1174113 | Association between dietary antioxidant quality score and severity of coronavirus infection: a case–control study |
| Case control study of 295 COVID-19 patients in Iran, showing lower risk of severe cases with higher dietary antioxidant quality scores, and with higher intake of vitamin D. | ||
|
Jun 30
|
et al., Exploratory Animal and Medical Research, doi:10.52635/eamr/13.1.16-21 | Vitamin D status in Covid-19 patients admitted to the critical care unit of an Eastern India hospital |
| Analysis of 97 COVID-19 CCU patients in India. Patients with severe COVID-19 had significantly lower vitamin D levels compared to those with moderate COVID-19. There was a significant correlation between lower vitamin D levels and more se.. | ||
|
Jun 22
|
et al., Frontiers in Nutrition, doi:10.3389/fnut.2023.1132528 | The effects of vitamin D on all-cause mortality in different diseases: an evidence-map and umbrella review of 116 randomized controlled trials |
| Meta analysis showing significantly lower mortality for COVID-19 patients with vitamin D treatment, however it’s not clear why Annweiler et al. is considered an RCT here, or why most of the COVID-19 vitamin D RCTs are not included. | ||
|
Jun 20
|
et al., Explore, doi:10.1016/j.explore.2023.06.009 | Melatonin, vitamins and minerals supplements for the treatment of Covid-19 and Covid-like illness: a prospective, randomized, double-blind multicenter study. |
| 67% improved recovery (p=0.32). RCT 164 low-risk (no hospitalizations) patients in Tunisia, showing improved recovery with zinc, melatonin, and vitamins A-E. This study includes COVID-19 and COVID-like illness, with 49% of 128 patients receiving a PCR test being COVID-1.. | ||
|
Jun 15
|
et al., Journal of Clinical Medicine, doi:10.3390/jcm12124054 | The Association of Weight Reduction and Other Variables after Bariatric Surgery with the Likelihood of SARS-CoV-2 Infection |
| 35% fewer cases (p=0.001). Retrospective 3,038 bariatric surgery patients in Israel, showing higher risk of SARS-CoV-2 infection with vitamin D deficiency, and lower risk with physical activity. | ||
|
Jun 15
|
et al., European Review for Medical and Pharmacological Sciences, doi:10.26355/eurrev_202306_32651 | Association between vitamin D hypovitaminosis and severe forms of COVID-19 |
| 90% lower mortality (p=0.009). Retrospective 74 COVID-19 patients in Serbia, showing higher mortality with severe vitamin D deficiency in unadjusted results. Patients with severe deficiency were older (63.7 vs. 52.8). | ||
|
Jun 14
|
et al., Frontiers in Pharmacology, doi:10.3389/fphar.2023.1197973 | A report on SARS-CoV-2 first wave in Ecuador: drug consumption dynamics |
| Retrospective 10,175 people PCR tested in Ecuador, showing lower risk of PCR+ with multivitamin use and suggesting higher risk with acetaminophen use. The study analyzed drug consumption for COVID-19 symptoms during the 14 days before the.. | ||
|
Jun 1
|
et al., IJID Regions, doi:10.1016/j.ijregi.2023.05.007 | An investigation of the correlation of vitamin D status and management outcomes in patients with severe COVID-19 at a South African tertiary hospital |
| 1% lower mortality (p=0.97). Prospective analysis of 68 COVID-19 ICU patients in South Africa, showing a high prevalence of vitamin D deficiency/insufficiency. There was no significant difference in mortality based on vitamin D sufficiency, however this result does n.. | ||
|
Jun 1
|
et al., Intervirology, doi:10.1159/000530906 | Impact of Age and Clinico-Biochemical Parameters on Clinical severity of SARS-CoV-2 Infection |
| 72% lower severe cases (p=0.007). Retrospective 236 COVID-19 patients in India, showing higher risk of severe cases with vitamin D deficiency. | ||
|
May 31
|
et al., Journal of Cardiovascular Disease Research, doi:10.31838/jcdr.2023.14.05.215 | Demographical Profile and Clinical Outcomes of Covid-19 Patients at a Tertiary Care Centre |
| Retrospective 100 COVID-19 patients in India, showing higher vitamin D levels associated with survival and lower severity in unadjusted results. | ||
|
May 29
|
et al., University of Thi-Qar Journal of Medicine, 25:1 | Vitamin D Deficiency and Clinical Outcomes in Patients with COVID-19 |
| Analysis of 59 COVID-19 patients and 25 healthy controls in Iraq, showing lower vitamin D levels in COVID-19 patients. | ||
|
May 25
|
et al., BMJ Open, doi:10.1136/bmjopen-2022-064058 | Prevention of COVID-19 with oral vitamin D supplemental therapy in essential healthcare teams (PROTECT): protocol for a multicentre, triple-blind, randomised, placebo-controlled trial |
| Report on the PROTECT vitamin D prophylaxis trial for healthcare workers, terminated after 34 patients and providing no results. Authors indicate the trial was terminated for low enrollment due to high use of vitamin D and a high concurre.. | ||
|
May 21
|
et al., Nutrition, doi:10.1016/j.nut.2023.112087 | Early oral nutritional supplement improves COVID-19 outcomes among hospitalized older patients during the omicron wave |
| PSM retrospective 1,181 COVID-19 patients ≥60 years old in China, showing significantly lower mortality with a nutritional supplement. Hospitalization time and viral clearance time was improved with earlier initiation of treatment. The su.. | ||
|
May 12
|
et al., Medical Journal MEDICUS, 28:1 | Vitamin D status in patients with COVID-19 – sex differences associated with severity of the disease |
| Retrospective 115 COVID-19 patients in North Macedonia, showing lower vitamin D levels associated with hospitalization. | ||
|
May 12
|
et al., The Journal of Steroid Biochemistry and Molecular Biology, doi:10.1016/j.jsbmb.2023.106329 | Normal 24-hour Urine Calcium Concentrations after Long-term Daily Oral Intake of Vitamin D in Doses Ranging from 5000 to 50,000 International Units in 14 Adult Hospitalized Psychiatric Patients |
| Retrospective psychiatric patients in the USA finding that prolonged daily oral intake of vitamin D3 from 5,000 to 10,000 IU/day was safe. There was no evidence for hypercalcemia, renal failure, calcium crystal formation, nephrolithiasis… | ||
|
May 3
|
et al., Medicina, doi:10.3390/medicina59050877 | COVID-19 Biomarkers Comparison: Children, Adults and Elders |
| Retrospective 1,376 patients in Romania, showing vitamin D levels inversely related to COVID-19 symptoms, severity, ICU admission, and death. | ||
|
May 3
|
et al., The American Journal of the Medical Sciences, doi:10.1016/j.amjms.2023.04.019 | Clinical Characteristics and Comorbidities associated with SARS-CoV-2 breakthrough infection in the University of California Healthcare Systems |
| 47% fewer cases (p<0.0001). Retrospective 110,380 patients in the USA, showing higher risk of COVID-19 breakthrough cases with vitamin D deficiency. Authors note that “lockdown measures pose an increased risk for individuals to develop vitamin D deficiency”.. | ||
|
May 1
|
et al., Nutr. clín. diet. hosp., doi:10.12873/432taslim | The Effects of 10,000 IU Vitamin D Supplementation on Improvement of Clinical Outcomes, Inflammatory and Coagulation Markers in Moderate COVID-19 Patients: A Randomized-Controlled Trial |
| 71% lower need for oxygen therapy (p=0.01), 21% shorter hospitalization (p=0.0002), and 38% faster viral clearance (p<0.0001). RCT 72 moderate COVID-19 patients with vitamin D deficiency or insufficiency in Indonesia, showing faster viral clearance and improved recovery with 10,000IU vitamin D vs. 1,000IU vitamin D. Higher vitamin D levels were associated with sh.. | ||
|
Apr 30
|
et al., Indian Journal of Endocrinology and Metabolism, doi:10.4103/ijem.ijem_383_22 | Correlation between Serum Vitamin D3 levels and severity of COVID-19, experience from a COVID-19-dedicated tertiary care hospital from Western India |
| 21% lower mortality (p=0.67), 15% lower ventilation (p=0.73), and 435% higher severe cases (p=0.13). Prospective analysis of 200 hospitalized COVID-19 patients in India, showing no significant differences in outcomes with vitamin D deficiency. | ||
|
Apr 28
|
et al., BMJ Open, doi:10.1136/bmjopen-2022-069037 | History of heart failure and chronic kidney disease and risk of all-cause death after COVID-19 during the first three waves of the pandemic in comparison with influenza outbreaks in Sweden: a registry-based, retrospective, case–control study |
| 9% lower mortality (p<0.0001). Retrospective 44,866 hospitalized COVID-19 patients in Sweden, showing higher mortality with vitamin D deficiency and with acetaminophen use. The study focuses on cardiorenal disease, finding higher risk of mortality with CRD. Authors als.. | ||
|
Apr 26
|
et al., Immunity, Inflammation and Disease, doi:10.1002/iid3.844 | The association between vitamin D intake with inflammatory and biochemical indices and mortality in critically ill patients with COVID‐19: A case‐control study |
| 69% lower mortality (p=0.04). Case control study with 200 critical COVID-19 patients in Iran, showing lower mortality with higher vitamin D supplement intake. Authors do not provide enough information to assess confounding. Authors indicate that treatment was based on.. | ||
|
Apr 25
|
et al., Annals of Thoracic Medicine, doi:10.4103/atm.atm_435_22 | Risk factors predicting disease severity and mortality in coronavirus disease 2019 Saudi Arabian patients |
| Retrospective 206 COVID-19 patients in Saudi Arabia, showing no significant difference in vitamin D levels based on survival. | ||
|
Apr 25
|
et al., Biomedicines, doi:10.3390/biomedicines11051277 | Effect of Single High Dose Vitamin D Substitution in Hospitalized COVID-19 Patients with Vitamin D Deficiency on Length of Hospital Stay |
| 300% higher ventilation (p=0.2). RCT late stage patients showing no significant differences with the addition of single dose 140,000IU vitamin D treatment. All patients received vitamin D 800IU daily. There was a non‐significant shorter length of stay for patients with v.. | ||
|
Apr 24
|
et al., Nutrients, doi:10.3390/nu15092050 | Significance of 1,25-Dihydroxyvitamin D3 on Overall Mortality in Peritoneal Dialysis Patients with COVID-19 |
| 67% lower mortality (p=0.02). Prospective analysis of 52 peritoneal dialysis patients, 31 on calcitriol (vitamin D) therapy. All patients tested positive for COVID-19 during followup (median 26 months). Mortality was significantly lower for patients on calcitriol ther.. | ||
|
Apr 19
|
et al., Nutrients, doi:10.3390/nu15081972 | Influence of Strict Lockdown on Vitamin D Deficiency in Pregnant Women: A Word of Caution |
| Retrospective 886 pregnant women in Spain, showing that strict lockdowns increased the risk of vitamin D deficiency. | ||
|
Apr 19
|
et al., Clinical Nutrition ESPEN, doi:10.1016/j.clnesp.2023.04.012 | Correlation of vitamin D levels with serum parameters in Covid-19 patients |
| Retrospective 140 COVID-19 patients in Iran showing lower vitamin D levels associated with hospitalization. | ||
|
Apr 17
|
et al., The International Journal of Psychiatry in Medicine, doi:10.1177/00912174231171220 | Correlates of poor clinical outcomes related to COVID-19 among older people with psychiatric illness – a mixed methods study |
| 90% lower mortality (p=0.05) and 82% lower progression (p=0.09). Retrospective 81 pyschiatric inpatients in the UK, mean age 76, showing vitamin D deficiency associated with COVID-19 mortality. | ||
|
Apr 13
|
et al., F1000Research, doi:10.12688/f1000research.132214.1 | Impact of vitamin D deficiency in relation to the clinical outcomes of hospitalized COVID-19 patients |
| 95% lower mortality (p=0.04) and 78% lower severe cases (p=0.01). Prospective study of hospitalized patients in Indonesia, showing higher risk of mortality and severe cases with vitamin D deficiency. | ||
|
Apr 13
|
et al., The Journal of Clinical Endocrinology & Metabolism, doi:10.1210/clinem/dgad207 | Low vitamin D levels are associated with Long COVID syndrome in COVID-19 survivors |
| Retrospective 50 COVID-19 patients with long COVID and 50 matched patients without long COVID, showing lower vitamin D levels associated with long COVID. | ||
|
Apr 11
|
et al., Physiological Reports, doi:10.14814/phy2.15592 | Calcitriol modifies tight junctions, improves barrier function, and reduces TNF‐α‐induced barrier leak in the human lung‐derived epithelial cell culture model, 16HBE 14o‐ |
| In Vitro study showing that calcitriol improved barrier function in human airway epithelial cells. Authors note that this mechanism could explain in part the efficacy of vitamin D seen for COVID-19 and other airway diseases. | ||
|
Apr 6
|
et al., Cells, doi:10.3390/cells12071092 | Lung Inflammation Induced by Inactivated SARS-CoV-2 in C57BL/6 Female Mice Is Controlled by Intranasal Instillation of Vitamin D |
| C57BL/6 mouse study showing intranasal administration of vitamin D decreased inflammation following intranasal inactivated SARS-CoV-2. Authors suggest a promising potential of intranasal vitamin D to control pulmonary inflammation associa.. | ||
|
Apr 6
|
et al., Nutrients, doi:10.3390/nu15071781 | Plasma 25-Hydroxyvitamin D Level and VDR Gene Single Nucleotide Polymorphism rs2228570 Influence on COVID-19 Susceptibility among the Kazakh Ethnic Group—A Pilot Study |
| 77% fewer cases (p=0.06). Retrospective 119 patients in Kazakhstan, showing significantly lower vitamin D levels in COVID-19 patients. There was an association between rs2228570 of the VDR gene and COVID-19. The C allele was associated with reduced likelihood of C.. | ||
|
Apr 6
|
et al., Molecular Genetics & Genomic Medicine, doi:10.1002/mgg3.2172 | The role of vitamin D receptor and IL‐6 in COVID‐19 |
| Retrospective 120 hospitalized COVID-19 patients and 120 controls, showing no significant difference in vitamin D levels, however vitamin D receptor gene expression was significantly lower in COVID-19 patients. Vitamin D receptor (VDR) ge.. | ||
|
Apr 5
|
et al., Turkish Archives of Pediatrics, doi:10.5152/turkarchpediatr.2023.22217 | Association Between Vitamin D Levels and COVID-19 Infection in Children: A Case-Control Study |
| 33% fewer cases (p=0.23). Retrospective 73 COVID-19 and 76 healthy pediatric patients in Turkey, showing significantly lower vitamin D levels in COVID-19 patients. | ||
|
Apr 1
|
et al., Nutrients, doi:10.3390/nu15071736 | Effect of an Immune-Boosting, Antioxidant and Anti-Inflammatory Food Supplement in Hospitalized COVID-19 Patients: A Prospective Randomized Pilot Study |
| 61% lower mortality (p=0.05). RCT 162 late stage (65% on oxygen) patients in Spain, 78 treated with probiotics, prebiotics, vitamin D, zinc, and selenium, showing lower mortality with treatment, statistically significant only within the patients with high severity at .. | ||
|
Mar 31
|
et al., Experimental Lung Research, doi:10.1080/01902148.2023.2193637 | The multiphasic TNF-α-induced compromise of Calu-3 airway epithelial barrier function |
| In Vitro study showing that TNF-α induced a multiphasic transepithelial leak in Calu-3 cell layers, and that vitamin A and vitamin D (calcitriol) were effective at reducing the barrier compromise caused by TNF-α. | ||
|
Mar 29
|
et al., Scientific Reports, doi:10.1038/s41598-023-31944-7 | Mortality rates of severe COVID-19-related respiratory failure with and without extracorporeal membrane oxygenation in the Middle Ruhr Region of Germany |
| 21% lower mortality (p=0.31). Retrospective 149 patients under invasive mechanical ventilation in Germany showing no significant difference in mortality with vitamin D prophylaxis in unadjusted results. | ||
|
Mar 29
|
et al., Elsevier BV, doi:10.2139/ssrn.4401710 | Influence of a High Vitamin D2 Dose on the Prevention and Improvement of Symptomatic COVID-19 in Health Care Workers: A Multicenter Randomized Clinical Trial |
| 23% lower progression (p=0.2), 9% fewer cases (p=0.57), and 11% faster viral clearance. RCT 214 low risk (no hospitalization) healthcare workers in China, showing no significant differences with short-term vitamin D2 prophylaxis. Patients with higher vitamin D levels (across both groups) were less likely to be infected. The .. | ||
|
Mar 28
|
et al., Molecular and Cellular Biomedical Sciences, doi:10.21705/mcbs.v7i1.306 | Association between 25(OH)D3 Levels and the Presence of COVID-19 Symptoms |
| 71% fewer symptomatic cases (p<0.0001). Retrospective 47 patients in Indonesia showing lower vitamin D levels associated with increased COVID-19 symptoms. Adjusted results are only provided for vitamin D levels as a continuous value. | ||
|
Mar 28
|
et al., Research Square, doi:10.21203/rs.3.rs-2718581/v1 | The Role of Free Vitamin D and Vitamin D Binding Protein in SARS-Cov-2 Infection in Children |
| Prospective study of 82 pediatric patients in Turkey, showing symptom severity associated with free vitamin D and bioavailable vitamin D levels. | ||
|
Mar 27
|
et al., Epidemiol Prev., doi:10.19191/EP23.1.A503.016 | COVID-19 severity appears to be reduced in spring/summer |
| Retrospective 8,221 COVID+ patients in Italy, showing significantly lower ICU admission and CPAP/NIV use in the spring/summer compared to the winter. There was no significant difference in viral load. Vitamin D levels were higher and CRP .. | ||
|
Mar 24
|
et al., Clinical Science of Nutrition, doi:10.5152/ClinSciNutr.2023.22059 | Does the Level of Vitamin D in COVID-19 Patients Affect the Survival and Duration of Hospital Stay? |
| 51% lower mortality (p=0.07). Retrospective 168 hospitalized COVID-19 patients, showing no significant association between vitamin D levels and mortality. Adjusted results are only provided for vitamin D as a continuous variable. | ||
|
Mar 24
|
et al., Nutrients, doi:10.3390/nu15071581 | Frequency of COVID-19 Infection as a Function of Vitamin D Levels |
| 58% fewer cases (p=0.02). Retrospective 134 patients in Poland between ages 6-50, showing higher risk of COVID-19 cases with vitamin D levels <12 ng/mL. | ||
|
Mar 24
|
et al., Frontiers in Medicine, doi:10.3389/fmed.2023.1121256 | Effect of vitamin D status on adult COVID-19 pneumonia induced by Delta variant: A longitudinal, real-world cohort study |
| 25% faster recovery (p=0.02). Retrospective COVID-19 pneumonia patients in China, showing slower recovery with vitamin D deficiency. | ||
|
Mar 22
|
et al., Journal of Clinical Medicine, doi:10.3390/jcm12062429 | Identification of Clinical Response Predictors of Tocilizumab Treatment in Patients with Severe COVID-19 Based on Single-Center Experience |
| 86% lower mortality (p=0.003). Prospective study of 120 severe COVID-19 patients in Poland treated with tocilizumab, showing significantly higher mortality with low vitamin D levels. | ||
|
Mar 17
|
et al., Frontiers in Nutrition, doi:10.3389/fnut.2023.1070808 | Global and regional prevalence of vitamin D deficiency in population-based studies from 2000 to 2022: A pooled analysis of 7.9 million participants |
| Meta analysis of the global and regional prevalence of vitamin D deficiency from 308 studies, showing that globally 48% of people had vitamin D levels <50 nmol/l. The prevalence in winter-spring was 1.7 times that in summer-autum. | ||
|
Mar 15
|
et al., Konuralp Tıp Dergisi, doi:10.18521/ktd.1134319 | Relationship between vitamin D level and clinical status in COVID-19 patients |
| 75% lower mortality (p=0.02). Retrospective 47 outpatient and 47 hospitalized COVID-19 patients in Turkey, showing higher mortality with vitamin D deficiency in unadjusted results. | ||
|
Mar 15
|
et al., Inflammopharmacology, doi:10.1007/s10787-023-01183-3 | Nutritional deficiencies that may predispose to long COVID |
| Review of 22 nutritional factors that have been linked to COVID-19 outcomes, the role of nutrients in COVID-19 infection, and the prevalence of multiple nutritional deficiencies in the population. | ||
|
Mar 14
|
et al., Frontiers in Public Health, doi:10.3389/fpubh.2023.1048087 | Comparison of anthropometric parameters and laboratory test results before and after the COVID-19 outbreak among Chinese children aged 3–18 years |
| Retrospective 2,162 children 3-18 in China, showing 2.8 times greater vitamin D deficiency, and increased obesity, hypercholesterol, and hyperuricemia after extended COVID-19 lockdown in China. | ||
|
Mar 13
|
et al., Revista de Nutrición Clínica y Metabolismo, doi:10.35454/rncm.v6n2.485 | Vitamin D on admission and disease severity in patients with COVID-19 in the Intensive Care Unit |
| 66% lower mortality (p=0.05). Retrospective 164 ICU patients in Argentina, showing significantly higher mortality with severe vitamin D deficiency. | ||
|
Mar 9
|
et al., F1000Research, doi:10.12688/f1000research.131730.1 | The effect of Vitamin D levels on the course of COVID-19 in hospitalized patients – a 1-year prospective cohort study |
| 56% lower mortality (p=0.24), 59% higher ICU admission (p=0.59), and 61% higher severe cases (p=0.009). Prospective study of 301 hospitalized patients in Slovenia, showing higher mortality with vitamin D deficiency, without statistical significance. Fewer patients with severe cases were deficient, which authors hypothesize was due to their.. | ||
|
Mar 6
|
et al., Diagnostics, doi:10.3390/diagnostics13050998 | Association of Vitamin D Deficiency and Insufficiency with Pathology in Hospitalized Patients |
| 28% fewer cases (p<0.0001). Retrospective 11,182 hospitalized patients in Romania, showing vitamin D deficiency associated with COVID-19 cases. | ||
|
Mar 6
|
et al., Journal of Infection, doi:10.1016/j.jinf.2023.03.004 | Effect of calcifediol supplementation as add-on therapy on the immune repertoire in recipients of the ChAdOx1 nCoV-19 vaccine: A prospective open-label, placebo-controlled, clinical trial |
| 34% fewer symptomatic cases (p=0.01). Prospective study of 580 ChAdOx1 recipients, 262 treated with calcifediol (patient choice), showing lower cases with treatment. Supplementation did not significantly affect antibody levels following ChAdOx1 receipt. Calcifediol patients w.. | ||
|
Mar 5
|
et al., The Journal of Nutrition, doi:10.1016/j.tjnut.2023.03.001 | Vitamin D and SARS-CoV-2 Infection: SERVE Study (SARS-CoV-2 Exposure and the Role of Vitamin D among Hospital Employees) |
| Prospective study of 250 healthcare workers in the USA. The results are unclear – Figure 3 shows ~40% lower incidence with vitamin D supplementation, while the text indicates OR 1.18. Authors collected symptom information, stating that &q.. | ||
|
Mar 3
|
et al., Scientific Reports, doi:10.1038/s41598-023-30859-7 | Association of ApaI rs7975232 and BsmI rs1544410 in clinical outcomes of COVID-19 patients according to different SARS-CoV-2 variants |
| Retrospective 3,184 patients in Iran, showing COVID-19 outcomes for specific variants were associated with genotypes of the ApaI rs7975232 and BsmI rs1544410 vitamin D receptor polymorphisms. | ||
|
Feb 28
|
et al., NCT05670444 | Melatonin, Vitamins and Minerals Supplements for the Treatment of Covid-19 and Covid-like Illness: Results of a Prospective, Randomised, Double-blinded Multicentre Study |
| 150 patient vitamin D early treatment RCT with results not reported over 6 months after completion. | ||
|
Feb 28
|
et al., Bratislava Medical Journal, doi:10.4149/bll_2023_069 | Serum vitamin D levels and inflammatory status in COVID-19 patients |
| 30% lower severe cases (p=0.16). Retrospective 100 hospitalized COVID-19 patients in Bulgaria and 40 healthy controls, showing significantly lower vitamin D levels in COVID-19 patients, and lower levels in patients with severe vs. moderate disease. | ||
|
Feb 28
|
et al., Nutrients, doi:10.3390/nu15051227 | 25 Hydroxyvitamin D Serum Concentration and COVID-19 Severity and Outcome—A Retrospective Survey in a Romanian Hospital |
| 31% lower mortality (p=0.02) and 11% lower severe cases (p=0.02). Retrospective 2,342 hospitalized COVID-19 patients in Romania with vitamin D levels measured on admission day, showing lower risk of mortality and severe/critical cases with vitamin D levels ≥ 20ng/mL. | ||
|
Feb 28
|
et al., Nutrients, doi:10.3390/nu15051234 | Vitamin D Supplementation and Clinical Outcomes in Severe COVID-19 Patients—Randomized Controlled Trial |
| 21% lower mortality (p=0.2), no change in recovery (p=0.71), and 6% longer hospitalization (p=0.76). Very late stage RCT 155 ICU patients in Croatia with low vitamin D levels, showing no significant differences with 10,000IU cholecalciferol daily. Calcifediol or calcitriol, which avoids several days delay in conversion, may be more succe.. | ||
|
Feb 28
|
et al., Infection and Drug Resistance, doi:10.2147/idr.s400561 | Plasma 25(OH)D Level is Associated with the Nucleic Acid Negative Conversion Time of COVID-19 Patients: An Exploratory Study |
| 40% improved viral clearance (p=0.01). Retrospective 158 COVID+ patients in China, showing low vitamin D levels associated with slower viral clearance. | ||
|
Feb 27
|
et al., Nutrients, doi:10.3390/nu15051188 | The Effect of Weekly 50,000 IU Vitamin D3 Supplements on the Serum Levels of Selected Cytokines Involved in Cytokine Storm: A Randomized Clinical Trial in Adults with Vitamin D Deficiency |
| RCT 100 patients in Jordan, showing that high-dose cholecalciferol (50,000 IU/week) significantly increased IL-6, indicating that high weekly doses could have a negative effect for cytokine storm with COVID-19. Other studies have found no.. | ||
|
Feb 27
|
et al., Journal of the ASEAN Federation of Endocrine Societies, doi:10.15605/jafes.038.01.07 | Association of Vitamin D levels on the Clinical Outcomes of Patients Hospitalized for COVID-19 in a Tertiary Hospital |
| 71% lower progression (p=0.04), 91% lower mortality (p=0.002), and 82% lower ICU admission (p=0.01). Retrospective 135 hospitalized COVID-19 patients in the Philippines, showing higher risk of a poor outcome with vitamin D deficiency. | ||
|
Feb 16
|
et al., Journal of Neurology, doi:10.1007/s00415-023-11618-0 | Modifiable risk factors of COVID-19 in patients with multiple sclerosis: a single-centre case–control study |
| Case control analysis with 149 multiple sclerosis patients and 292 matched controls in Italy, showing lower risk of COVID-19 cases with higher vitamin D levels. | ||
|
Feb 15
|
et al., Critical Reviews in Food Science and Nutrition, doi:10.1080/10408398.2023.2174948 | Micronutrient perspective on COVID-19: Umbrella review and reanalysis of meta-analyses |
| Systematic review and meta analysis of micronutrient supplementation, showing vitamin D supplementation associated with lower mortality, mechanical ventilation, ICU admission, and severity. Note that forest plots have OR>1 favoring supple.. | ||
|
Feb 14
|
et al., Archives of Medical Research, doi:10.1016/j.arcmed.2023.02.002 | Potential Role of Vitamin D, ACE2 and the Proteases as TMPRSS2 and Furin on SARS-CoV-2 Pathogenesis and COVID-19 Severity |
| 82% lower mortality (p=0.09). Analysis of 68 COVID-19 patients and 17 healthy controls, showing higher mortality with vitamin D deficiency, and with 1,25(OH)2D levels <1 ng/mL, statistically significant only for 1,25(OH)2D levels. Serum ACE2, 1,25(OH)2D, and ACE2 mRNA.. | ||
|
Feb 13
|
et al., Scientific Reports, doi:10.1038/s41598-023-29519-7 | Contribution of vitamin D3 and thiols status to the outcome of COVID-19 disease in Italian pediatric and adult patients |
| Retrospective 173 patients in Italy showing significantly lower glutathione levels and high prevalence of vitamin D deficiency in COVID-19 patients, and lower levels of glutathione and vitamin D associated with mortality. Acetaminophen (p.. | ||
|
Feb 2
|
et al., Nutrients, doi:10.3390/nu15030771 | Global Dietary and Herbal Supplement Use during COVID-19—A Scoping Review |
| Review of 14 global studies showing that the most frequently used dietary supplements during COVID-19 were vitamin C, vitamin D, zinc, and multivitamins. The most common reason was for improved immune system functioning or reduced COVID-1.. | ||
|
Jan 30
|
et al., Journal of Food and Nutrition Research, doi:10.12691/jfnr-11-1-10 | Dietary Supplement Use among Children Whose Parents Work at National Research Centre: A Pilot Study |
| Survey of dietary supplementation showing high usage, and greater use by more highly educated people. The survey covered 200 children whose parents were employees of a research center in Egypt, showing 50% prevalence of supplementation du.. | ||
|
Jan 24
|
et al., Annals of African Medicine, doi:10.4103/aam.aam_21_22 | Association of vitamin D with the severity of disease and mortality in COVID-19: Prospective study in central India |
| Prospective study of 766 hospitalized patients in India, showing higher vitamin D levels associated with lower COVID-19 severity and mortality. | ||
|
Jan 22
|
et al., Journal of Renal Injury Prevention, doi:10.34172/jrip.2022.32126 | The association between vitamin D3 deficiency and acute kidney injury in COVID-19 patients |
| 40% lower mortality (p=0.28), 39% lower ICU admission (p=0.2), and 42% improvement (p=0.13). Retrospective 69 hospitalized COVID-19 patients in Iran, showing lower vitamin D associated with higher mortality, ICU admission, and AKI in unadjusted results. The mean age of deficient patients was lower. Statistical significance is not.. | ||
|
Jan 18
|
et al., Frontiers in Nutrition, doi:10.3389/fnut.2022.1023997 | The possible therapeutic role of curcumin and quercetin in the early-stage of COVID-19—Results from a pragmatic randomized clinical trial |
| 29% improved recovery (p=0.11) and 91% improved viral clearance (p=0.05). Small RCT with 50 outpatients, 25 treated with curcumin, quercetin, and vitamin D, showing improved recovery and viral clearance with treatment. 168mg curcumin, 260mg, 360IU vitamin D3 daily for 14 days. | ||
|
Jan 16
|
et al., The Gazette of Medical Sciences, doi:10.46766/thegms.pubheal.22120905 | Intravenous high dose vitamin C and ozonated saline effective treatment for Covid -19: The Evolution of Local Standard of Care |
| Retrospective 479 high risk outpatients in the USA treated with a protocol including intravenous vitamin C, vitamin D, zinc, quercetin, bromelain, lactoferrin, HCQ, ivermectin, ozonated saline, azithromycin, ceftriaxone, methylprednisolon.. | ||
|
Jan 16
|
et al., Pharmaceuticals, doi:10.3390/ph16010130 | Protective Effect of Vitamin D Supplementation on COVID-19-Related Intensive Care Hospitalization and Mortality: Definitive Evidence from Meta-Analysis and Trial Sequential Analysis |
| 51% lower mortality (p=0.0002) and 72% lower ICU admission (p<0.0001). Meta analysis and trial sequential analysis of 5 vitamin D RCTs, showing significantly lower mortality and ICU admission with treatment. Only a small subset of the RCTs are included. Note that [Nogués] uses randomization by ward, was cen.. | ||
|
Jan 10
|
et al., Work, doi:10.3233/WOR-220387 | Vitamin D status and COVID-19 prevention in a worker subgroup in Italy |
| Report on vitamin D supplementation with 139 employees in Italy from April to June 2021, showing only one confirmed COVID-19 case (0.7%) and 4 cases of flu-like symptoms, compared to ~7-9% COVID-19 incidence for the same Italian district .. | ||
|
Dec 31
2022 |
et al., Cukurova Anestezi ve Cerrahi Bilimler Dergisi, doi:10.36516/jocass.1185181 | Serum Vitamin D Concentrations and Covid-19 In Pregnant Women, Does Vitamin D Supplementation Impact Results? A Comprehensive Study |
| 69% fewer cases (p=0.004). Retrospective 318 pregnant women, 54 COVID+ and 264 healthy controls, showing lower risk of COVID-19 with vitamin D supplementation, and with higher vitamin D levels. | ||
|
Dec 29
2022 |
et al., Nutrients, doi:10.3390/nu15010169 | Possible Impact of Vitamin D Status and Supplementation on SARS-CoV-2 Infection Risk and COVID-19 Symptoms in a Cohort of Patients with Inflammatory Bowel Disease |
| 88% lower IgG positivity (p=0.002). Prospective study of 106 IBD patients in Italy, showing lower risk of IgG positivity with vitamin D supplementation. Vitamin D levels below 30 ng/mL were associated with a higher probability of symptomatic cases. | ||
|
Dec 26
2022 |
et al., Diagnostics, doi:10.3390/diagnostics13010059 | Association between Vitamin D Status and Secondary Infections in Patients with Severe COVID-19 Admitted in the Intensive Care Unit of a Tertiary-Level Hospital in Turkey |
| 72% lower mortality (p<0.0001) and 23% improvement (p=0.03). Retrospective 194 ICU patients and 30 non-COVID-19 patients in Turkey, showing significantly lower vitamin D levels in COVID-19 patients. There was significantly higher COVID-19 mortality with vitamin D deficiency, and significantly highe.. | ||
|
Dec 25
2022 |
et al., arXiv, doi:10.48550/arXiv.2301.02660 | Decreased serum vitamin D level as a prognostic marker in patients with COVID-19 |
| Retrospective 719 COVID-19 patients in China, showing higher vitamin D levels associated with faster viral clearance and lower severity. | ||
|
Dec 15
2022 |
et al., Nutrients, doi:10.3390/nu14245329 | The Impact of Serum Levels of Vitamin D3 and Its Metabolites on the Prognosis and Disease Severity of COVID-19 |
| Analysis of 103 COVID-19 patients and 50 healthy controls in Saudi Arabia, showing significantly lower vitamin D and vitamin D metabolite levels in COVID-19 patients, and correlations between vitamin D levels and ACE2 levels, IL-6, and NL.. | ||
|
Dec 8
2022 |
et al., Asian Journal of Research in Biochemistry, doi:10.9734/ajrb/2022/v11i2214 | Vitamin D, Calcium and Phosphorus Status Involvement during COVID-19 Infection |
| Retrospective 50 hospitalized COVID-19 patients and 50 healthy controls, showing lower vitamin D levels in COVID-19 patients, and a negative correlation between vitamin D level and COVID-19 severity. | ||
|
Dec 7
2022 |
et al., Nutrients, doi:10.3390/nu14245204 | Correlation between 25-hydroxyvitamin D/D3 Deficiency and COVID-19 Disease Severity in Adults from Northern Colorado |
| Analysis of 131 COVID+ patients and 18 healthy controls, showing COVID-19 severity associated with lower vitamin D levels. | ||
|
Dec 5
2022 |
et al., Qatar Medical Journal, doi:10.5339/qmj.2022.48 | Association of Serum Vitamin D level and COVID-19 infection: A Case-control Study |
| 23% fewer cases (p<0.0001). Retrospective 16,446 COVID-19 patients and 46,005 healthy controls in Qatar, showing higher risk of COVID-19 infection with vitamin D deficiency. | ||
|
Dec 2
2022 |
et al., International Journal of Molecular Sciences, doi:10.3390/ijms232315188 | Association between 25-OH Vitamin D Deficiency and COVID-19 Severity in Pregnant Women |
| 83% lower severe cases (p=0.04). Retrospective 165 pregnant women in Mexico, showing increased risk of severe COVID-19 with vitamin D deficiency. | ||
|
Nov 30
2022 |
et al., International Journal of General Medicine, doi:10.2147/IJGM.S386815 | Clinical and Prognostic Significance of Baseline Serum Vitamin D Levels in Hospitalized Egyptian Covid-19 Patients |
| 93% lower mortality (p<0.0001), 95% lower ventilation (p<0.0001), and 91% lower ICU admission (p<0.0001). Retrospective hospitalized patients in Egypt, showing lower vitamin D levels associated with COVID-19 severity and mortality. Adjusted results are only provided for vitamin D as a continuous variable. | ||
|
Nov 26
2022 |
et al., Nutrients, doi:10.3390/nu14235029 | Impact of Zinc, Vitamins C and D on Disease Prognosis among Patients with COVID-19 in Bangladesh: A Cross-Sectional Study |
| 28% lower severe cases (p=0.001). Retrospective 962 COVID-19 patients in Bangladesh, showing significantly lower severity with vitamin C, vitamin D, and zinc supplementation, and improved results from the combination of all three. | ||
|
Nov 18
2022 |
et al., Journal of Clinical Medicine, doi:10.3390/jcm11226818 | COVID-19 Prevention: Vitamin D Is Still a Valid Remedy |
| Discussion of limitations and concerns for [Jolliffe]. | ||
|
Nov 16
2022 |
et al., Work, doi:10.3233/wor-220292 | Clinical characteristics of bus drivers and field officers infected with COVID-19: A cross-sectional study from Istanbul |
| 5% lower hospitalization (p=0.89). Retrospective 477 COVID+ public transportation workers in Turkey, showing no significant difference in hospitalization with vitamin D use in unadjusted results. | ||
|
Nov 15
2022 |
et al., Diabetes Research and Clinical Practice, doi:10.1016/j.diabres.2022.110156 | Impact of diabetes status and related factors on COVID-19-associated hospitalization: A nationwide retrospective cohort study of 116,370 adults with SARS-CoV-2 infection |
| 42% lower hospitalization (p<0.0001). Retrospective 116,370 COVID+ patients in the USA, showing higher risk of hospitalization with vitamin D deficiency/insufficiency. | ||
|
Nov 12
2022 |
et al., Scientific Reports, doi:10.1038/s41598-022-24053-4 | Association between vitamin D supplementation and COVID-19 infection and mortality |
| 33% lower mortality (p<0.0001) and 20% fewer cases (p<0.0001). PSM retrospective in the USA, showing lower COVID-19 mortality and cases with vitamin D prophylaxis. | ||
|
Nov 8
2022 |
et al., 1st Samarra International Conference for Pure and Applied Sciences (SICPS2021), doi:10.1063/5.0121166 | The risk of up normal values of two parameters obesity and vitamin D in incidence of coronavirus disease-19 among Iraqi patients |
| 93% lower hospitalization (p<0.0001). Retrospective 86 COVID-19 hospitalized patients and 86 healthy controls in Iraq, showing COVID-19 cases associated with severe vitamin D deficiency. | ||
|
Nov 8
2022 |
et al., 1st Samarra International Conference for Pure and Applied Sciences (SICPS2021), doi:10.1063/5.0122108 | Evaluation of vitamin D in COVID-19 patients |
| 42% fewer cases (p=0.27). Case control study with 52 COVID-19 patients and 30 matched controls, showing significantly lower vitamin D levels in COVID-19 patients. | ||
|
Nov 8
2022 |
et al., Frontiers in Pharmacology, doi:10.3389/fphar.2022.1011522 | The effect of Nigella sativa and vitamin D3 supplementation on the clinical outcome in COVID-19 patients: A randomized controlled clinical trial |
| 42% improved recovery (p=0.57) and 49% improved viral clearance (p=0.2). 120 patient RCT comparing vitamin D, nigella sativa, and combined vitamin D+nigella sativa, showing improved symptom recovery and viral clearance with both vitamin D and nigella sativa, and further improvements with the combination of bot.. | ||
|
Nov 7
2022 |
et al., European Journal of General Practice, doi:10.1080/13814788.2022.2138855 | A higher frequency of physical activity is associated with reduced rates of SARS-CoV-2 infection |
| 19% fewer cases (p<0.0001). Retrospective 113,075 people in Israel, showing lower risk of COVID-19 cases with higher vitamin D levels. | ||
|
Nov 3
2022 |
et al., Scientific Reports, doi:10.1038/s41598-022-22045-y | Effect of vitamin D3 supplementation on cellular immunity and inflammatory markers in COVID-19 patients admitted to the ICU |
| 27% lower mortality (p=0.18), 7% lower ventilation (p=0.68), 94% longer ICU admission (p=0.001), and 41% longer hospitalization (p=0.007). RCT ICU patients in Russia, showing significantly increased lymphocyte counts with treatment. Mortality was lower but without statistical significance. 40% of patients were on mechanical ventilation at baseline in the treatment group, com.. | ||
|
Oct 28
2022 |
et al., bioRxiv, doi:10.1101/2022.10.27.514012 | Vitamin D deficiency and SARS-CoV-2 infection: Big-data analysis from March 2020 to March 2021. D-COVID study |
| 39% lower mortality (p<0.0001), 55% lower ICU admission (p<0.0001), and 43% lower hospitalization (p<0.0001). Retrospective free-text analysis of 143,157 COVID-19 patients, showing vitamin D deficiency associated with mortality, ICU admission, and hospitalization in unadjusted results. | ||
|
Oct 22
2022 |
et al., Scientific Reports, doi:10.1038/s41598-022-22307-9 | Vitamin D enhances type I IFN signaling in COVID-19 patients |
| 63% lower mortality (p=0.04). Retrospective 80 ICU patients, and in vitro study with human airway epithelial cells, showing that vitamin D enhances host IFN-a/β signaling. Significantly lower mortality was seen with vitamin D treatment. | ||
|
Oct 18
2022 |
et al., Journal of Clinical Medicine, doi:10.3390/jcm11206138 | Early Outpatient Treatment of COVID-19: A Retrospective Analysis of 392 Cases in Italy |
| Retrospective 392 outpatients in Italy showing 0.2% mortality with early treatment, compared with >3% in Italy at the time. Treatment varied for individual patients and included HCQ, vitamin D, vitamin C, vitamin A, zinc, quercetin, bromh.. | ||
|
Oct 7
2022 |
et al., Egyptian Rheumatology and Rehabilitation, doi:10.1186/s43166-022-00155-9 | Serum vitamin D level in COVID-19 patients and its correlation with disease severity |
| Retrospective 80 COVID-19 patients in Egypt, showing lower vitamin D levels associated with mechanical ventilation and mortality. | ||
|
Oct 3
2022 |
et al., Journal of Pharmaceutical Care, doi:10.18502/jpc.v10i3.10790 | Evaluating the Effects of Clinical Characteristics and Therapeutic Regimens on Mortality in Hospitalized Patients with Severe COVID-19 |
| 79% lower mortality (p<0.0001). Retrospective 478 moderate to severe hospitalized patients in Iran, showing lower mortality with vitamin D treatment. | ||
|
Sep 27
2022 |
et al., Medicina, doi:10.3390/medicina58101358 | Evidence for the Efficacy of a High Dose of Vitamin D on the Hyperinflammation State in Moderate-to-Severe COVID-19 Patients: A Randomized Clinical Trial |
| 19% lower mortality (p=0.003), 74% greater improvement (p=0.03), and 31% shorter hospitalization (p=0.04). RCT comparing 200,000IU IM cholecalciferol and 1mcg/day alfacalcidol, showing lower mortality and improved recovery with high dose treatment. | ||
|
Sep 24
2022 |
et al., The Egyptian Journal of Internal Medicine, doi:10.1186/s43162-022-00159-z | Association of serum zinc level and clinical outcome in Egyptian COVID-19 patients |
| Retrospective 30 ICU patients and 30 non-ICU hospitalized patients in Egypt, showing lower vitamin D levels in ICU patients. | ||
|
Sep 19
2022 |
et al., Microbial Pathogenesis, doi:10.1016/j.micpath.2022.105792 | The effect of Nutrition Bio-shield superfood (NBS) on disease severity and laboratory biomarkers in patients with COVID-19: A randomized clinical trial |
| 61% lower mortality (p=0.002) and 28% shorter hospitalization (p=0.001). RCT 70 hospitalized severe COVID-19 patients in Iran, showing lower mortality and improved clinical markers with treatment combining vitamins A, B1–B3, B5, B6, B9, C, D, K, and magnesium, potassium, phosphorus, sulfur, manganese, calcium,.. | ||
|
Sep 17
2022 |
et al., Nutrients, doi:10.3390/nu15010180 (date from preprint) | Vitamin D3 Supplementation at 5000 IU Daily for the Prevention of Influenza-like Illness in Healthcare Workers: A Pragmatic Randomized Clinical Trial |
| 98% fewer cases (p=0.07). Prospective prophylaxis trial with 255 healthcare workers taking vitamin D and 2,827 controls, showing significantly lower influenza-like illness with treatment, and lower COVID-19 cases, without statistical significance. While the interv.. | ||
|
Sep 12
2022 |
et al., Medical Science Monitor, doi:10.12659/MSM.937741 | Effect of Vitamin D Concentration on Course of COVID-19 |
| Retrospective 505 hospitalized patients in Poland, showing low vitamin D levels associated with oxygen therapy and ventilation. There was no significant difference for cases. | ||
|
Sep 9
2022 |
et al., Pediatric Research, doi:10.1038/s41390-022-02275-6 | Vitamin D deficiency and vitamin D receptor FokI polymorphism as risk factors for COVID-19 |
| 62% lower hospitalization (p=0.002). Prospective study of 180 moderate to critical hospitalized pediatric COVID-19 patients and 200 matched controls, showing vitamin D deficiency and the VDR Fok I polymorphism associated with COVID-19 hospitalization. | ||
|
Sep 7
2022 |
et al., BMJ, doi:10.1136/bmj-2022-071245 | Prevention of covid-19 and other acute respiratory infections with cod liver oil supplementation, a low dose vitamin D supplement: quadruple blinded, randomised placebo controlled trial |
| 11% lower hospitalization (p=1), 20% higher severe cases (p=0.17), and no change in cases (p=0.98). RCT 17,278 low-risk patients (zero mortality) treated with 5mL/day cod liver oil (~400IU vitamin D) and 17,323 placebo patients in Norway with, showing no significant differences with treatment. The placebo group had higher vitamin D at b.. | ||
|
Sep 2
2022 |
et al., Food Science & Nutrition, doi:10.1002/fsn3.3034 | Antioxidants and clinical outcomes of patients with coronavirus disease 2019: A systematic review of observational and interventional studies |
| Systematic review showing that vitamin C, vitamin D, selenium, and zinc can improve COVID-19 clinical outcomes. | ||
|
Aug 24
2022 |
et al., Life Sciences, doi:10.1016/j.lfs.2022.120909 | Vitamin D modulates systemic inflammation in patients with severe COVID-19 |
| 36% shorter ICU admission (p=0.01). Retrospective 20 ICU patients treated with vitamin D in the UAE, and 25 matched controls, showing significantly shorter ICU stay with treatment. Lower proinflammatory cytokines were associated with lower severity markers. Authors also per.. | ||
|
Aug 15
2022 |
et al., Antioxidants, doi:10.3390/antiox11081580 | Vitamin C Deficiency in Blood Samples of COVID-19 Patients |
| Analysis of 74 COVID-19 patients and 8 controls in Germany, showing low vitamin C levels associated with mortality. There was no significant difference for vitamin A, D, or E levels. Very few group details are provided, for example the ag.. | ||
|
Aug 12
2022 |
et al., Technium BioChemMed, doi:10.47577/biochemmed.v3i2.7179 | Evaluation of the level of vitamin D3 in the blood serum of patients infected with COVID-19 in Al-Amiriya city |
| Analysis of 35 COVID-19 patients and 25 healthy controls in Iraq, showing significantly lower vitamin D levels in COVID-19 patients. | ||
|
Aug 11
2022 |
et al., The Eurasian Journal of Medicine, doi:10.5152/eurasianjmed.2022.21088 | Vitamin D Level in Laboratory Confirmed COVID-19 and Disease Progression |
| 33% lower mortality (p=0.29) and no change in severe cases (p=1). Analysis of 831 hospitalized patients in Iran, showing higher mortality with severe vitamin D deficiency, without statistical significance. | ||
|
Aug 10
2022 |
et al., Journal of King Saud University – Science, doi:10.1016/j.jksus.2022.102277 | Docking and molecular dynamics studies of human ezrin protein with a modelled SARS-CoV-2 endodomain and their interaction with potential invasion inhibitors |
| In Silico study of SARS-CoV-1&2 endodomains and ezrin docking, identifying ivermectin, quercetin, calcifediol, calcitriol, selamectin, and minocycline as potential therapeutic drugs with strong ezrin binding which may restrict viral endod.. | ||
|
Aug 9
2022 |
et al., Antibiotics, doi:10.3390/antibiotics11081078 | Factors Influencing Disease Stability and Response to Tocilizumab Therapy in Severe COVID-19: A Retrospective Cohort Study |
| 94% lower mortality (p=0.07). Retrospective 49 severe COVID-19 patients treated with tocilizumab, showing lower mortality with vitamin D treatment and a dose-dependent response. | ||
|
Aug 9
2022 |
et al., Nutrients, doi:10.3390/nu14163252 | Vitamin D Status and Mortality from SARS CoV-2: A Prospective Study of Unvaccinated Caucasian Adults |
| 78% lower mortality (p=0.006), 15% lower ICU admission (p=0.63), and 53% lower progression (p=0.12). Prospective study of 232 hospitalized COVID-19 pneumonia patients, showing higher risk of mortality with vitamin D deficiency. | ||
|
Aug 4
2022 |
et al., Journal of Tropical Pediatrics, doi:10.1093/tropej/fmac072 | The Clinical Significance of Vitamin D and Zinc Levels with Respect to Immune Response in COVID-19 Positive Children |
| 64% fewer cases (p=0.003). Prospective study of 88 pediatric COVID-19 patients and 88 healthy controls, showing significantly lower zinc and vitamin D levels in COVID-19 patients. | ||
|
Jul 31
2022 |
et al., Medical Journal of İzmir Hospital, 26:3 | Vitamin D levels and disease severity in COVID-19 |
| Retrospective 153 COVID-19 patients in Turkey, showing lower age-adjusted vitamin D levels in hospitalized patients vs. outpatients. | ||
|
Jul 31
2022 |
et al., Journal of Preventive Medicine and Public Health, doi:10.3961/jpmph.21.640 | Vitamin D Deficiency and Comorbidities as Risk Factors of COVID-19 Infection: A Systematic Review and Meta-analysis |
| Systematic review and meta analysis showing low vitamin D levels associated with COVID-19 cases. | ||
|
Jul 27
2022 |
et al., Archives of Clinical and Biomedical Research, doi:10.26502/acbr.50170273 | Effect of Short Term High Dose Oral Vitamin D Therapy on the Inflammatory Markers in Patients with COVID 19 Disease |
| 61% lower mortality (p=0.27), 22% lower ICU admission (p=0.74), and 7% shorter hospitalization (p=0.9). RCT 44 treatment and 43 control patients with vitamin D levels <30ng/ml, showing significant reduction in inflammatory markers with treatment of 60,000IU vitamin D per day for 8 days (10 days for BMI >25). Death and ICU admission was lowe.. | ||
|
Jul 26
2022 |
et al., Nutrients, doi:10.3390/nu14153073 | Association of Vitamin D Prescribing and Clinical Outcomes in Adults Hospitalized with COVID-19 |
| 9% higher mortality (p<0.0001) and 41% higher ventilation (p<0.0001). N3C retrospective showing higher risk with vitamin D treatment for hospitalized patients. As noted by authors, confounding by indication may be significant. The more extreme ventilation result, which is a significant outlier among all stu.. | ||
|
Jul 26
2022 |
et al., Nutrients, doi:10.3390/nu14153048 | Positive Effects of Vitamin D Supplementation in Patients Hospitalized for COVID-19: A Randomized, Double-Blind, Placebo-Controlled Trial |
| 45% faster recovery (p=0.06) and 50% shorter hospitalization (p=0.003). RCT with 21 vitamin D and 22 placebo hospitalized patients in Belgium with vitamin D deficiency, showing significantly shorter hospitalization and improved clinical recovery with treatment. | ||
|
Jul 25
2022 |
et al., Frontiers in Nutrition, doi:10.3389/fnut.2022.960859 | Vitamin D levels and clinical outcomes of SARS-CoV-2 Omicron subvariant BA.2 in children: A longitudinal cohort study |
| Retrospective 116 hospitalized pediatric patients in China, showing accelerated viral clearance early in the disease course, and greater pneumonia lesion improvement with vitamin D sufficiency. | ||
|
Jul 25
2022 |
et al., Frontiers in Pediatrics, doi:10.3389/fped.2022.943529 | Efficacy and safety of vitamin D supplementation in hospitalized COVID-19 pediatric patients: A randomized controlled trial |
| 79% lower mortality (p=0.11), 72% lower ventilation (p=0.08), and 73% lower ICU admission (p=0.006). RCT 45 hospitalized high-risk pediatric patients requiring supplemental oxygen in Mexico, showing lower mortality, ventilation, and intensive care with vitamin D treatment, however there were less severe and critical cases at baseline in .. | ||
|
Jul 21
2022 |
et al., Trials, doi:10.1186/s13063-023-07114-5 | Effect of vitamin D supplementation versus placebo on recovery delay among COVID-19 Tunisian patients: a randomized-controlled clinical trial |
| 8% improved recovery (p=0.85) and 58% worse viral clearance (p=0.02). Long COVID RCT with mostly asymptomatic patients that remained PCR positive for 14 days, showing slower viral conversion with treatment. Authors report “a 30-day follow-up of our patients showed that a long-lasting COVID-19 was no.. | ||
|
Jul 19
2022 |
et al., Complementary Therapies in Medicine, doi:10.1016/j.ctim.2022.102855 | Vitamin D deficiency is associated with increased risk of delirium and mortality among critically Ill, elderly covid-19 patients |
| 75% lower mortality (p=0.0007) and 45% higher ventilation (p=0.27). Prospective study of 310 COVID-19 ICU patients in Iran, showing higher mortality for patients with vitamin D deficiency. | ||
|
Jul 19
2022 |
et al., Research Square, doi:10.21203/rs.3.rs-1588325/v1 | PRevention of COVID-19 with Oral Vitamin D supplemental Therapy in Essential healthCare Teams (PROTECT): Ancillary study of a randomised controlled trial |
| 82% fewer cases (p=0.19). Early terminated prophylaxis RCT for healthcare workers in Canada, showing 0/19 cases with vitamin D prophylaxis vs. 2/15 for control. 100,000IU cholecalciferol at baseline, 10,000IU weekly for 16 weeks. | ||
|
Jul 15
2022 |
et al., medRxiv, doi:10.1101/2022.07.12.22277450 | Effect of Vitamin D3 supplementation vs. dietary-hygienic measures on SARS-COV-2 infection rates in hospital workers with 25-hydroxyvitamin D3 [25(OH)D3] levels >20 ng/mL |
| 79% fewer cases (p=0.008). RCT healthcare workers with vitamin D levels between 20-100 ng/mL, 43 treated with vitamin D 52,000 IU monthly, and 42 with dietary-hygienic measures, which were also focused on increasing vitamin D, including sun exposure for at least 10.. | ||
|
Jul 13
2022 |
et al., Research Square, doi:10.21203/rs.3.rs-1826271/v1 | Is suboptimal circulating level of vitamin D a risk factor for the poor prognosis of COVID-19? – A comparison of first and second waves in India |
| 11% lower mortality (p=0.74). Retrospective 179 hospitalized COVID-19 patients in India, showing no significant difference in mortality with vitamin D deficiency in unadjusted results. Patients with deficiency were younger. | ||
|
Jul 7
2022 |
et al., NCT04780061 | Dietary Supplements to Reduce Symptom Severity and Duration in People With SARS-CoV-2: A Randomized, Double Blind, Placebo Controlled Clinical Trial |
| 90 patient vitamin D early treatment RCT with results not reported over 1 year after completion. | ||
|
Jul 6
2022 |
et al., PLOS ONE, doi:10.1371/journal.pone.0268396 | Vitamin D and SARS-CoV2 infection, severity and mortality: A systematic review and meta-analysis |
| 65% lower mortality (p=0.004) and 62% lower severe cases (p=0.003). Systematic review showing significantly lower risk of mortality and severe cases with vitamin D supplementation, and for high vs. low vitamin D levels. | ||
|
Jul 6
2022 |
et al., Research Square, doi:10.21203/rs.3.rs-1806260/v1 | A strong association between the VDR gene markers and SARS-CoV-2 variants |
| Analysis of 300 PCR+ and 300 PCR- patients, showing COVID-19 associated with vitamin D receptor polymorphisms FokI and TaqI. Notably, these polymorphisms have been found to be associated with improved response to vitamin D supplementation.. | ||
|
Jul 5
2022 |
et al., Frontiers in Nutrition, doi:10.3389/fnut.2022.934258 | Vitamin D 25OH Deficiency and Mortality in Moderate to Severe COVID-19: A Multi-Center Prospective Observational Study |
| 15% lower mortality (p=0.29). Prospective 361 consecutive hospitalized patients in Italy, showing 77% had vitamin D deficiency. There was no statistically significant difference in mortality with deficiency. | ||
|
Jul 4
2022 |
et al., Frontiers in Pharmacology, doi:10.3389/fphar.2022.863587 | Beneficial Effect of Short-Term Supplementation of High Dose of Vitamin D3 in Hospitalized Patients With COVID-19: A Multicenter, Single-Blinded, Prospective Randomized Pilot Clinical Trial |
| 79% lower ICU admission (p=0.2) and 28% lower ARDS (p=0.74). RCT 85 hospitalized patients in Spain, comparing 10,000IU/day vs. 2,000IU/day cholecalciferol, showing beneficial effects of the larger dose. | ||
|
Jul 2
2022 |
et al., Nutrients, doi:10.3390/nu14132757 | Temporal Association of Reduced Serum Vitamin D with COVID-19 Infection: Two Single-Institution Case–Control Studies |
| Retrospective study of 107 COVID-19 patients with vitamin D levels measured within 180 days before diagnosis, and 203 patients with levels measured after diagnosis, showing lower vitamin D levels for COVID-19 hospitalized patients compare.. | ||
|
Jun 29
2022 |
et al., Nutrients, doi:10.3390/nu14132716 | Vitamin D Endocrine System and COVID-19: Treatment with Calcifediol |
| Review of the use of calcifediol for COVID-19. Authors note several advantages of calcifediol vs. cholecalciferol: calcifediol induces a more rapid increase in circulating 250HD; calcifediol is more potent than cholecalciferol; calcifedio.. | ||
|
Jun 29
2022 |
et al., Journal of General Internal Medicine, doi:10.1007/s11606-022-07701-3 | Medications Associated with Lower Mortality in a SARS-CoV-2 Positive Cohort of 26,508 Veterans |
| 47% lower mortality (p=0.0007). Retrospective 26,508 consecutive COVID+ veterans in the USA, showing lower mortality with multiple treatments including vitamin D. Treatment was defined as drugs administered ≥50% of the time within 2 weeks post-COVID+, and may be a conti.. | ||
|
Jun 26
2022 |
et al., Farmacia, doi:10.31925/farmacia.2022.3.17 | The evaluation of vitamin D deficiency as a risk factor in the case of patients with moderate COVID-19 |
| Retrospective 128 hospitalized patients in Romania, showing a negative outcome associated with lower vitamin D levels. | ||
|
Jun 23
2022 |
et al., Cureus, doi:10.7759/cureus.26266 | The Association Between Vitamin D Serum Level and COVID-19 Patients’ Outcomes in a Tertiary Center in Saudi Arabia: A Retrospective Cohort Study |
| 43% lower mortality (p=0.46) and 7% lower ICU admission (p=0.8). Retrospective 545 hospitalized patients in Saudi Arabia, showing higher mortality with vitamin D deficiency, without statistical significance. | ||
|
Jun 23
2022 |
et al., Nutrients, doi:10.3390/nu14132602 | Effect of Cholecalciferol Supplementation on the Clinical Features and Inflammatory Markers in Hospitalized COVID-19 Patients: A Randomized, Open-Label, Single-Center Study |
| 86% lower ICU admission (p=0.11) and 7% lower need for oxygen therapy (p=0.85). RCT with 56 cholecalciferol and 54 control hospitalized patients with vitamin D insufficiency or deficiency in Russia, showing positive effects on immune status. The median age in the treatment group was 7 years lower and deficiency was l.. | ||
|
Jun 17
2022 |
et al., Abstracts from the 2022 Annual Meeting of the Society of General Internal Medicine, Journal of General Internal Medicine, doi:10.1007/s11606-022-07653-8 | The effects of vitamin D therapy on outcomes for hispanic patients hospitalized for COVID-19 |
| 38% lower mortality (p=0.001). Retrospective 1,478 hospitalized Hispanic patients in the USA with 705 receiving vitamin D treatment, showing lower mortality with treatment in unadjusted results. Very minimal information is currently available. | ||
|
Jun 14
2022 |
et al., Clinical Nutrition ESPEN, doi:10.1016/j.clnesp.2022.05.027 | Vitamin D deficiency predicts 30-day hospital mortality of adults with COVID-19 |
| 57% lower mortality (p=0.05) and 20% higher ICU admission (p=0.81). Retrospective 115 hospitalized patients in Brazil, showing lower mortality with higher vitamin D levels. Adjusted results are only provided for vitamin D as a continuous variable. | ||
|
Jun 1
2022 |
et al., Abstracts Criticare – IJCCM2022, Indian J. Crit. Care Med., doi:10.5005/ijccm-26-S1-S1 | Single, High Dose Vitamin D Supplementation in Vitamin D Deficient Severe COVID-19: Randomized, Double-Blind, Placebocontrol Study (Shade-S) |
| 45% lower mortality (p=0.05). RCT 90 vitamin D deficient moderate/severe COVID-19 ARDS patients in India, showing lower mortality with vitamin D treatment. 600,000IU nanoformulation cholecalciferol. Minimal information is currently available. | ||
|
May 31
2022 |
et al., PLoS Medicine, doi:10.1371/journal.pmed.1003999 | High-dose versus standard-dose vitamin D supplementation in older adults with COVID-19 (COVIT-TRIAL): A multicenter, open-label, randomized controlled superiority trial |
| 30% lower mortality (p=0.29). RCT comparing single dose 400,000IU and single dose 50,000IU vitamin D in France, showing lower mortality with the higher dose, statistically significant only at day 14. The aHR for days 0-5 was 1.30 [0.31-5.35], compared to 0.11 [0.02-0… | ||
|
May 30
2022 |
et al., Journal of Health Sciences and Medicine, doi:10.32322/jhsm.1063405 | Correlation of vitamin D level with the clinical-radiological severity of COVID-19 in geriatric patients |
| 22% lower mortality (p=0.43) and 59% lower ICU admission (p=0.005). Retrospective 75 patients in Turkey showing lower ICU admission with vitamin D treatment in unadjusted results subject to confounding by time and indication (treatment was given to patients with low levels and only during a certain period.. | ||
|
May 30
2022 |
et al., Cureus, doi:10.7759/cureus.25467 | Efficacy and Safety of Aspirin, Promethazine, and Micronutrients for Rapid Clinical Recovery in Mild to Moderate COVID-19 Patients: A Randomized Controlled Clinical Trial |
| 89% improved recovery (p=0.05). RCT 260 patients in India, 130 treated with aspirin, promethazine, vitamin C, D, B3, zinc, and selenium, showing faster recovery with treatment. There was no hospitalization, ICU admission, or supplemental oxygen requirements in either gr.. | ||
|
May 27
2022 |
et al., Nutrients, doi:10.3390/nu14112254 | Suboptimal Consumption of Relevant Immune System Micronutrients Is Associated with a Worse Impact of COVID-19 in Spanish Populations |
| Ecological study in Spain, showing lower intake of vitamin D, A, B9, and zinc in regions with the highest COVID-19 incidence and mortality. Vitamin D intake was associated with lower prevalence, incidence, and a combined incidence+mortali.. | ||
|
May 27
2022 |
et al., PLOS ONE, doi:10.1371/journal.pone.0267918 | High-dose vitamin D versus placebo to prevent complications in COVID-19 patients: Multicentre randomized controlled clinical trial |
| 25% lower ventilation (p=0.85), 27% lower ICU admission (p=0.62), and 3% lower progression (p=0.82). Late stage RCT with 115 patients treated with a single dose of 500,000IU cholecalciferol and 103 placebo patients, showing no significant differences. Authors do not explain why they did very late treatment with cholecalciferol instead of.. | ||
|
May 22
2022 |
et al., Healthcare, doi:10.3390/healthcare10050956 | Effectiveness of Vitamin D Supplements among Patients Hospitalized for COVID-19: Results from a Monocentric Matched-Cohort Study |
| 93% lower mortality (p=0.02), 50% lower ventilation (p=0.36), 50% lower ICU admission (p=0.36), and 48% lower progression (p=0.04). Retrospective 116 patients with D levels < 30ng/mL, 58 treated with vitamin D 100,000IU daily for two days, and 58 matched controls, showing significantly lower mortality with treatment. | ||
|
May 20
2022 |
et al., Nutrients, doi:10.3390/nu14102134 | Effects of Vitamin D Supplementation on COVID-19 Related Outcomes: A Systematic Review and Meta-Analysis |
| 54% lower mortality (p=0.0004), 65% lower ICU admission (p=0.0003), and 9% fewer cases (p=0.11). Systematic review and meta analysis showing significantly lower ICU admission and mortality with vitamin D treatment. There was no significant difference for cases. | ||
|
May 16
2022 |
et al., Bratislava Medical Journal, doi:10.4149/BLL_2022_065 | Is there a relationship between vitamin D levels, inflammatory parameters, and clinical severity of COVID-19 infection? |
| 46% lower severe cases (p=0.1). Retrospective 300 hospitalized patients in Turkey with vitamin D levels measured with 6 months before admission, showing no significant difference in severity based on vitamin D deficiency. | ||
|
May 13
2022 |
et al., Obesity Medicine, doi:10.1016/j.obmed.2022.100420 | Survival analysis based on body mass index in patients with Covid-19 admitted to the intensive care unit of Amir Al-Momenin Hospital in Arak – 2021 |
| 26% higher mortality (p=0.4). Retrospective 193 ICU patients in Iran, showing no significant difference with vitamin D treatment. | ||
|
May 13
2022 |
et al., Mechanisms of Ageing and Development, doi:10.1016/j.mad.2022.111684 | Association between vitamin D status and physical performance in COVID-19 survivors: Results from the Gemelli against COVID-19 post-acute care project |
| Analysis of 681 COVID-19 survivors in Italy, showing a high prevalence of vitamin D deficiency. Low vitamin D levels were associated with poor physical performance, and were more common in patients that had been hospitalized. | ||
|
May 11
2022 |
et al., Pakistan Journal of Medical and Health Sciences, doi:10.53350/pjmhs221631053 | Protective Effect of Vitamin-D Supplementation in Patients of Acute Coronary Syndrome During COVID-19 Pandemic |
| 89% fewer symptomatic cases (p=0.11). Prospective study of 40 acute coronary syndrome patients in Pakistan, 20 given a single dose of 200,000IU vitamin D, showing lower incidence of COVID-19 in the following 2 months. | ||
|
May 7
2022 |
et al., BMC Infectious Diseases, doi:10.1186/s12879-022-07438-8 | Comparison of the cardiovascular system, clinical condition, and laboratory results in COVID-19 patients with and without vitamin D insufficiency |
| 76% lower mortality (p=0.26) and 5% higher severe cases (p=1). Retrospective 202 hospitalized COVID-19 patients in Iran, showing no significant difference in outcomes based on vitamin D levels. | ||
|
May 5
2022 |
et al., AJRCCM Conference | Vitamin D Deficiency and Thrombosis in Hospitalized SARS-CoV-2 Patients with Suspected Pulmonary Embolism |
| 73% lower mortality (p=0.02) and 67% lower ICU admission (p=0.001). Retrospective 208 hospitalized COVID+ patients in the USA, showing vitamin D deficiency associated with higher mortality and ICU admission. | ||
|
May 3
2022 |
et al., PLOS ONE, doi:10.1371/journal.pone.0268038 | 25-hydroxyvitamin D is a predictor of COVID-19 severity of hospitalized patients |
| 81% lower mortality (p=0.008), 53% lower ventilation (p=0.13), and 74% higher hospital discharge (p<0.0001). Retrospective 88 COVID-19 hospitalized patients and 122 controls, showing higher mortality, ventilation, and length of stay with vitamin D deficiency. | ||
|
May 1
2022 |
et al., Frontiers in Pharmacology, doi:10.3389/fphar.2022.898062 | Oral Co-Supplementation of Curcumin, Quercetin, and Vitamin D3 as an Adjuvant Therapy for Mild to Moderate Symptoms of COVID-19—Results From a Pilot Open-Label, Randomized Controlled Trial |
| 33% improved recovery (p=0.15) and 50% improved viral clearance (p=0.009). RCT 50 COVID+ outpatients in Pakistan, 25 treated with curcumin, quercetin, and vitamin D, showing significantly faster viral clearance, significantly improved CRP, and faster resolution of acute symptoms (p=0.154). 168mg curcumin, 260mg .. | ||
|
Apr 30
2022 |
et al., Nutrients, doi:10.3390/nu14091862 | Prevalence of Micronutrient Deficiencies in Patients Hospitalized with COVID-19: An Observational Cohort Study |
| 23% lower combined mortality/ICU admission (p=0.55). Prospective study of 57 consecutive hospitalized COVID-19 patients in Switzerland, showing higher risk of mortality/ICU admission with vitamin A, vitamin D, and zinc deficiency, with statistical significance only for vitamin A and zinc. A.. | ||
|
Apr 26
2022 |
et al., International Journal of Pharmaceutical and Clinical Research, 14:5 | The Effect of Vitamin B12, Magnesium and Vitamin D in COVID-19 among Geriatric Patients |
| 87% lower ICU admission (p=0.09) and 38% shorter hospitalization (p<0.0001). Prospective study of 30 patients treated with vitamin D, magnesium, and vitamin B12, and 25 control patients, showing shorter hospitalization and lower oxygen and ICU requirements with treatment. Cholecalciferol 1000IU, magnesium oxide 15.. | ||
|
Apr 26
2022 |
et al., Southern African Journal of Infectious Diseases, doi:10.4102/sajid.v37i1.359 | Vitamin D status and COVID-19 severity |
| 60% fewer symptomatic cases (p<0.0001). Prospective study of 100 COVID-19 patients in South Africa, 50 with COVID-19 pneumonia and 50 asymptomatic, showing higher risk of symptomatic COVID-19 with vitamin D deficiency and with lower exposure to sunlight. Authors analyzed sunlig.. | ||
|
Apr 20
2022 |
et al., Informatics in Medicine Unlocked, doi:10.1016/j.imu.2022.100951 | Unravelling Vitamin B12 as a potential inhibitor against SARS-CoV-2: A computational approach |
| In Silico study showing significant interaction with SARS-CoV-2 targets for multiple vitamins. | ||
|
Apr 20
2022 |
et al., European Journal of Translational Myology, doi:10.4081/ejtm.2022.10453 | Association of vitamin D and severity of COVID-19 in children |
| Analysis of 99 pediatric COVID-19 cases in Iran, mean age 2.9, showing severity associated with vitamin D levels. | ||
|
Apr 18
2022 |
et al., Archives of Medical Research, doi:10.1016/j.arcmed.2022.04.003 | Efficacy and Safety of Vitamin D Supplementation to Prevent COVID-19 in Frontline Healthcare Workers. A Randomized Clinical Trial |
| 78% fewer cases (p=0.001). RCT 321 healthcare workers in Mexico, showing significantly lower SARS-CoV-2 infection with vitamin D prophylaxis. 4,000IU daily for 30 days. In comparison to [Jolliffe], this study used a higher dose, the participants had much higher exp.. | ||
|
Apr 14
2022 |
et al., Biomedicine & Pharmacotherapy, doi:10.1016/j.biopha.2022.112965 | Changes in the immune response against SARS-CoV-2 in individuals with severe COVID-19 treated with high dose of vitamin D |
| 28% lower ARDS (p=0.74) and 31% shorter hospitalization. RCT comparing 41 patients treated with 10,000IU/day cholecalciferol and 44 treated with 2,000IU/day in Spain, showing significantly shorter hospitalization for ARDS patients with the higher dose. There was also an increase of anti-inflamm.. | ||
|
Apr 14
2022 |
et al., Nutrients, doi:10.3390/nu14081641 | Vitamin D and COVID-19 Severity in Hospitalized Older Patients: Potential Benefit of Prehospital Vitamin D Supplementation |
| 50% lower mortality (p=0.11), 51% lower ICU admission (p=0.008), and 39% lower severe cases (p=0.01). Retrospective 228 hospitalized COVID-19 patients, median age 78, showing significantly lower risk of ICU admission and severe cases with vitamin D prophylaxis. NCT04877509. | ||
|
Apr 9
2022 |
et al., Clinical Nutrition ESPEN, doi:10.1016/j.clnesp.2022.04.003 | Association between 25-hydroxyvitamin D levels and COVID-19 severity |
| Retrospective 117 consecutive COVID+ hospitalized patients in Japan, showing lower vitamin D levels associated with mechanical ventilation or mortality. | ||
|
Apr 5
2022 |
et al., Scientific Reports, doi:10.1038/s41598-022-09785-7 | Relationship of anti-SARS-CoV-2 IgG antibodies with Vitamin D and inflammatory markers in COVID-19 patients |
| Prospective study of 69 COVID+ patients in Kosovo, showing lower vitamin D levels associated with COVID-19 severity. | ||
|
Mar 31
2022 |
et al., Gaceta Médica de México, doi:10.24875/GMM.M22000637 | Evaluation of the usefulness of vitamin D as a predictor of mortality in patients with COVID-19 |
| 52% lower mortality (p=0.04). Retrospective 154 consecutive COVID-19 patients in Mexico, showing low vitamin D levels associated with higher mortality. | ||
|
Mar 29
2022 |
et al., Frontiers in Medicine, doi:10.3389/fmed.2022.843737 | Vitamin D Status in Relation to the Clinical Outcome of Hospitalized COVID-19 Patients |
| 98% lower mortality (p=0.02). Retrospective 126 hospitalized COVID-19 patients in the UAE, showing vitamin D deficiency associated with mortality. | ||
|
Mar 26
2022 |
et al., International Journal of Environmental Research and Public Health, doi:10.3390/ijerph19073965 | Serum 25(OH) Vitamin D Levels in Pregnant Women with Coronavirus Disease 2019 (COVID-19): A Case-Control Study |
| 63% fewer cases (p=0.01). Retrospective 256 pregnant women, 82 with COVID-19 and 174 controls, showing significantly lower vitamin D levels for COVID-19 patients. | ||
|
Mar 23
2022 |
et al., European Journal of Clinical Nutrition, doi:10.1038/s41430-022-01095-5 | Low serum levels of zinc and 25-hydroxyvitmain D as potential risk factors for COVID-19 susceptibility: a pilot case-control study |
| 42% fewer cases (p=0.09). Case control study with 90 COVID-19 cases and 95 matched controls in Iran, showing significantly lower vitamin D levels for cases. | ||
|
Mar 23
2022 |
et al., BMJ, doi:10.1136/bmj-2022-071230 (date from preprint) | Effect of a test-and-treat approach to vitamin D supplementation on risk of all cause acute respiratory tract infection and covid-19: phase 3 randomised controlled trial (CORONAVIT) |
| 41% higher hospitalization (p=0.16) and 9% more cases (p=0.55). RCT 5,979 low risk patients (0 COVID-19 deaths) in the UK, showing no significant differences with vitamin D prophylaxis. CORONAVIT. NCT04579640. For more discussion see [ reddit.com , twitter.com ] . 51% of confirmed COVID-19 cases were .. | ||
|
Mar 16
2022 |
et al., Journal of Communicable Diseases, doi:10.24321/0019.5138.202227 | Vitamin D Levels and its Association with Inflammatory Markers, Severity and Outcome in Hospitalised COVID-19 Patients – An Indian Perspective |
| 93% lower severe cases (p<0.0001). Retrospective 209 hospitalized patients in India, showing vitamin D deficiency associated with COVID-19 severity. | ||
|
Mar 10
2022 |
et al., International Journal of Molecular Sciences, doi:10.3390/ijms23062995 | Micronutrient Improvement of Epithelial Barrier Function in Various Disease States: A Case for Adjuvant Therapy |
| Review of epithelial and endothelial barrier compromise and associated disease risk including COVID-19, and the potential benefits of vitamin A, vitamin D, and zinc for improving barrier function. | ||
|
Mar 7
2022 |
et al., The International Arabic Journal of Antimicrobial Agents, doi:10.3823/862 | The Effect of Vitamin D treatment on COVID 19- Patients, an Inverted Propensity Score Weighting (IPSW), and Inverted Probability of Treatment Weighting (IPTW) Analyzed Study |
| Retrospective study comparing 847 patients receiving ≤149,000IU vitamin D and 170 receiving ≥150,000IU, showing no significant differences, however the result may not be very meaningful – membership in the higher cumulative dose group req.. | ||
|
Mar 2
2022 |
et al., Pharmaceuticals, doi:10.3390/ph15030305 | Vitamin D Status and Immune Response in Hospitalized Patients with Moderate and Severe COVID-19 |
| 22% lower severe cases (p=0.01). Retrospective 331 hospitalized patients in Russia, showing lower risk of severe cases with higher vitamin D levels. | ||
|
Feb 28
2022 |
et al., Tropical Journal of Pharmaceutical Research, doi:10.4314/tjpr.v21i2.13 | Immune-boosting effect of natural remedies and supplements on progress of, and recovery from COVID-19 infection |
| 46% lower severe cases (p=0.2). Retrospective survey-based analysis of 349 COVID-19 patients, showing a lower risk of severe cases with vitamin D, zinc, turmeric, and honey prophylaxis in unadjusted analysis, without statistical significance. REC/UG/2020/03. | ||
|
Feb 28
2022 |
et al., Bosnian Journal of Basic Medical Sciences, doi:10.17305/bjbms.2021.7009 | The impact of vitamin and mineral supplements usage prior to COVID-19 infection on disease severity and hospitalization |
| 33% lower hospitalization (p=0.001) and 29% lower severe cases (p=0.01). Retrospective 2,148 COVID-19 recovered patients in Jordan, showing lower risk of severity and hospitalization with vitamin D prophylaxis. | ||
|
Feb 24
2022 |
et al., Nutrición Hospitalaria, doi:10.20960/nh.03731 | Severe COVID-19 patients have severe vitamin D deficiency in Northeast Mexico |
| 39% lower severe cases (p=0.05). Retrospective 181 diagnostic center patients and 116 ICU patients in Mexico, showing higher risk of severity with vitamin D levels <10ng/mL. | ||
|
Feb 24
2022 |
et al., Journal of Clinical Medicine Research, doi:10.14740/jocmr4658 | “MATH+” Multi-Modal Hospital Treatment Protocol for COVID-19 Infection: Clinical and Scientific Rationale |
| Review of the data supporting the MATH+ hospital treatment protocol for COVID-19. | ||
|
Feb 22
2022 |
et al., Viruses, doi:10.3390/v14030451 | Angiotensin Converting Enzyme Inhibitors May Increase While Active Vitamin D May Decrease the Risk of Severe Pneumonia in SARS-CoV-2 Infected Patients with Chronic Kidney Disease on Maintenance Hemodialysis |
| 45% lower severe cases (p=0.02). Retrospective 85 COVID+ hemodialysis patients in Poland, showing lower severity with existing vitamin D use. Patients in this study are also analyzed in [Tylicki]. | ||
|
Feb 21
2022 |
et al., The Egyptian Journal of Internal Medicine, doi:10.1186/s43162-022-00116-w | Cholecalciferol level and its impact on COVID-19 patients |
| Prospective study of 414 COVID+ ICU patients in Egypt, showing mortality associated with lower vitamin D levels. | ||
|
Feb 19
2022 |
et al., Cureus, doi:10.7759/cureus.22385 | The Relationship Between Vitamin D Status and the Clinical Severity of COVID-19 Infection: A Retrospective Single-Center Analysis |
| 18% lower progression (p=0.26) and 38% shorter hospitalization (p=0.16). Retrospective 71 hospitalized COVID-19 patients in Greece with vitamin D levels measured within 48 hours of admission, showing longer hospitalization, more radiographic findings, and higher inflammatory and cellular damage markers with vi.. | ||
|
Feb 19
2022 |
et al., Irish Journal of Medical Science (1971 -), doi:10.1007/s11845-022-02952-9 | A combined role for low vitamin D and low albumin circulating levels as strong predictors of worse outcome in COVID-19 patients |
| 64% lower progression (p=0.03). Prospective study of 69 hospitalized COVID-19 pneumonia patients, showing higher risk of combined NIV/IMV/60-day death with low vitamin D levels. | ||
|
Feb 18
2022 |
et al., BMC Medicine, doi:10.1186/s12916-022-02290-8 | A single-oral bolus of 100,000 IU of cholecalciferol at hospital admission did not improve outcomes in the COVID-19 disease: the COVID-VIT-D — a randomised multicentre international clinical trial |
| 44% higher mortality (p=0.31), 5% higher ICU admission (p=0.82), and 5% longer hospitalization. RCT 274 very late stage (>80% pulmonary involvement at baseline) hospitalized COVID-19 patients treated with a single dose of cholecalciferol, and 269 control patients, showing no significant differences. High serum calcidiol levels at ad.. | ||
|
Feb 17
2022 |
et al., BMC Geriatrics, doi:10.1186/s12877-022-02776-3 | Chronic diseases, chest computed tomography, and laboratory tests as predictors of severe respiratory failure and death in elderly Brazilian patients hospitalized with COVID-19: a prospective cohort study |
| 22% lower mortality (p=0.61) and 31% lower progression (p=0.26). Prospective study of 201 COVID+ hospitalized adults in Brazil, mean age 73, showing a lower risk of mortality and respiratory failure with vitamin D supplementation in unadjusted results, without statistical significance, and a higher ris.. | ||
|
Feb 15
2022 |
et al., QJM: An International Journal of Medicine, doi:10.1093/qjmed/hcac040 | Does vitamin D supplementation reduce COVID-19 severity? – a systematic review |
| 52% lower mortality (p<0.0001), 46% lower ventilation (p<0.0001), and 64% lower ICU admission (p<0.0001). Meta-analysis of seven systematic reviews showing that vitamin D supplementation reduces the risk of COVID-19 mortality, ventilation, and ICU admission. Authors note that oral and IV supplements were well tolerated, safe, and effective. | ||
|
Feb 8
2022 |
et al., International Journal of Environmental Research and Public Health, doi:10.3390/ijerph19031901 | The Impact of Vitamin D Status on COVID-19 Severity among Hospitalized Patients in the Western Region of Saudi Arabia: A Retrospective Cross-Sectional Study |
| 32% lower ventilation (p=0.27) and 4% lower ICU admission (p=0.87). Retrospective 197 hospitalized patients in Saudi Arabia, showing no significant differences based on vitamin D levels. Adjusted results are provided only for vitamin D as a continuous variable. | ||
|
Feb 5
2022 |
et al., Nutrition, doi:10.1016/j.nut.2022.111899 (date from preprint) | REsCue Trial: Randomized Controlled Clinical Trial with Extended-Release Calcifediol in Symptomatic COVID-19 Outpatients |
| 34% improved recovery (p=0.56). Small RCT with low-risk patients in Florida, USA, showing no significant differences in overall recovery. Minimal details on outcomes are provided in the preprint. Authors note significantly faster resolution of respiratory symptoms when .. | ||
|
Feb 2
2022 |
et al., Nutrients, doi:10.3390/nu14030639 | A Narrative Review of the Evidence for Variations in Serum 25-Hydroxyvitamin D Concentration Thresholds for Optimal Health |
| Review of the benefits of vitamin D for cardiovascular disease, hypertension, cancer, type 2 diabetes, and COVID-19. Authors conclude that optimal levels are above 30ng/mL for cardiovascular disease and all-cause mortality, whereas the th.. | ||
|
Jan 31
2022 |
et al., International Journal of General Medicine, doi:10.2147/ijgm.s346169 | The Impact of Vitamin D Level on the Severity and Outcome of Hospitalized Patients with COVID-19 Disease |
| 39% lower mortality (p=0.5), 31% lower ventilation (p=0.51), and 42% lower ICU admission (p=0.2). Retrospective 203 hospitalized COVID-19 patients in Saudi Arabia, showing no significant difference in outcomes with vitamin D deficiency. | ||
|
Jan 31
2022 |
et al., Gerontology, doi:10.1159/000521412 | Frail Older Adults with Presymptomatic SARS-CoV-2 Infection: Clinical Course and Prognosis |
| 30% lower combined mortality/hospitalization (p=0.05). Retrospective 849 COVID-19+ patients in skilled nursing homes, showing lower risk of combined hospitalization/death with vitamin D prophylaxis, very close to statistical significance. | ||
|
Jan 31
2022 |
et al., The American Journal of Clinical Nutrition, doi:10.1093/ajcn/nqac027 | Vitamin D, D-binding protein, free vitamin D and COVID-19 mortality in hospitalized patients |
| 27% lower mortality (p=0.12). Retrospective 427 hospitalized COVID-19 patients in the United Kingdom, showing lower mortality with vitamin D supplementation (p=0.12), and higher mortality with both low and high vitamin D levels compared to a reference range of 50-74 n.. | ||
|
Jan 29
2022 |
et al., Mediterranean Journal of Nutrition and Metabolism, doi:10.3233/MNM-211521 | The difference in the dietary inflammatory index, functional food, and antioxidants intake between COVID -19 patients and healthy persons |
| Retrospective dietary survey analysis of 500 COVID-19 patients and 500 healthy matched controls in Iran, showing that COVID-19 patients had lower daily consumption of vitamin C, vitamin D, vitamin E, zinc, and selenium. IR.ARUMS.REC.1400… | ||
|
Jan 27
2022 |
et al., Journal of Medical Virology, doi:10.1002/jmv.27606 | Oxidative stress status and vitamin D levels of asymptomatic to mild symptomatic COVID-19 infections during the third trimester of pregnancy: A retrospective study in Metz, France |
| Retrospective 15 COVID+ pregnant women and 20 healthy controls in France, showing that all COVID+ patients were vitamin D deficient, and vitamin D levels were significantly lower in symptomatic patients compared to controls or asymptomati.. | ||
|
Jan 24
2022 |
et al., Nutrients, doi:10.3390/nu14030505 | Vitamin D Intake May Reduce SARS-CoV-2 Infection Morbidity in Health Care Workers |
| 95% fewer symptomatic cases (p=0.002) and 42% fewer cases (p=0.1). Small RCT in Russia with 45 high dose vitamin D patients (50,000IU/wk for 2 wks followed by 5,000IU/day) and 46 low dose patients (2,000IU/day), showing lower cases and lower symptomatic cases with high dose treatment. | ||
|
Jan 24
2022 |
et al., Frontiers in Immunology, doi:10.3389/fimmu.2021.745713 | Is There a Crucial Link Between Vitamin D Status and Inflammatory Response in Patients With COVID-19? |
| 36% lower ARDS (p=0.43). Retrospective 93 COVID-19 pneumonia patients in Italy, showing low vitamin D levels associated with severe ARDS, and significantly lower vitamin D levels for non-survivors. | ||
|
Jan 22
2022 |
et al., International Journal of Infectious Diseases, doi:10.1016/j.ijid.2022.01.044 | COVID-19 pneumonia patients with 25(OH)D levels lower than 12 ng/ml are at increased risk of death |
| 19% lower mortality (p=0.05). Retrospective 357 COVID-19 pneumonia patients in Slovakia, showing higher mortality with vitamin D deficiency (<12ng/mL). All patients received vitamin D supplementation in hospital. In multivariable linear regression, vitamin D levels we.. | ||
|
Jan 15
2022 |
et al., Diabetes/Metabolism Research and Reviews, doi:10.1002/dmrr.3517 | The effect of vitamin D supplementation on mortality and intensive care unit admission of COVID-19 patients. A systematic review, meta-analysis and meta-regression |
| 40% lower mortality (p=0.11) and 67% lower ICU admission (p=0.005). Systematic review and meta analysis of 10 vitamin D studies showing lower mortality, and ICU admission with treatment, statistically significant only for ICU admission. | ||
|
Jan 15
2022 |
et al., Gene Reports, doi:10.1016/j.genrep.2022.101509 | Serum levels of vitamin D and immune system function in patients with COVID-19 admitted to intensive care unit |
| Analysis of 50 COVID-19 ICU patients and 50 healthy controls in Iran, showing significantly lower vitamin D levels in COVID-19 patients. | ||
|
Jan 13
2022 |
et al., Scientific Reports, doi:10.1038/s41598-022-04778-y | The impact of calcitriol and estradiol on the SARS-CoV-2 biological activity: a molecular modeling approach |
| In Silico study predicting that calcitriol and estradiol disrupt the interaction between the SARS-CoV-2 spike protein and ACE2. Authors note that calcitriol may be more effective in the presence of estradiol. | ||
|
Jan 13
2022 |
et al., Nutrients, doi:10.3390/nu14020317 | Vitamin D Status and SARS-CoV-2 Infection in a Cohort of Kidney Transplanted Patients |
| 33% fewer cases (p=0.21). Retrospective 61 COVID+ kidney transplant patients and 122 matched controls, showing significantly lower vitamin D levels in COVID+ patients, and lower cases with vitamin D supplementation, without statistical significance. | ||
|
Jan 7
2022 |
et al., BioMetals, doi:10.1007/s10534-021-00355-48 | Essential metals, vitamins and antioxidant enzyme activities in COVID-19 patients and their potential associations with the disease severity |
| Prospective study of 155 COVID-19 patients in Saudi Arabia, showing that 68% of patients were vitamin D deficient (<20.05 μg/L). Vitamin D levels were not significantly different between the asymptomatic (mean 10.9 μg/L), mild (14.2 μg/L).. | ||
|
Jan 6
2022 |
et al., Journal of Clinical Medicine, doi:10.3390/jcm11020285 | Predictors of Mortality in Hemodialyzed Patients after SARS-CoV-2 Infection |
| 14% lower mortality (p=0.61). Retrospective 133 COVID+ hemodialysis patients in Poland, showing lower mortality with existing vitamin D use, without statistical significance. | ||
|
Jan 1
2022 |
et al., Journal of General Internal Medicine, doi:10.1007/s11606-021-07170-0 | Association of Vitamin D Status and COVID-19-Related Hospitalization and Mortality |
| 45% lower mortality (p=0.001) and 22% lower hospitalization (p=0.01). Retrospective 4,599 COVID+ veterans in the USA with vitamin D levels measured 15 to 90 days prior to testing positive, showing a significant independent inverse dose-response relationship between vitamin D levels (from 15 to 60ng/mL) and .. | ||
|
Jan 1
2022 |
et al., Journal of Contemporary Medicine, doi:10.16899/jcm.990057 | Does Vitamin D Supplementation Reduce Cytokine Storm and Mortality in Geriatric Intensive Care Patients Diagnosed with COVID-19 |
| 23% lower mortality (p=0.26), 3% lower ventilation (p=1), 20% improved recovery (p=0.13), and 10% shorter ICU admission (p=0.44). Retrospective 80 elderly ICU patients in Turkey, 40 with vitamin D levels <30ng/ml received vitamin D treatment, showing no significant differences in outcomes. Although not statistically significant, results favored treatment which sugge.. | ||
|
Dec 31
2021 |
et al., Nat. Volatiles & Essent. Oils, 8:4 | Vitamin D Serum Levels and Its Association With COVID 19 Infection In Babylon Governorate, Iraq |
| Analysis of 120 COVID-19 and 120 control patients in Iraq, showing significantly lower vitamin D levels for COVID-19 patients. | ||
|
Dec 31
2021 |
et al., International Journal of Environmental Research and Public Health, doi:10.3390/ijerph19010447 | The Interaction of Vitamin D and Corticosteroids: A Mortality Analysis of 26,508 Veterans Who Tested Positive for SARS-CoV-2 |
| 49% lower mortality (p=0.1). Retrospective 26,508 COVID+ veterans in USA, showing lower mortality with vitamin D use after testing positive (defined as being administered ≥7 days or half of the survival time within 2 weeks after testing), with statistical significanc.. | ||
|
Dec 29
2021 |
et al., European Journal of Medical and Health Sciences, doi:10.24018/ejmed.2021.3.6.1159 | Coronavirus in HIP Fractures CHIP 2: Is Vitamin D Deficiency Associated with Increased Mortality from COVID-19 Infections in A Hip Fracture Population? |
| 9% lower mortality (p=0.67). Retrospective 517 hip fracture patients in the UK with vitamin D levels measured during COVID-19 admission, not showing significant differences in mortality for supplementation in unadjusted analysis with no group details and subject to c.. | ||
|
Dec 28
2021 |
et al., Research Square, doi:10.21203/rs.3.rs-1193578/v1 | Characteristics of the COVID-19 patients treated at Gulu Regional Referral Hospital, Northern Uganda: A cross-sectional study |
| 97% lower mortality (p=0.02). Retrospective COVID+ hospitalized patients in Uganda, 23 patients receiving vitamin D treatment, showing significantly lower mortality with treatment. | ||
|
Dec 22
2021 |
et al., Frontiers in Public Health, doi:10.3389/fpubh.2021.736665 | Vitamin D Status and SARS-CoV-2 Infection and COVID-19 Clinical Outcomes |
| Meta analysis concluding that “patients with low vitamin D levels present an increased risk of ARDS requiring admission to intensive care unit (ICU) or mortality due to SARS-CoV-2 infection and a higher susceptibility to SARS-CoV-2 i.. | ||
|
Dec 10
2021 |
et al., European Journal of Medical and Health Sciences, doi:10.24018/ejmed.2021.3.6.1131 | Vitamin D Levels among Hospitalized and Non-Hospitalized COVID-19 Patients in Dr. M. Djamil General Hospital Padang |
| 26% lower hospitalization (p=0.59). Case control study in Indonesia with 31 moderate to critical hospitalized COVID-19 patients, and 31 asymptomatic or mild non-hospitalized COVID-19 patients, showing lower vitamin D levels in the hospitalized patients, without reaching sta.. | ||
|
Dec 3
2021 |
et al., The American Journal of Clinical Nutrition, doi:10.1093/ajcn/nqab389 | Associations between predicted vitamin D status, vitamin D intake, and risk of SARS-CoV-2 infection and Coronavirus Disease 2019 severity |
| 49% lower hospitalization (p=0.04), 7% more symptomatic cases (p=0.25), and 17% fewer cases (p=0.07). Analysis of 39,915 patients with 1,768 COVID+ cases based on surveys in the Nurses’ Health Study II, showing higher predicted vitamin D levels associated with lower risk of COVID-19 cases. There was significantly lower risk of hospitaliza.. | ||
|
Nov 30
2021 |
et al., Acute and Critical Care, doi:10.4266/acc.2021.00605 | Association of vitamin D deficiency with COVID-19 severity and mortality in Iranian people: a prospective observational study |
| 42% lower mortality (p=0.07) and 38% lower severe cases (p=0.007). Prospective study of 248 hospitalized COVID+ patients in Iran with vitamin D levels measured in the previous year and again at admission, showing vitamin D status associated with severity and mortality. | ||
|
Nov 30
2021 |
et al., Indian Journal of Clinical Practice, 32:6 | Correlation of Vitamin D Levels with COVID-19 Severity and Outcome |
| 90% lower mortality (p<0.0001) and 90% lower ventilation (p<0.0001). Prospective study of 81 hospitalized COVID+ patients in India, showing low vitamin D levels associated with COVID-19 severity and mortality. | ||
|
Nov 29
2021 |
et al., Journal of Research in Medical Sciences, doi:10.4103/jrms.JRMS_1151_20 | Serum level of Vitamin D is associated with COVID-19 mortality rate in hospitalized patients |
| 42% lower mortality (p=0.07). Retrospective 317 COVID-19 hospitalized patients in Iran, showing mortality associated with lower vitamin D levels. | ||
|
Nov 24
2021 |
et al., Clinical Nutrition ESPEN, doi:10.1016/j.clnesp.2021.11.025 | COVID-19 mortality is associated with low Vitamin D levels in patients with risk factors and/or advanced age |
| Retrospective 257 hospitalized patients in Hungary, showing mortality associated with lower vitamin D levels for all patients, for patients >60, and for age-matched patients with risk factors or age >60. The non-age-matched analyses are c.. | ||
|
Nov 23
2021 |
et al., BioMed Research International, doi:10.1155/2021/1676914 | Factors Affecting the Incidence, Progression, and Severity of COVID-19 in Type 1 Diabetes Mellitus |
| Retrospective type 1 diabetes patients in Saudi Arabia showing that mean vitamin D levels were significantly lower in type 1 diabetes patients with COVID-19 than in type 1 diabetes patients without COVID-19, or in a control group of patie.. | ||
|
Nov 23
2021 |
et al., The Journal of Maternal-Fetal & Neonatal Medicine, doi:10.1080/14767058.2021.2005564 | Correlation between 25-hydroxy vitamin D levels and COVID-19 severity in pregnant women: a cross-sectional study |
| 47% lower severe cases (p=0.006). Prospective study of 403 pregnant COVID+ hospitalized women in Turkey, showing higher risk of severe disease or poor prognostic factors with vitamin D deficiency. | ||
|
Nov 21
2021 |
et al., medRxiv, doi:10.1101/2021.11.18.21266489 | Causal Inference and COVID-19 Nursing Home Patients: Identifying Factors That Reduced Mortality Risk |
| 10% lower mortality (p=0.28). Retrospective causal inference analysis of 4,091 COVID+ long-term care high risk patients in the USA, showing lower mortality with vitamin D, without statistical significance. | ||
|
Nov 21
2021 |
et al., Acta Medica Iranica, doi:10.18502/acta.v59i11.7779 | Vitamin D Insufficiency in Disease Severity and Prognosis of the Patients With SARS Corona Virus-2 Infection |
| 73% lower mortality (p=0.03) and 66% lower progression (p=0.02). Retrospective 98 moderate/severe hospitalized COVID-19+ patients in Iran, showing significantly increased risk of mortality and severity with vitamin D deficiency. IR.AJAUMS.REC.1399.060. | ||
|
Nov 15
2021 |
et al., Global Journal of Health Science, doi:10.5539/gjhs.v14n1p1 | Vitamin D, Zinc and Iron in Adult Patients with Covid-19 and Their Action in the Immune Response as Biomarkers |
| 46% fewer cases (p=0.16). Retrospective 13 COVID-19 patients and 7 controls in Brazil, showing higher prevalence of vitamin D deficiency for COVID-19 cases, without statistical significance. | ||
|
Nov 14
2021 |
et al., Trials, doi:10.1186/s13063-021-05795-4 | The effect of supplementation with vitamins A, B, C, D, and E on disease severity and inflammatory responses in patients with COVID-19: a randomized clinical trial |
| 89% lower mortality (p=0.11), 41% lower hospitalization (p=0.25), and 45% improved recovery (p=0.001). Small RCT 60 ICU patients in Iran, 30 treated with vitamins A, B, C, D, and E, showing significant improvement in SOFA score and several inflammatory markers at day 7 with treatment. 5,000 IU vitamin A daily, 600,000 IU vitamin D once, 30.. | ||
|
Nov 12
2021 |
et al., Transplantation Proceedings, doi:10.1016/j.transproceed.2021.08.060 | Risk of severe COVID-19 infection in kidney transplant recipients |
| Retrospective 63 COVID+ kidney transplant recipients, showing significantly lower vitamin D levels before infection in patients requiring ICU admission. | ||
|
Nov 12
2021 |
et al., Nutrients, doi:10.3390/nu13114047 | Rapid and Effective Vitamin D Supplementation May Present Better Clinical Outcomes in COVID-19 (SARS-CoV-2) Patients by Altering Serum INOS1, IL1B, IFNg, Cathelicidin-LL37, and ICAM1 |
| 21% lower hospitalization (p=0.11). Retrospective 867 hospitalized COVID-19 patients in Turkey, showing worse outcomes with vitamin D deficiency (without statistical significance); followed by a prospective study of 210 patients with vitamin D supplementation for those that.. | ||
|
Nov 10
2021 |
et al., Am. J. Trop. Med. Hyg., doi:10.4269/ajtmh.21-0577 | Evaluation of Vitamin-D Status and Its Association with Clinical Outcomes Among COVID-19 Patients in Pakistan |
| 53% lower mortality (p=0.05), 19% lower ventilation (p=0.32), and 33% lower ICU admission (p=0.54). Retrospective 91 hospitalized patients in Pakistan, showing vitamin D deficiency associated with mortality in multivariate Cox regression. | ||
|
Nov 3
2021 |
et al., Nutrients, doi:10.3390/nu13113932 | Vitamin D Serum Levels in Subjects Tested for SARS-CoV-2: What Are the Differences among Acute, Healed, and Negative COVID-19 Patients? A Multicenter Real-Practice Study |
| Analysis of 117 patients in Italy, showing COVID-19 patients had significantly lower vitamin D levels than control patients. | ||
|
Nov 2
2021 |
et al., Redox Report, doi:10.1080/13510002.2021.1999126 | Vitamin D levels and oxidative stress markers in patients hospitalized with COVID-19 |
| 59% lower severe cases (p=0.13). Retrospective 33 COVID-19 hospitalized patients in North Macedonia, showing significantly lower vitamin D levels for severe vs. moderate cases. Oxidative stress was also higher for vitamin D insufficient patients. | ||
|
Oct 25
2021 |
et al., International Journal of Environmental Research and Public Health, doi:10.3390/ijerph19031172 (date from preprint) | Effect of a Nutritional Support System to Increase Survival and Reduce Mortality in Patients with COVID-19 in Stage III and Comorbidities: A Blinded Randomized Controlled Clinical Trial |
| 86% lower mortality (p=0.03) and 57% lower ventilation (p=0.31). 80 patient RCT with 40 patients treated with a comprehensive regimen of nutritional support, showing significantly lower mortality with treatment. Treatment contained cholecalciferol, vitamin C, zinc, spirulina maxima, folic acid, glutami.. | ||
|
Oct 22
2021 |
et al., BMJ Open, doi:10.1136/bmjopen-2021-055435 | Vitamin D insufficiency in COVID-19 and influenza A, and critical illness survivors: a cross-sectional study |
| 68% lower mortality (p=0.005) and 66% lower ventilation (p=0.004). Analysis of 259 hospitalized COVID-19 patients in the UK, showing a majority of patients had vitamin D deficiency/insufficiency, which was associated with poor outcomes. Both free and total 25(OH)D were analyzed with consistent results… | ||
|
Oct 20
2021 |
et al., Nutrients, doi:10.3390/nu13113680 | Associations between Genetic Variants in the Vitamin D Metabolism Pathway and Severity of COVID-19 among UAE Residents |
| 68% lower severe cases (p=0.0007). Retrospective 646 COVID-19 patients in the UAE, showing significant associations between genetic determinants of vitamin D metabolism and COVID-19 severity, and an association with vitamin D deficiency and COVID-19 severity. Patients in t.. | ||
|
Oct 15
2021 |
et al., Archives of Medical Research, doi:10.1016/j.arcmed.2021.09.006 | Very Low Vitamin D Levels are a Strong Independent Predictor of Mortality in Hospitalized Patients with Severe COVID-19 |
| 32% lower mortality (p<0.0001) and 22% shorter hospitalization (p=0.001). Retrospective 2,908 hospitalized patients in Mexico with vitamin D levels measured on admission, showing significantly lower mortality for patients without vitamin D deficiency. | ||
|
Oct 13
2021 |
et al., Endocrine Practice, doi:10.1016/j.eprac.2021.09.016 | Treatment with 25-hydroxyvitamin D3 (calcifediol) is associated with a reduction in the blood neutrophil-to-lymphocyte ratio marker of disease severity in patients hospitalized with COVID-19: a pilot, multicenter, randomized, placebo-controlled double blind clinical trial |
| 40% lower ICU admission (p=0.42) and 17% shorter hospitalization (p=0.1). RCT 106 hospitalized patients with vitamin D levels <30ng/ml in Iran, 53 treated with calcifediol, showing that treatment was able to correct vitamin D deficiency/insufficiency, resulting in improved immune system function. Hospitalizatio.. | ||
|
Oct 12
2021 |
et al., The Tohoku Journal of Experimental Medicine, doi:10.1620/tjem.255.127 | Prevalence and Clinical Outcomes of Vitamin D Deficiency in COVID-19 Hospitalized Patients: A Retrospective Single-Center Analysis |
| 55% lower mortality (p=0.002), 56% lower ventilation (p<0.0001), and 34% lower ICU admission (p=0.0001). Retrospective 646 COVID-19+ hospitalized patients in Iran, showing higher mortality with vitamin D deficiency. | ||
|
Oct 12
2021 |
et al., Annals of Palliative Medicine, doi:10.21037/apm-21-1707 | Low mortality from COVID-19 at a nursing facility in France following a combined preventive and active treatment protocol |
| Report on the relatively low mortality and relatively mild COVID-19 symptoms at a French nursing facility that has adopted several treatments including vitamin D, zinc, anticoagulants, corticosteroids, and a multivitamin. | ||
|
Oct 9
2021 |
et al., Medicina, doi:10.3390/medicina57101079 | Effect of Vitamin D Supplementation on Muscle Status in Old Patients Recovering from COVID-19 Infection |
| Small RCT with 30 patients examining the effect of vitamin D supplementation on muscle status in elderly recovering COVID-19 patients, showing serum creatine kinase levels returned to optimal values, however there was no significant diffe.. | ||
|
Oct 5
2021 |
et al., FEBS Open Bio, doi:10.1002/2211-5463.13309 | Seasonal UV exposure and vitamin D: Association with the dynamics of COVID-19 transmission in Europe |
| Analysis of UV and temperature levels in 26 European countries, showing that low temperature, UV index, and cloud-free vitamin D UV dose levels were negatively correlated with COVID-19 prevalence. Authors suggest that low UV exposure can .. | ||
|
Oct 2
2021 |
et al., Infection, Genetics and Evolution, doi:10.1016/j.meegid.2021.105098 | Association of Vitamin D receptor gene polymorphisms and clinical/severe outcomes of COVID-19 patients |
| Analysis of 500 hospitalized patients in Iran, showing associations between specific vitamin D receceptor gene polymorphisms and COVID-19 outcomes. | ||
|
Sep 27
2021 |
et al., Bratislava Medical Journal, doi:10.4149/BLL_2021_119 | The prognostic significance of vitamin D deficiency in patients with COVID-19 pneumonia |
| 81% lower mortality (p=0.04), 94% lower ICU admission (p=0.13), and 10% shorter hospitalization (p=0.32). Retrospective 207 hospitalized patients in Turkey, 37 with vitamin D levels <30ng/ml treated with a 300,000IU vitamin D, showing lower mortality with treatment. | ||
|
Sep 25
2021 |
et al., Nutrients, doi:10.3390/nu13103596 (date from preprint) | COVID-19 Mortality Risk Correlates Inversely with Vitamin D3 Status, and a Mortality Rate Close to Zero Could Theoretically Be Achieved at 50 ng/mL 25(OH)D3: Results of a Systematic Review and Meta-Analysis |
| Meta analysis of 8 studies with vitamin D levels measured pre-infection or on the day of hospital admission, showing a correlation between the levels and mortality. Authors recommend combining vaccination with vitamin D supplementation to.. | ||
|
Sep 24
2021 |
et al., Frontiers in Public Health, doi:10.3389/fpubh.2021.758347 | Previous Vitamin D Supplementation and Morbidity and Mortality Outcomes in People Hospitalised for COVID19: A Cross-Sectional Study |
| 12% higher mortality (p=0.59), 43% lower ventilation (p=0.22), 44% lower ICU admission (p=0.03), and 12% shorter hospitalization (p=0.2). Retrospective 1,267 hospitalized patients in Spain, 189 on vitamin D supplementation before admission, showing lower ICU admission with supplementation, and no statistically significant difference for mortality or ventilation. | ||
|
Sep 22
2021 |
et al., Journal of Inflammation Research, doi:10.2147/JIR.S323356 | Implications for Systemic Approaches to COVID-19: Effect Sizes of Remdesivir, Tocilizumab, Melatonin, Vitamin D3, and Meditation |
| Review of the effects of COVID-19 on inflammatory markers, and the effects on those markers of standard treatments vs. vitamin D, melatonin, and meditation, showing comparable or superior effects with the non-standard treatments. The stan.. | ||
|
Sep 22
2021 |
et al., medRxiv, doi:10.1101/2021.09.20.21263865 | Vitamin D and socioeconomic deprivation mediate COVID-19 ethnic health disparities |
| UK Biobank retrospective showing that vitamin supplements, including vitamin D, mediate the Asian disparity in COVID-19 susceptibility, and vitamin D levels mediate Asian and Black COVID-19 severity disparities. Authors conclude that the .. | ||
|
Sep 20
2021 |
et al., Internal and Emergency Medicine, doi:10.1007/s11739-021-02902-w | Vitamin D deficiency is associated with higher risks for SARS-CoV-2 infection and COVID-19 severity: a retrospective case–control study |
| 34% lower severe cases (p=0.0001) and 20% fewer cases (p<0.0001). Retrospective 41,757 PCR+ patients in Israel and 417,570 matched contols, showing an inverse correlation between vitamin D levels and the risks of SARS-CoV-2 infection and of severe disease in those infected. COM-0046–20. | ||
|
Sep 19
2021 |
et al., Food Science & Nutrition, doi:10.1002/fsn3.2591 | The predictive power of serum vitamin D for poor outcomes in COVID-19 patients |
| 45% lower mortality (p=0.05), 42% lower ventilation (p=0.09), and 37% lower ICU admission (p=0.04). Retrospective 290 hospitalized patients in Iran, showing higher mortality with vitamin D deficiency. | ||
|
Sep 14
2021 |
et al., International Immunopharmacology, doi:10.1016/j.intimp.2020.107001 | Lower levels of vitamin D are associated with SARS-CoV-2 infection and mortality in the Indian population: An observational study |
| Analysis of vitamin D levels and COVID-19 in Indian states and union territories, showing an inverse correlation of vitamin D levels with SARS-CoV-2 cases and mortality. | ||
|
Sep 9
2021 |
et al., PLOS Pathogens, doi:10.1371/journal.ppat.1009840 | Discovery of re-purposed drugs that slow SARS-CoV-2 replication in human cells |
| In Vitro studying identifying 35 compounds that inhibit SARS-CoV-2 in Vero cells and hepatocytes when treated prior to infection, and several compounds that slow replication when treated after infection: vitamin D, amodiaquine, atovaquone.. | ||
|
Sep 8
2021 |
et al., Bone, doi:10.1016/j.bone.2021.116175 | A Randomized Pilot Study Using Calcitriol in Hospitalized Patients |
| 86% lower mortality (p=0.23), 38% lower ICU admission (p=0.33), 40% shorter hospitalization (p=0.14), and 86% improved recovery (p=0.03). RCT 50 hospitalized patients in the USA, 25 treated with calcitriol, showing significantly improved oxygenation with treatment. Mortality, intubation, ICU admission, and hospitalization time also favored treatment, while not reaching stat.. | ||
|
Sep 6
2021 |
et al., Postgraduate Medical Journal, doi:10.1136/postgradmedj-2021-140564 | Vitamin D levels and mortality with SARS-COV-2 infection: a retrospective two-centre cohort study |
| 43% higher mortality (p=0.71). Retrospective 433 patients in the UK, 52 positive for COVID-19, showing no significant difference in mortality based on vitamin D levels. Authors also include results for all 433 patients, however given the expected test false negative ra.. | ||
|
Sep 5
2021 |
et al., Endocrine Abstracts, doi:10.1530/endoabs.70.EP552 | Vitamin D deficit in type 2 diabetes patients during COVID-19 lockdown with and without supplementation |
| 27% fewer cases (p=1). Analysis of 239 consecutive diabetic patients, 97 taking vitamin D supplements, showing significantly higher vitamin D levels in supplemented patients. There was no statistically significant difference in cases based on supplementation, w.. | ||
|
Sep 1
2021 |
et al., Journal of Family & Reproductive Health, doi:10.18502/jfrh.v14i3.4668 | Supplement Usage Pattern in a Group of COVID-19 Patients in Tehran |
| 71% lower severe cases (p=0.02) and 38% lower hospitalization (p=0.11). Retrospective 510 patients in Iran, showing lower risk of severity with vitamin D (statistically significant) and zinc (not statistically significant) supplementation. IR.TUMS.VCR.REC.1398.1063. | ||
|
Sep 1
2021 |
et al., Proceedings of Singapore Healthcare, doi:10.1177/20101058211041405 | Impact of Vitamin D Therapy on the Progress COVID-19: Six Weeks Follow-Up Study of Vitamin D Deficient Elderly Diabetes Patients |
| 63% lower mortality (p=0.21), 20% lower ventilation (p=0.56), and 20% improved recovery (p=0.56). Small RCT with 56 eldery diabetes patients hospitalized in Egypt, 40 treated with cholecalciferol, not showing significant differences. | ||
|
Aug 31
2021 |
et al., Journal of the American College of Nutrition, doi:10.1080/07315724.2021.1951891 | Association between Vitamin D Status and Risk of Developing Severe COVID-19 Infection: A Meta-Analysis of Observational Studies |
| Meta analysis of 24 observational studies with 3,637 participants, showing low vitamin D status associated with a higher risk of death and a higher risk of developing severe COVID-19 pneumonia. | ||
|
Aug 29
2021 |
et al., Nutrients, doi:10.3390/nu13093021 | Low 25(OH)D Level Is Associated with Severe Course and Poor Prognosis in COVID-19 |
| 78% lower mortality (p=0.006) and 67% lower severe cases (p=0.005). Retrospective 161 hospitalized patients in Russia, showing COVID-19 severity and mortality associated with vitamin D deficiency. Patients in this study may overlap with those in an earlier smaller study from some of the same authors. | ||
|
Aug 28
2021 |
et al., Journal of Infection and Public Health, doi:10.1016/j.jiph.2021.08.030 | COVID-19 related treatment and outcomes among COVID-19 ICU patients: A retrospective cohort study |
| 66% higher mortality (p=0.6). Retrospective 118 ICU patients in Saudi Arabia showing no significant differences in unadjusted results with zinc, vitamin D, and favipiravir treatment. | ||
|
Aug 27
2021 |
et al., Journal of Primary Care & Community Health, doi:10.1177/21501327211041206 | Vitamin D Status and Severe COVID-19 Disease Outcomes in Hospitalized Patients |
| 70% higher mortality (p=0.52), 10% higher ventilation (p=0.89), and 30% higher ICU admission (p=0.61). Retrospective 92 hospitalized patients not showing significant differences in outcomes based on vitamin D status or supplementation. | ||
|
Aug 26
2021 |
et al., Nutrients, doi:10.3390/nu13103368 (date from preprint) | The Association between Vitamin D and Zinc Status and the Progression of Clinical Symptoms among Outpatients Infected with SARS-CoV-2 and Potentially Non-Infected Participants: A Cross-Sectional Study |
| 25% more cases (p=0.56). Analysis of vitamin D and zinc levels in 53 PCR+ outpatients and 53 matched controls, showing lower zinc levels in COVID-19 patients, and increased risk of cases and symptoms with vitamin D deficiency. There was no significant difference .. | ||
|
Aug 26
2021 |
et al., Nutrients, doi:10.3390/nu13103368 (date from preprint) | The Association between Vitamin D and Zinc Status and the Progression of Clinical Symptoms among Outpatients Infected with SARS-CoV-2 and Potentially Non-Infected Participants: A Cross-Sectional Study |
| 90% improved recovery (p<0.0001) and 72% fewer cases (p=0.07). Analysis of vitamin D and zinc levels in 53 PCR+ outpatients and 53 matched controls, showing lower zinc levels in COVID-19 patients, and increased risk of cases and symptoms with vitamin D deficiency. There was no significant difference .. | ||
|
Aug 25
2021 |
et al., Expert Review of Anti-infective Therapy, doi:10.1080/14787210.2022.2035217 | COVID-19 and Vitamin D (Co-VIVID Study): a systematic review and meta-analysis of randomized controlled trials |
| Meta analysis of 6 vitamin D treatment RCTs, showing statistically significant improvements for pooled outcomes and PCR positivity, and positive but not statistically significant improvements for mortality, mechanical ventilation, ICU adm.. | ||
|
Aug 24
2021 |
et al., Nutrition Research and Practice, doi:10.4162/nrp.2021.15.S1.S32 | 25-Hydroxyvitamin D level is associated with mortality in patients with critical COVID-19: a prospective observational study in Mexico City |
| 99% lower mortality (p<0.0001). Prospective study of 94 COVID-19 patients in Mexico, showing lower vitamin D levels associated with mortality in multivariate analysis. 84% of patients were vitamin D deficient, and the remaining 16% had insufficient vitamin D levels. | ||
|
Aug 20
2021 |
et al., Journal of Biomolecular Structure and Dynamics, doi:10.1080/07391102.2021.1964601 | Vitamin D3 and its hydroxyderivatives as promising drugs against COVID-19: a computational study |
| In Silico study suggesting that vitamin D3 and its biologically active hydroxyderivatives can serve as an TMPRSS2 inhibitor, and inhibit ACE2 binding with the SARS-CoV-2 RBD. | ||
|
Aug 18
2021 |
et al., Journal of Medical Virology, doi:10.1002/jmv.27277 | Evaluation of the relationship between serum levels of zinc, vitamin B12, vitamin D, and clinical outcomes in patients with COVID-19 |
| Retrospective 293 hospitalized patients in Iran showing lower levels of zinc, vitamin B12, and vitamin D in patients that died, with statistical significance reached only for zinc. | ||
|
Aug 17
2021 |
et al., Proceedings of the Nutrition Society, doi:10.1017/S0029665121002214 | The relationship between vitamin D, biomarkers and clinical outcome in hospitalised Covid-19 patients |
| 56% lower progression (p=0.03). Retrospective 138 COVID-19 hospitalized patients in Ireland, showing increased risk of infiltrates on chest X-ray for patients with vitamin D deficiency, and lower vitamin D levels in patients that died (21.8 nmol/L vs. 37.8 nmol/L, p = 0.. | ||
|
Aug 17
2021 |
et al., Proceedings of the Nutrition Society, doi:10.1017/S0029665121002482 | An observational study of the association of vitamin D status and other patient characteristics with COVID-19 severity and mortality |
| 90% lower mortality (p=0.06) and 73% lower need for oxygen therapy (p=0.05). Retrospective 114 hospitalized COVID-19 patients in Ireland, showing higher risk of mortality and oxygen therapy with vitamin D deficiency, with statistical significance for oxygen therapy. | ||
|
Aug 12
2021 |
et al., The Journal of Clinical Endocrinology & Metabolism, doi:10.1210/clinem/dgab599 | Vitamin D levels associate with blood glucose and BMI in COVID-19 patients predicting disease severity |
| 11% lower mortality (p=1), 42% lower ICU admission (p=0.22), and 40% lower severe cases (p=0.04). Retrospective 88 patients in Italy, showing vitamin D deficiency associated with severe cases, blood glucose, and BMI. | ||
|
Aug 11
2021 |
et al., The Journal of Steroid Biochemistry and Molecular Biology, doi:10.1016/j.jsbmb.2021.105964 | Impact of vitamin D on the course of COVID-19 during pregnancy: A case control study |
| 90% lower severe cases (p=0.35) and 19% more moderate/severe cases (p=0.64). Retrospective 159 COVID-19+ pregnant women in Turkey and 332 healthy pregnant controls, showing significantly lower vitamin D levels in COVID-19+ patients. 23% of COVID-19 patients where on vitamin D supplementation, while none of the 7 s.. | ||
|
Aug 10
2021 |
et al., Epidemiology & Infection, doi:10.1017/S0950268821001825 | Vitamin D levels in children with COVID-19: a report from Turkey |
| 73% fewer cases (p=0.0005). Retrospective 75 COVID-19 hospitalized pediatric patients in Turkey and 80 healthy controls, showing significantly lower vitamin D levels in COVID-19 patients. | ||
|
Aug 5
2021 |
et al., BMJ Nutrition, Prevention & Health, doi:10.1136/bmjnph-2021-000270 | Nutritional parameters and outcomes in patients admitted to intensive care with COVID-19: a retrospective single-centre service evaluation |
| 64% lower mortality (p=0.1). Retrospective 72 ICU patients in the UK, showing higher mortality with vitamin D deficiency, not reaching statistical significance. | ||
|
Aug 5
2021 |
et al., Clinica Chimica Acta, doi:10.1016/j.cca.2021.08.003 | Previous vitamin D status and total cholesterol are associated with SARS-CoV-2 infection |
| 50% fewer cases (p=0.02). Retrospective 1,634 patients tested for SARS-CoV-2 in Brazil, showing vitamin D levels <30ng/mL associated with greater odds of a positive SARS-CoV-2 test in patients older than 49 years. | ||
|
Aug 5
2021 |
et al., Annals of Medicine and Surgery, doi:10.1016/j.amsu.2021.102661 | Vitamin D deficiency and COVID-19: A case-control study at a tertiary care hospital in India |
| 50% lower mortality (p=0.17) and 68% lower severe cases (p=0.003). Case control study with 156 PCR+ cases in India and 204 controls, showing more frequent vitamin D deficiency in COVID-19 patients, and an association between lower vitamin D levels and COVID-19 severity. | ||
|
Aug 4
2021 |
et al., Infectious Diseases in Clinical Practice, doi:10.1097/IPC.0000000000001051 | Comparing Serum Levels of Vitamin D and Zinc in Novel Coronavirus–Infected Patients and Healthy Individuals in Northeastern Iran, 2020 |
| Analysis of 56 COVID-19 patients and 46 healthy control patients in Iran, showing that severe cases had lower levels of vitamin D compared with non-severe cases and healthy controls. | ||
|
Aug 4
2021 |
et al., Nutrition & Food Science, doi:10.1108/NFS-11-2020-0421 | Do body mass index (BMI) and history of nutritional supplementation play a role in the severity of COVID-19? A retrospective study |
| 12% fewer cases (p=0.09). Retrospective 603 patients in Iran, 192 taking vitamin D supplements, showing no significant difference in COVID-19 cases in unadjusted results. IR.SHOUSHTAR.REC.1399.015. | ||
|
Jul 30
2021 |
et al., Archives of Microbiology, doi:10.1007/s00203-021-02482-5 | The sufficient vitamin D and albumin level have a protective effect on COVID-19 infection |
| 66% fewer cases (p<0.0001). Case control study with 191 COVID-19 patients and 203 healthy controls in Iran, showing an association between vitamin D deficiency and COVID-19 infection and severity. 84.4% of COVID-19 patients had vitamin D deficiency. | ||
|
Jul 29
2021 |
et al., Open Forum Infectious Diseases, doi:10.1093/ofid/ofab408 | Vitamin K & D Deficiencies Are Independently Associated With COVID-19 Disease Severity |
| Case control study with 100 COVID-19+ patients and 50 age and gender matched controls, showing vitamin K and vitamin D levels independently associated with COVID-19 severity. | ||
|
Jul 29
2021 |
et al., Nutrition & Food Science, doi:10.1108/NFS-05-2021-0143 | In COVID-19 patients, low 25-hydroxyvitamin D level in serum is associated with longer viral clearance time and higher risk of intensive care unit admission |
| 44% lower ICU admission (p=0.03). Retrospective 450 hospitalized patients in Bahrain, showing increased risk of ICU admission and slower viral clearance with vitamin D deficiency. | ||
|
Jul 29
2021 |
et al., The International Journal of Clinical Practice, doi:10.1111/ijcp.14675 | The Role of Vitamin D in the Age of COVID-19: A Systematic Review and Meta-Analysis |
| Systematic review and meta analysis of 23 studies, finding significantly higher risk of COVID-19 cases and severity with vitamin D deficiency. Mortality risk was higher with deficiency, but not reaching statistical significance, OR 1.6 [0.. | ||
|
Jul 29
2021 |
et al., The Journal of Steroid Biochemistry and Molecular Biology, doi:0.1016/j.jsbmb.2021.105958 | Vitamin D supplementation prior to or during COVID-19 associated with better 3-month survival in geriatric patients: Extension phase of the GERIA-COVID study |
| 64% lower mortality (p=0.002). Report on extended results from the GERIA-COVID study, showing significantly lower mortality at 3 months with vitamin D treatment. Results combine prophylaxis and early treatment. | ||
|
Jul 27
2021 |
et al., Endocrinology and Metabolism, doi:10.1152/ajpendo.00174.2021 | Vitamin D and lumisterol novel metabolites can inhibit SARS-CoV-2 replication machinery enzymes |
| In Silico analysis showing that vitamin D and lumisterol metabolites may inhibit SARS-CoV-2 Mpro and RdRP. | ||
|
Jul 27
2021 |
et al., PLoS ONE, doi:10.1371/journal.pone.0255132 | Lower serum 25(OH)D levels associated with higher risk of COVID-19 infection in U.S. Black women |
| 39% fewer cases (p=0.04). Prospective study of vitamin D levels and COVID-19 infection in the Black Women’s Health Study, showing higher risk of infection for lower vitamin D levels. Vitamin D levels were from 3-7 years before infection. Levels at the time of infe.. | ||
|
Jul 27
2021 |
et al., Epidemiology and Global Health Microbiology and Infectious Disease, doi:10.7554/eLife.68165 | Identification of drugs associated with reduced severity of COVID-19: A case-control study in a large population |
| 13% lower hospitalization (p=0.003). Case control study examining medication usage with a healthcare database in Israel, showing lower risk of hospitalization with vitamin D (defined as being picked up within 35 days prior to PCR+). Other patients may have acquired vitamin D.. | ||
|
Jul 26
2021 |
et al., Nutrients, doi:10.3390/nu13082559 | Mortality in Hemodialysis Patients with COVID-19, the Effect of Paricalcitol or Calcimimetics |
| 50% lower mortality (p=0.02). Retrospective 288 hemodialysis patients in Spain, 137 with existing vitamin D treatments (94 with paricalcitol), showing lower mortality with treatment. There was no significant difference in outcomes based on serum levels, however author.. | ||
|
Jul 23
2021 |
et al., European Journal of Clinical Nutrition, doi:10.1038/s41430-021-00984-5 | The effect of high-dose parenteral vitamin D3 on COVID-19-related inhospital mortality in critical COVID-19 patients during intensive care unit admission: an observational cohort study |
| 25% lower mortality (p=0.32). Retrospective 175 ICU patients, 113 treated with a single dose of 300,000IU intramuscular cholecalciferol, showing lower mortality with treatment, but not reaching statistical significance. Calcifediol or calcitriol, which avoids several .. | ||
|
Jul 17
2021 |
et al., Journal of Endocrinological Investigation, doi:10.1007/s40618-021-01639-9 | Vitamin D supplementation and COVID-19 risk: a population-based, cohort study |
| 1% higher mortality (p=0.91) and 1% fewer cases (p=0.65). Retrospective study of cholecalciferol and calcitriol supplementation in Catalonia showing a small but significant lower risk of cases with cholecalciferol, but no significant difference for mortality, or for calcitriol supplementation. S.. | ||
|
Jul 9
2021 |
et al., Food Science & Nutrition, doi:10.1002/fsn3.2458 | Nutritional and lifestyle changes required for minimizing the recovery period in home quarantined COVID-19 patients of Punjab, Pakistan |
| Survey of 80 recovered COVID-19 patients in Pakistan, showing faster recovery with vitamin C, vitamin D, and zinc supplementation. | ||
|
Jul 7
2021 |
et al., International Journal of Environmental Research and Public Health, doi:10.3390/ijerph18147266 | Association of Food Intake Quality with Vitamin D in SARS-CoV-2 Positive Patients from Mexico: A Cross-Sectional Study |
| 25% fewer symptomatic cases (p=0.04). Retrospective 40 COVID+ patients in Mexico, showing higher risk of symptoms with vitamin D deficiency. Higher food intake quality and intense physical activity were associated with vitamin D sufficiency. Insufficient intake of several mic.. | ||
|
Jul 6
2021 |
et al., Journal of Evidence-Based Integrative Medicine, doi:10.1177/2515690X211026193 | 20-Week Study of Clinical Outcomes of Over-the-Counter COVID-19 Prophylaxis and Treatment |
| 94% fewer cases (p=0.003). Retrospective 113 outpatients, 53 (patient choice) treated with zinc, quercetin, vitamin C/D/E, l-lysine, and quina, showing lower cases with treatment. Results are subject to selection bias and limited information on the groups is provid.. | ||
|
Jul 1
2021 |
et al., Nutrition, doi:10.1016/j.nut.2021.111408 | Prevalence of vitamin D deficiency and its prognostic impact on patients hospitalized with COVID-19 |
| 18% lower mortality (p=0.59) and 16% lower combined mortality/ICU admission (p=0.53). Prospective study of 200 hospitalized patients in Italy, showing 80% of patients had vitamin D deficiency. There was no significant differences in outcomes based on vitamin D levels. There was also no significant difference in vitamin D l.. | ||
|
Jun 30
2021 |
et al., Journal of Cardiovascular Disease Research, 12:6 | Association of vitamin D status with severity of COVID-19 |
| Analysis of 50 COVID-19 hospitalized patients, showing lower vitamin D levels associated with COVID-19 severity. | ||
|
Jun 30
2021 |
et al., International Journal of Infectious Diseases, doi:10.1016/j.ijid.2021.04.083 | Does vitamin D serum level affect prognosis of COVID-19 patients? |
| 9% higher mortality (p=0.89). Retrospective 329 COVID-19 patients in Iran, showing lower vitamin D levels associated with longer hospitalization, but no significant association with mortality. | ||
|
Jun 27
2021 |
et al., Reviews in Medical Virology, doi:10.1002/rmv.2269 | Vitamin D supplementation and Covid‐19 outcomes: A systematic review, meta‐analysis and meta‐regression |
| 63% lower mortality (p=0.0007), 66% lower ventilation (p=0.005), and 73% lower ICU admission (p=0.02). Meta analysis of 11 COVID-19 studies showing lower mortality, mechanical ventilation, and ICU admission with vitamin D. Authors also perform meta-regression showing greater efficacy with increasing age. | ||
|
Jun 24
2021 |
et al., Nutrients, doi:10.3390/nu13072170 | Effects of a 2-Week 5000 IU versus 1000 IU Vitamin D3 Supplementation on Recovery of Symptoms in Patients with Mild to Moderate Covid-19: A Randomized Clinical Trial |
| 14% higher hospital discharge (p=0.14) and 14% faster recovery (p=0.97). Small RCT of 69 hospitalized patients comparing 1,000IU and 5,000IU daily cholecalciferol, showing faster recovery with the higher dose (statistically significant only for cough and ageusia). | ||
|
Jun 24
2021 |
et al., Journal of Endocrinological Investigation, doi:10.1007/s40618-021-01614-4 | Vitamin D supplementation and clinical outcomes in COVID-19: a systematic review and meta-analysis |
| Meta analysis of 13 vitamin D treatment studies, showing significantly lower ICU admission/mortality with treatment. | ||
|
Jun 24
2021 |
et al., Nutrition, doi:10.1016/j.nut.2021.111400 | The association between serum levels of micronutrients and the severity of disease in patients with COVID-19 |
| Retrospective 60 ICU patients in Iran, showing that lower levels of vitamin D, magnesium, and zinc were significantly associated with higher APACHE scores (P = 0.001, 0.028, and <0.001, respectively) and higher lung involvement (P = 0.002.. | ||
|
Jun 23
2021 |
et al., Frontiers in Immunology, doi:10.3389/fimmu.2021.594356 | Vitamin D and Exercise Are Major Determinants of Natural Killer Cell Activity, Which Is Age- and Gender-Specific |
| Analysis of 2,095 patients in South Korea, showing exercise and vitamin D associated with improved natural killer cell activity. | ||
|
Jun 22
2021 |
et al., Nutrients, doi:10.3390/nu13072129 | Vitamin D Metabolites and Clinical Outcome in Hospitalized COVID-19 Patients |
| 46% lower mortality (p=0.08). Retrospective 148 patients in Austria, showing no statistically significant differences in vitamin D levels and metabolites for mortality or respiratory support. | ||
|
Jun 17
2021 |
et al., Journal of Clinical Endocrinology & Metabolism, doi:10.1210/clinem/dgab439 | Vitamin D deficiency is associated with higher hospitalisation risk from COVID-19: a retrospective case-control study |
| 72% lower hospitalization (p<0.0001). Retrospective 80,670 people in the UK with vitamin D levels measured within the last 12 months, showing higher risk of hospitalization with low vitamin D levels. | ||
|
Jun 14
2021 |
et al., BMC Infectious Diseases, doi:10.1186/s12879-021-06281-7 | Vitamin D and COVID-19 severity and related mortality: a prospective study in Italy |
| 88% lower severe cases (p<0.0001). Prospective study of 103 hospitalized patients in Italy, showing very high prevalence of vitamin D deficiency, and increased severity for lower vitamin D levels. Vitamin D supplementation was significantly less common for cases. | ||
|
Jun 9
2021 |
et al., Nutrients, doi:10.3390/nu13061988 | Bad Prognosis in Critical Ill Patients with COVID-19 during Short-Term ICU Stay regarding Vitamin D Levels |
| Prospective analysis of 37 critical COVID-19 patients, showing mechanical ventilation associated with lower vitamin D levels. | ||
|
Jun 7
2021 |
et al., PLOS ONE, doi:10.1371/journal.pone.0263069 (date from preprint) | Pre-infection 25-hydroxyvitamin D3 levels and association with severity of COVID-19 illness |
| 85% lower severe cases (p=0.001). Retrospective 253 hospitalized patients in Israel showing higher mortality and higher risk of severe cases with vitamin D deficiency. Vitamin D levels were measured 14 to 730 days before the COVID-19 test. Adjusted results are only provid.. | ||
|
Jun 6
2021 |
et al., Journal of Steroid Biochemistry and Molecular Biology, doi:10.1016/j.jsbmb.2021.105928 | The relationship between 25(OH) vitamin D levels and COVID-19 onset and disease course in Spanish patients |
| 73% lower ICU admission (p=0.02). Retrospective 1,549 patients in Spain showing that the frequency of vitamin D deficiency was higher in admitted patients compared to the overall Spanish population, and that vitamin D deficiency was associated with increased risk of ICU a.. | ||
|
Jun 4
2021 |
et al., Frontiers in Nutrition, doi:10.3389/fnut.2021.689419 | Association of Vitamin D, Zinc and Selenium Related Genetic Variants With COVID-19 Disease Severity |
| Analysis of variants in genes significant for the status of vitamin D in 120 Serbian COVID-19 patients, showing that vitamin D related genetic variants DHCR7/NADSYN rs12785878 and CYP2R1 rs10741657 were associated with severe COVID-19 in .. | ||
|
Jun 2
2021 |
et al., Movement Disorders, doi:10.1002/mds.28176 | COVID-19 in Parkinson’s Disease Patients Living in Lombardy, Italy |
| 42% fewer cases (p=0.05). Retrospective phone survey of 1,486 Parkinson’s disease patients in Italy, showing lower risk of COVID-19 cases with vitamin D supplementation. This paper also presents a case control study of PD patients and family member control patients. | ||
|
Jun 1
2021 |
et al., PLOS Medicine, doi:10.1371/journal.pmed.1003605 | Vitamin D and COVID-19 susceptibility and severity in the COVID-19 Host Genetics Initiative: A Mendelian randomization study |
| Mendelian randomization study not finding significant differences in COVID-19 outcomes based on vitamin D level. This study does not compare patients with deficiency/insuffiency/sufficiency, only providing ORs for increase in D levels. Au.. | ||
|
May 31
2021 |
et al., Clinical Nutrition ESPEN, doi:10.1016/j.clnesp.2021.05.021 | Low vitamin D levels and increased neutrophil in patients admitted at ICU with COVID-19 |
| 29% lower mortality (p=1). Retrospective 25 ICU patients in Brazil, showing vitamin D deficiency associated with higher neutrophil-lymphocyte ratio. There appears to be a typo in the mortality percentage for vitamin D deficiency (20% is not valid for the group size.. | ||
|
May 29
2021 |
et al., Clinical Nutrition ESPEN, doi:10.1016/j.clnesp.2021.05.011 | Impact of vitamin D deficiency on COVID-19 |
| Analysis of vitamin D deficiency and COVID-19 cases and deaths in 47 countries, showing vitamin D deficiency significantly associated with mortality. | ||
|
May 28
2021 |
, J. Clinical Medicine, doi:10.3390/jcm10112378 | Vitamin D Levels in COVID-19 Outpatients from Western Mexico: Clinical Correlation and Effect of Its Supplementation |
| 89% lower severe cases (p=0.04) and 81% improved recovery (p=0.22). Very small 42 PCR+ outpatient RCT in Mexico, 22 treated with vitamin D. Most patients had insufficient vitamin D levels, there were more symptoms in those with insufficient levels, and there were less cases with fever or with >3 symptoms .. | ||
|
May 28
2021 |
et al., Journal of Clinical Oncology, doi:10.1200/JCO.2021.39.15_suppl.6589 | Assessment of vitamin D deficiency and COVID-19 diagnosis in patients with breast or prostate cancer using electronic medical records |
| 35% fewer cases (p=0.01). Retrospective 16,287 breast cancer and 14,919 prostate cancer showing increased risk of COVID-19 cases with vitamin D deficiency. | ||
|
May 26
2021 |
et al., Journal of Pharmaceutical Research International, doi:10.9734/jpri/2021/v33i29B31603 | Vitamin D is a New Promising Inhibitor to the Main Protease (Mpro) of COVID-19 by Molecular Docking |
| In Silico study showing vitamin D binding with Mpro of SARS-CoV-2. Among the compounds tested, vitamin D had the highest potential interaction in terms of total H-bond, van der Waal, torsional, and desolvation energy. Authors recommend ad.. | ||
|
May 25
2021 |
et al., World J. Virology, doi:10.5501/wjv.v10.i3.111] | Association between population vitamin D status and SARS-CoV-2 related serious-critical illness and deaths: An ecological integrative approach |
| Country analysis showing negative correlations between population vitamin D level and severe cases and death (but not with cases overall). Authors conclude that higher vitamin D levels may protect from severe cases and death, even more so.. | ||
|
May 22
2021 |
et al., Endocrine Abstracts, doi:10.1530/endoabs.73.PEP14.2 | Selenium, zinc, and vitamin D supplementation affect the clinical course of COVID-19 infection in Hashimoto’s thyroiditis |
| 97% lower ventilation (p<0.0001), 99% lower hospitalization (p<0.0001), and 100% lower severe cases (p<0.0001). Retrospective 356 Hashimoto’s thyroiditis outpatients, 270 taking vitamin D, zinc, and selenium, showing significantly lower hospitalization with treatment. Authors adjust for age, gender, BMI, and smoking status, reporting statistically .. | ||
|
May 21
2021 |
et al., The American Journal of Clinical Nutrition, doi:10.1093/ajcn/nqab151 | Influence of vitamin D status on hospital length of stay and prognosis in hospitalized patients with moderate to severe COVID-19: a multicenter prospective cohort study |
| 23% lower mortality (p=0.82), 45% higher ventilation (p=0.77), 33% higher hospital discharge (p=0.18), and 22% shorter hospitalization (p=0.06). Prospective study of 220 hospitalized patients in Brazil, showing no significant differences based on vitamin D levels. There was a trend (p=0.057) towards longer hospital stay for patients with levels <10ng/mL. | ||
|
May 21
2021 |
et al., Nutrients, doi:10.3390/nu13061760 | Calcifediol Treatment and Hospital Mortality Due to COVID-19: A Cohort Study |
| 81% lower mortality (p=0.04). Retrospective 537 patients in Spain, 79 treated with calcifediol, showing significantly lower mortality with treatment. The treated group had a higher risk of comorbidity, whereas the control group had lower O2 saturation, higher CURB-65,.. | ||
|
May 19
2021 |
et al., Nutrients, doi:10.3390/nu13051714 | COVID-19 Disease Severity and Death in Relation to Vitamin D Status among SARS-CoV-2-Positive UAE Residents |
| 59% lower mortality (p=0.05) and 33% lower severe cases (p=0.005). Retrospective 464 patients in United Arab Emirates showing low D levels at first hospital visit associated with higher COVID-19 severity and mortality. | ||
|
May 19
2021 |
et al., JAMA Network Open, doi:10.1001/jamanetworkopen.2021.11634 | Assessment of the Association of Vitamin D Level With SARS-CoV-2 Seropositivity Among Working-Age Adults |
| 9% fewer cases (p=0.24). Cohort study of 18,148 patients in the USA showing low vitamin D associated with COVID-19 PCR+ status before adjustments but not after. Authors state that “low vitamin D levels were not independently associated with the risk of.. | ||
|
May 18
2021 |
et al., BMC Infectious Diseases, doi:10.1186/s12879-021-06168-7 | Lack of association between vitamin D insufficiency and clinical outcomes of patients with COVID-19 infection |
| 12% higher mortality (p=1), 16% lower ventilation (p=1), 28% lower ICU admission (p=0.74), and 68% higher severe cases (p=0.3). Retrospective 153 hospitalized patients in Iran, showing no significant difference in outcomes based on vitamin D levels. Adjusted results are only provided for vitamin D as a continuous variable. | ||
|
May 18
2021 |
et al., BJPsych Bulletin, doi:10.1192/bjb.2021.55 | Revisiting vitamin D status and supplementation for in-patients with intellectual and developmental disability in the North of England, UK |
| 22% fewer symptomatic cases (p=0.65). Retrospective 64 patients with intellectual and developmental disability in the UK, showing no significant difference in COVID-19 status with vitamin D supplementation. Only 6 patients were not on vitamin D supplementation. | ||
|
May 11
2021 |
et al., International Journal of Environmental Research and Public Health, doi:10.3390/ijerph18105086 | Patients’ Behavior Regarding Dietary or Herbal Supplements before and during COVID-19 in Saudi Arabia |
| 49% higher hospitalization (p=0.002). Retrospective survey-based analysis of 738 COVID-19 patients in Saudi Arabia, showing lower hospitalization with vitamin C, turmeric, zinc, and nigella sativa, and higher hospitalization with vitamin D. For vitamin D, most patients contin.. | ||
|
May 8
2021 |
et al., Annals of the Romanian Society for Cell Biology, 25:6 | Comparison between Vitamin D Level of Asymptomatic Confirmed Covid-19 Patients with Symptomatic Confirmed Covid-19 Patients in Makassar |
| 88% fewer symptomatic cases (p<0.0001). Retrospective 42 PCR+ patients in Indonesia, showing significantly higher risk of symptomatic cases with vitamin D deficiency. | ||
|
May 7
2021 |
et al., Journal of Clinical Practice, doi:10.17816/clinpract64976 | Prevalence of hypovitaminosis D in COVID-19 patients in the intensive care unit |
| 36% lower mortality (p=0.03). Retrospective 103 COVID-19 ICU patients in Russia, showing higher mortality with low vitamin D levels in unadjusted results. | ||
|
May 3
2021 |
et al., Journal of the Endocrine Society, doi: 10.1210/jendso/bvab048.567 | The Effect of Vitamin D Supplementation on Severe COVID-19 Outcomes in Patients With Vitamin D Insufficiency |
| 31% lower severe cases (p=0.25). Retrospective 129 hospitalized patients with vitamin D levels measured within 90 days prior to admission, showing lower, but not statistically significant, risk of severe cases with vitamin D supplementation among patients with levels <20.. | ||
|
Apr 30
2021 |
et al., PLOS ONE, doi:10.1371/journal.pone.0251085 | Epidemiology, outcomes, and utilization of intensive care unit resources for critically ill COVID-19 patients in Libya: A prospective multi-center cohort study |
| 23% lower mortality (p=0.29). Prospective study of 465 COVID-19 ICU patients in Libya showing no significant differences with treatment. | ||
|
Apr 30
2021 |
et al., J. Mazandaran Univ. Med. Sci. 31:195 | Serum Vitamin D Concentrations in CoVID19 Patients |
| Retrospective 80 COVID-19 patients in Iran and 70 healthy controls, showing significantly lower vitamin D levels in COVID-19 patients. | ||
|
Apr 29
2021 |
et al., Scientific Reports, doi:10.1038/s41598-021-02701-5 (date from preprint) | Real world evidence of calcifediol or vitamin D prescription and mortality rate of COVID-19 in a retrospective cohort of hospitalized Andalusian patients |
| 33% lower mortality (p=0.009). Retrospective 15,968 hospitalized patients in Spain showing a significant reduction in mortality associated with the prescription of vitamin D, especially calcifediol, within 15-30 days prior to hospitalization. | ||
|
Apr 26
2021 |
et al., Journal of Translational Medicine, doi:10.1186/s12967-021-02838-x | Vitamin D status of Arab Gulf residents screened for SARS-CoV-2 and its association with COVID-19 infection: a multi-centre case–control study |
| Case control study with 220 adults showing significantly lower vitamin D levels in PCR+ patients. | ||
|
Apr 18
2021 |
et al., Clinical Nutrition ESPEN, doi:10.1016/j.clnesp.2021.03.040 | Serum vitamin D, calcium, and zinc levels in patients with COVID-19 |
| Case control study with 93 hospitalized patients in Iran and 186 control patients, showing significantly lower vitamin D, zinc, and calcium levels in cases. IR.SHOUSHTAR.REC.1399.017. | ||
|
Apr 17
2021 |
et al., International Immunopharmacology, doi:10.1016/j.intimp.2021.107686 | The role of vitamin D in reducing SARS-CoV-2 infection: An update |
| Review of vitamin D for COVID-19 noting that infections are likely to be more prevalent in the winter season; clinical trials show vitamin D as a potential therapeutic agent; vitamin D is beneficial against COVID-19 by reducing inflammato.. | ||
|
Apr 8
2021 |
et al., Open Medicine, doi:10.1515/med-2021-0273 | COVID-19 severity in relation to sociodemographics and vitamin D use |
| 41% lower hospitalization (p=0.3). Survey of 428 recovered COVID-19 patients in Iraq, showing fewer hospital visits for patients on prophylactic vitamin C or D. Hospitalization was lower for those on vitamin C, D, or zinc, without statistical significance. | ||
|
Apr 6
2021 |
et al., Biomedicines, doi:10.3390/biomedicines9050509 (date from preprint) | Association of Calcitriol Supplementation with Reduced COVID-19 Mortality in Patients with Chronic Kidney Disease: A Population-based Study |
| 43% lower mortality (p=0.001), 43% lower severe cases (p=0.0008), and 22% fewer cases (p=0.01). Retrospective study of calcitriol supplementation with chronic kidney disease patients in Catalonia showing lower cases, severe cases, and mortality with supplementation. A dose-response relationship was found for severe cases and mortali.. | ||
|
Apr 5
2021 |
et al., Journal of Endocrinological Investigation, doi:10.1007/s40618-021-01566-9 | Retrospective analysis of vitamin D status on ınflammatory markers and course of the disease in patients with COVID-19 infection |
| 81% lower mortality (p=0.23) and 73% lower need for oxygen therapy (p=0.07). Retrospective 56 patients in Turkey showing greater need for oxygen therapy and higher mortality with vitamin D deficiency, and significantly lower risk of pneumonia with vitamin D supplementation. | ||
|
Apr 2
2021 |
et al., Int. J. Clinical Practive, doi:10.1111/ijcp.14166 | Detectable respiratory SARS-CoV-2 RNA is associated with low vitamin D levels and high social deprivation |
| 51% fewer cases (p=0.02). Retrospective 104 consecutive patients tested for COVID-19 in a hospital in the UK, showing lower vitamin D and higher social deprivation associated with COVID-19 positive results. | ||
|
Mar 31
2021 |
et al., European Journal of Pediatrics, doi:10.1007/s00431-021-04030-1 | The association between vitamin D levels and the clinical severity and inflammation markers in pediatric COVID-19 patients: single-center experience from a pandemic hospital |
| 70% lower severe cases (p=0.03). Retrospective 103 pediatric hospitalized COVID-19 patients, showing an association between vitamin D deficiency and clinical severity. | ||
|
Mar 30
2021 |
et al., Thorax, doi:10.1136/thoraxjnl-2021-217487 | Risk factors for developing COVID-19: a population-based longitudinal study (COVIDENCE UK) |
| 7% fewer cases (p=0.53). Prospective survey-based study with 15,227 people in the UK, showing lower risk of COVID-19 cases with vitamin A, vitamin D, zinc, selenium, probiotics, and inhaled corticosteroids; and higher risk with metformin and vitamin C. Statistica.. | ||
|
Mar 29
2021 |
et al., Front. Nutr. 8:660420, doi:10.3389/fnut.2021.660420 | Low Serum 25-hydroxyvitamin D (Vitamin D) Level Is Associated With Susceptibility to COVID-19, Severity, and Mortality: A Systematic Review and Meta-Analysis |
| Systematic review and meta analysis showing that low vitamin D levels was associated with COVID-19 cases, severity, and mortality. | ||
|
Mar 27
2021 |
et al., International Journal of Environmental Research and Public Health, doi:10.3390/ijerph18073491 | Vitamin D Levels Are Reduced at the Time of Hospital Admission in Sicilian SARS-CoV-2-Positive Patients |
| 79% fewer cases (p<0.0001). Retrospective 50 COVID-19 hospitalized patients in Italy with vitamin D levels measured on admission, and 100 matched control patients, showing significantly lower vitamin D levels in COVID-19 patients. Vitamin D levels were also lower in.. | ||
|
Mar 27
2021 |
et al., medRxiv, doi:10.1101/2021.03.22.21254032 | Vitamin D-related polymorphisms and vitamin D levels as risk biomarkers of COVID-19 infection severity |
| 41% lower mortality (p=0.02). Analysis of 491 hospitalized patients in Portugal showing that polymorphisms in the vitamin D binding protein encoded by the GC gene are related to COVID-19 severity (p = 0.005). There was an association between vitamin D polygenic risk s.. | ||
|
Mar 26
2021 |
et al., The Journal of Steroid Biochemistry and Molecular Biology, doi:10.1016/j.jsbmb.2021.105883 | Therapeutic and prognostic role of vitamin D for COVID-19 infection: A systematic review and meta-analysis of 43 observational studies |
| Meta analysis showing vitamin D deficiency associated with higher risk of COVID-19, worse severity, and higher mortality. Supplementation with vitamin D reduced the risk of severe cases and mortality. | ||
|
Mar 22
2021 |
et al., BMJ Nutrition, Prevention & Health, doi:10.1136/bmjnph-2021-000265 | When Mendelian randomisation fails |
| Analysis of why Mendelian randomization may fail in vitamin D studies. Authors suggest that it may come down to the use of 25(OH)D concentration in serum as a less than ideal proxy for vitamin D status of cells involved in the immune resp.. | ||
|
Mar 19
2021 |
et al., JAMA Netw Open., doi:10.1001/jamanetworkopen.2021.4117 | Association of Vitamin D Levels, Race/Ethnicity, and Clinical Characteristics With COVID-19 Test Results |
| 35% fewer cases (p=0.11). Retrospective 4,638 individuals with vitamin D levels within 1 year before COVID-19 testing, showing higher risk of COVID-19 PCR+ for vitamin D deficient individuals, and lower (but not statistically significant) cases for individuals usi.. | ||
|
Mar 15
2021 |
et al., Wiener klinische Wochenschrift, doi:10.1007/s00508-021-01833-y | Strong correlation between prevalence of severe vitamin D deficiency and population mortality rate from COVID-19 in Europe |
| Analysis of COVID-19 in European countries, finding a correlation between the prevalence of severe vitamin D deficiency and the mortality rate. | ||
|
Mar 14
2021 |
et al., medRxiv, doi:10.1101/2021.03.12.21253490 | Serum Vitamin D Levels Are Associated With Increased COVID-19 Severity and Mortality Independent of Whole-Body and Visceral Adiposity |
| 53% lower mortality (p=0.006). Retrospective 551 moderate to severe COVID-19 patients in Mexico showing vitamin D ≤12ng/mL independently associated with COVID-19 mortality. No association was found between vitamin D levels and the need for intubation. Vitamin D deficie.. | ||
|
Mar 13
2021 |
et al., Diabetes & Metabolic Syndrome: Clinical Research & Reviews, doi:10.1016/j.dsx.2021.03.006 | Impact of the vitamin D deficiency on COVID-19 infection and mortality in Asian countries |
| Analysis of Asian countries finding that prevalence of vitamin D deficiency and lower vitamin D levels were associated with COVID-19 infection and mortality. Positive correlations were observed for prevalence of vitamin D deficiency with .. | ||
|
Mar 12
2021 |
et al., medRxiv, doi:10.1101/2021.03.11.21253361 | Mean Vitamin D levels in 19 European Countries & COVID-19 Mortality over 10 months |
| 54% lower mortality (p=0.03). Retrospective 19 European countries showing countries with mean vitamin D levels > 50nmol/L have a 2.2 times lower risk of mortality (p = 0.032) compared to those with mean levels < 50 nmol/L. | ||
|
Mar 9
2021 |
et al., Pharmaceutical Sciences, doi:10.34172/PS.2021.13 | The impact of vitamin D supplementation on mortality rate and clinical outcomes of COVID-19 patients: A systematic review and meta-analysis |
| 74% lower mortality (p=0.008). Meta analysis of 4 supplementation studies, finding that vitamin D supplementation “seems to decrease the mortality rate, the severity of the disease, and serum levels of the inflammatory markers”. Mortality odds ratio OR 0.264,.. | ||
|
Mar 8
2021 |
et al., Endocrine Practice, doi:10.1016/j.eprac.2021.02.013 | Association of vitamin D status with hospital morbidity and mortality in adult hospitalized COVID-19 patients |
| 34% lower mortality (p=0.26), 37% lower ventilation (p=0.17), and 23% lower ICU admission (p=0.28). Retrospective 287 hospitalized patients in the USA showing significantly lower mortality with vitamin D sufficiency in elderly patients and patients without obesity; and lower mortality for all patients but not reaching statistical signif.. | ||
|
Mar 7
2021 |
et al., Clinical Nutrition, doi:10.1016/j.clnu.2021.03.001 | Vitamin D deficiency in critically ill COVID-19 ARDS patients |
| Retrospective 26 ICU patients showing that the majority of patients had vitamin D deficiency. There was no statistically significant association of 25-hydroxyvitamin D status and clinical course, however low levels of 1,25-dihydroxyvitami.. | ||
|
Mar 5
2021 |
et al., Critical Case Reports, doi:10.1002/ccr3.4010 | Vitamin D and COVID-19 in an immunocompromised patient with multiple comorbidities—A Case Report |
| Case report of a high-risk immunocompromised patient with multiple comorbidities that had a mild case of COVID-19. The patient had UVB phototherapy three months earlier and had normal vitamin D levels (92.2 nmol/L, normal range 50-125). | ||
|
Mar 5
2021 |
et al., J Endocrinol. Invest., doi:10.1007/s40618-021-01535-2 | Vitamin D deficiency, secondary hyperparathyroidism and respiratory insufficiency in hospitalized patients with COVID-19 |
| 19% lower mortality (p=0.49) and 67% higher ventilation (p=0.08). Retrospective 348 hospitalized patients in Italy showing vitamin D deficiency associated with acute hypoxemic respiratory failure. Vitamin D supplementation during hospitalization was not significantly associated with mortality or ventila.. | ||
|
Mar 4
2021 |
et al., Pancreatology, doi:10.1016/j.pan.2020.10.005 | COVID-19 in patients with hepatobiliary and pancreatic diseases in East London: a single-centre cohort study |
| 42% higher mortality (p=0.35) and 146% more cases (p<0.0001). Retrospective 15,440 patients with hepatobiliary and pancreatic diseases in the United Kingdom, 226 with confirmed COVID-19, showing higher risk with vitamin D supplementation. Results are likely confounded by impaired vitamin D processin.. | ||
|
Mar 4
2021 |
et al., American Journal of Physiology-Endocrinology and Metabolism, doi:10.1152/ajpendo.00517.2020 | Exploring the link between vitamin D and clinical outcomes in COVID-19 |
| 15% lower mortality (p=0.56), 19% lower ventilation (p=0.48), and 28% lower ICU admission (p=0.17). Retrospective 270 patients with vitamin D levels measured in the last year, showing no significant difference in outcomes based on vitamin D levels or vitamin D supplementation. | ||
|
Mar 3
2021 |
et al., Respiratory Research, doi:10.1186/s12931-021-01666-3 | Circulating Vitamin D levels status and clinical prognostic indices in COVID-19 patients |
| 88% lower mortality (p=0.07). Retrospective 52 hospitalized COVID-19 patients showing that vitamin D deficiency is associated with compromised inflammatory responses and higher pulmonary involvement. Vitamin D deficient patients also showed higher mortality, although .. | ||
|
Feb 28
2021 |
et al., International Journal of Progressive Science and Technologies, doi:10.52155/ijpsat.v27.2.3269 | Vitamin D Associated Peculiarities in Women with Mild Covid-19 and Effect of Calcifediol on the Level of Vitamin D and Possibly, on Disease Outcome – Prospective Pilot Study |
| Prospective study of 30 female COVID-19 patients, all treated with calcifediol on admission, showing significantly increased vitamin D levels with treatment. There was no mortality. | ||
|
Feb 24
2021 |
et al., Nutrients, doi:10.3390/nu13030717 | Vitamin D and Lung Outcomes in Elderly COVID-19 Patients |
| 76% fewer cases (p=0.0002). Retrospective 65 elderly COVID-19 patients and 65 matched controls, showing lower vitamin D levels associated with more severe lung involvement, longer disease duration, and higher mortality. Vitamin D supplementation was less common in t.. | ||
|
Feb 19
2021 |
et al., Journal of the American College of Nutrition, doi:10.1080/07315724.2020.1869626 | An Evaluation of Serum 25-Hydroxy Vitamin D Levels in Patients with COVID-19 in New York City |
| 5% higher mortality (p=0.83), 55% lower need for oxygen therapy (p=0.0002), and 4% lower hospitalization (p=0.41). Retrospective 437 mostly serious condition (85% hospitalized) patients in New York, showing vitamin D deficiency associated with increased likelihood of oxygen support, but no association with mortality and hospitalization. Multivariate a.. | ||
|
Feb 18
2021 |
et al., Journal of the American College of Nutrition, doi:10.1080/07315724.2021.1877580 | Low Vitamin D Status at Admission as a Risk Factor for Poor Survival in Hospitalized Patients With COVID-19: An Italian Retrospective Study |
| 55% lower mortality (p=0.05). Retrospective 137 hospitalized patients in Italy. All patients had low vitamin D levels, and lower levels were associated with higher mortality. In multivariate logistic regression, vitamin D levels were significantly inversely associated.. | ||
|
Feb 17
2021 |
et al., SICOT-J, doi:10.1051/sicotj/2021001 | Older patients with proximal femur fractures and SARS-CoV-2 infection – An observational study |
| 93% lower mortality (p=0.01). Small retrospective study of 29 hip fracture patients in the UK, 14 with COVID-19. All COVID-19 patients were treated with vitamin D except for 2 where testing and supplementation was missed due to a clerical error. The two COVID-19 patie.. | ||
|
Feb 12
2021 |
et al., Bratislava Medical Journal, doi:10.4149/bll_2021_034 | The relationship between vitamin D and the severity of COVID-19 |
| 69% lower severe cases (p=0.005). Prospective study of 204 patients with COVID-19-like pneumonia in Turkey, 42 outpatients (mild cases), and 162 inpatients (serious cases), showing significantly higher risk of severe cases with vitamin D deficiency. | ||
|
Feb 12
2021 |
et al., Journal of Medical Biochemistry, doi:10.5937/jomb0-30228 | Low levels of vitamin D were associated with coagulopathy among hospitalized coronavirus disease-19 (COVID-19) patients: A single-centered study in Indonesia |
| 91% lower mortality (p=0.32), 90% lower ICU admission (p=0.32), and 81% lower progression (p=0.04). Retrospective 50 hospitalized PCR+ patients in Indonesia showing ICU admission, mortality, ISTH DIC (Disseminated Intravascular Coagulation) score>=5, and increased D-dimer significantly associated with lower vitamin D levels. | ||
|
Feb 9
2021 |
et al., SSRN, doi:10.2139/ssrn.3779211 | Case Cluster of RT-PCR COVID-19 Positive Patients with an Unexpected Benign Clinical Course With Vitamin D, Melatonin, Vitamin C, and Viscum Album |
| Case series of 24 COVID-19 patients (12 confirmed PCR+) treated with vitamin D, vitamin C, and melatonin, showing positive outcomes with no patient having worse than a mild case, including 7 high risk patients. | ||
|
Feb 8
2021 |
et al., International Journal of Clinical Practice, doi:10.1111/ijcp.14078 | The association between micronutrient and hemogram values and prognostic factors in COVID-19 patients: A single-center experience from Turkey |
| Retrospective 310 hospitalized COVID-19 patients in Turkey, showing patients that were admitted to the ICU, intubated, or died had lower vitamin D levels compared to those that were not (statistically significant for ICU admission). | ||
|
Feb 3
2021 |
et al., Indian Journal of Clinical Biochemistry, doi:10.1007/s12291-020-00950-1 | Association of Vitamin D Status with COVID-19 Infection and Mortality in the Asia Pacific region: A Cross-Sectional Study |
| Analysis of vitamin D levels and COVID-19 in 37 Asia Pacific countries, finding a significant association with the number of cases/million (r = −0.394, p = 0.016) and a weak association with the number of deaths/ million (r = −0.280, p .. | ||
|
Feb 2
2021 |
et al., The Journal of Current Pediatrics, doi:10.4274/jcp.2021.0002 | Vitamin D Levels of COVID-19 Positive Sypmtomatic Pediatric Cases |
| Retrospective 30 hospitalized pediatric COVID-19 patients and 82 healthy controls, showing significantly lower vitamin D levels in COVID-19 patients. | ||
|
Feb 1
2021 |
et al., BMJ Nutrition, Prevention & Health, doi:10.1136/bmjnph-2021-000255 | Genetically predicted serum vitamin D and COVID-19: a Mendelian randomization study |
| 2% lower severe cases (p=0.11), no change in hospitalization (p=1), and no change in cases (p=1). UK Biobank Mendelian randomization study not finding significant differences in COVID-19 risk. The number of people predicted to have vitamin D deficiency does not appear to be provided. | ||
|
Jan 31
2021 |
et al., Critical Care Medicine, doi:10.1097/01.ccm.0000726440.30551.47 | Vitamin D Levels in Children With COVID-19 Admitted to the PICU |
| Retrospective 14 pediatric COVID-19 ICU patients showing that the majority were vitamin D deficient. | ||
|
Jan 29
2021 |
et al., Journal of Medical Virology, doi:10.1002/jmv.26832 | Vitamin D deficiency is associated with COVID-19 positivity and the severity of the disease |
| 89% lower severe cases (p=0.001), 87% shorter hospitalization (p=0.001), and 24% fewer cases (p=0.18). Retrospective cohort study of 487 patients finding that lower vitamin D levels is associated with more severe cases as measured by affected lung segments and increased hospitalization time for COVID-19 positive patients, and that lower vi.. | ||
|
Jan 29
2021 |
et al., The American Journal of Clinical Nutrition, doi:10.1093/ajcn/nqaa381 | Habitual use of vitamin D supplements and risk of coronavirus disease 2019 (COVID-19) infection: a prospective study in UK Biobank |
| 30% fewer cases (p=0.03). Retrospective 8,297 adults from the UK Biobank showing the habitual use of vitamin D supplements significantly associated with lower risk of COVID-19 cases. Note that the information on vitamin D supplement use was collected a median of 1.. | ||
|
Jan 29
2021 |
et al., Nutrition, doi:10.1016/j.nut.2021.111441 | A critical update on the role of mild and serious vitamin D deficiency prevalence and the COVID-19 epidemic in Europe |
| Analysis of vitamin D deficiency and COVID-19 cases and mortality in European countries showing significant correlation between mortality and prevalence of both mild vitamin D deficiency (r = 0.634, p = 0.003) and severe vitamin D deficie.. | ||
|
Jan 28
2021 |
, H., Nutrients, doi:10.3390/nu13020411 | Vitamin D Supplementation to Prevent COVID-19 Infections and Deaths—Accumulating Evidence from Epidemiological and Intervention Studies Calls for Immediate Action |
| Summary of epidemiological and intervention studies for vitamin D supplementation. Author concludes that despite limitations, evidence strongly supports widespread supplementation, in particular for high-risk populations, as well as high-.. | ||
|
Jan 25
2021 |
et al., Clinical Nutrition, doi:10.1016/j.clnesp.2021.01.014 | Evaluation of vitamin D levels in COVID-19 patients referred to Labafinejad hospital in Tehran and its relationship with disease severity and mortality |
| 48% lower mortality (p=0.07). Retrospective 205 patients in Iran, showing higher mortality with vitamin D deficiency, not quite reaching statistical significance. | ||
|
Jan 25
2021 |
et al., Panminerva Med., doi:10.23736/S0031-0808.21.04277-4 | Vitamin D in severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) patients with non-invasive ventilation support |
| 65% lower ventilation (p=0.15). Retrospective 118 consecutive hospitalized PCR+ patients in Italy showing higher ventilation and mortality with vitamin D deficiency. | ||
|
Jan 22
2021 |
et al., The Journal of Clinical Endocrinology & Metabolism, doi:10.1210/clinem/dgab405 | Calcifediol Treatment and COVID-19-Related Outcomes |
| 79% lower mortality (p=0.001) and 87% lower ICU admission (p<0.0001). Quasi-randomized trial with 930 hospitalized patients, 447 treated with calcifediol, showing significantly lower ICU admission and death with treatment. Note that the randomization in this trial is by ward. Authors report that patients we.. | ||
|
Jan 21
2021 |
, S., Nature, doi:10.1038/s41598-021-81419-w | Autumn COVID-19 surge dates in Europe correlated to latitudes, not to temperature-humidity, pointing to vitamin D as contributing factor |
| Analysis of the increase in COVID-19 cases in European countries, showing no correlation with temperature, but a significant correlation with country latitude. Since UV radiation decreases earlier for higher latitudes, this supports the t.. | ||
|
Jan 19
2021 |
et al., Clin Chem Lab Med, doi:10.1515/cclm-2020-1567 | Vitamin-D levels and intensive care unit outcomes of a cohort of critically ill COVID-19 patients |
| 59% lower ICU admission (p=0.001) and 9% lower ventilation (p=0.7). Retrospective 165 hospitalized patients with known vitamin D levels, showing an associated between vitamin D deficiency and ICU admission. There was no statistically significant difference in clinical outcomes for ICU patients. It’s uncle.. | ||
|
Jan 18
2021 |
et al., Scientific Reports, doi:10.1038/s41598-021-97017-9 (date from preprint) | The relationship between serum 25-hydroxyvitamin D levels and the severity of COVID-19 disease and its mortality |
| 30% lower mortality (p=0.45) and 64% lower ICU admission (p=0.009). Retrospective 508 hospitalized COVID-19 patients in Iran showing lower mortality with vitamin D supplementation (not reaching statistical significance), and an association between lower vitamin D levels and disease severity, ICU admission.. | ||
|
Jan 16
2021 |
et al., Endocrine, doi:/10.1007/s12020-020-02597-7 | Patients hospitalized with COVID-19 have low levels of 25-hydroxyvitamin D |
| Retrospective 330 hospitalized COVID-19 patients in Armenia, showing significantly higher prevalence of vitamin D deficiency (<12ng/mL) compared to health controls (45% vs. 13%). | ||
|
Jan 14
2021 |
et al., Nutrients, doi:10.3390/nu13010219 | Effectiveness of In-Hospital Cholecalciferol Use on Clinical Outcomes in Comorbid COVID-19 Patients: A Hypothesis-Generating Study |
| 37% lower combined mortality/ICU admission (p=0.13). Retrospective 91 hospitalized patients, 36 treated with high-dose cholecalciferol, showing lower combined death/ICU admission with treatment. Authors also analyze the relationship with comorbidity burden, finding that the positive effect .. | ||
|
Jan 12
2021 |
et al., Journal of the American College of Nutrition, doi:10.1080/07315724.2020.1856013 | Vitamin D Deficiency and Low Serum Calcium as Predictors of Poor Prognosis in Patients with Severe COVID-19 |
| 86% lower mortality (p=0.002). Prospective study of 120 severe cases of COVID-19 in Algeria finding low vitamin D and low calcium both associated with increased mortality. | ||
|
Jan 11
2021 |
et al., Aging and Disease, doi:10.14336/AD.2020.1108 | Metabolic Healthy Obesity, Vitamin D Status, and Risk of COVID-19 |
| 36% lower hospitalization (p<0.0001) and 29% fewer cases (p<0.0001). UK Biobank retrospective 353,299 patients showing that vitamin D insufficiency and deficiency are associated with increased COVID-19 risk. This study also analyzes metabolic/obesity phenotypes and the combination with vitamin D status. No.. | ||
|
Jan 9
2021 |
et al., Mayo Clinic Proceedings, doi:10.1016/j.mayocp.2021.01.001 | Vitamin D Status is Associated With In-hospital Mortality and Mechanical Ventilation: A Cohort of COVID-19 Hospitalized Patients |
| 88% lower mortality (p=0.01). Retrospective 144 patients in the USA showing significantly lower mortality for vitamin D levels >=30ng/mL. | ||
|
Jan 7
2021 |
et al., Frontiers in Medicine, doi:10.3389/fmed.2020.590805 | High Prevalence of Hypocalcemia in Non-severe COVID-19 Patients: A Retrospective Case-Control Study |
| Retrospective 72 non-severe COVID-19 patients in India, showing very high levels of vitamin D deficiency (70 of 72 patients). | ||
|
Jan 7
2021 |
et al., BMJ Nutrition, Prevention & Health, doi:10.1136/bmjnph-2020-000151 | No evidence that vitamin D is able to prevent or affect the severity of COVID-19 in individuals with European ancestry: a Mendelian randomisation study of open data |
| 32% higher progression (p=0.2) and 8% more cases (p=0.14). Analysis of vitamin D levels and COVID-19 cases and severity based on genetic predisposition to higher vitamin D levels or lower vitamin D deficiency, finding no significant association. | ||
|
Dec 31
2020 |
et al., Pakistan J. Med. Heal. Sci., 14:4 | Frequency of Severe Vitamin D Deficiency and its Association with Mortality in Patients with Corona virus Disease |
| 86% lower mortality (p=0.02). Prospective study of 125 severe COVID-19 patients in Pakistan, showing significantly higher mortality with vitamin D deficiency. | ||
|
Dec 31
2020 |
et al., Infectology, doi:10.22625/2072-6732-2020-12-3-21-27 | Serum 25(oH)D level in patients with CoVID-19 |
| 79% lower mortality (p=0.11) and 71% lower severe cases (p=0.05). Retrospective 80 COVID-19 patients showing low vitamin D levels associated with severity and mortality. | ||
|
Dec 30
2020 |
et al., Endocrine Research, doi:10.1080/07435800.2020.1867162 | Vitamin D Status and COVID-19 Clinical Outcomes in Hospitalized Patients |
| 6% higher mortality (p=1), 40% lower ventilation (p=0.21), and 27% lower hospital discharge (p=0.5). Retrospective 93 hospitalized patients with vitamin D levels 1-365 days before admission, not showing significant differences with vitamin D deficiency or vitamin D levels. Vitamin D levels may vary significantly throughout the year creat.. | ||
|
Dec 30
2020 |
et al., Reviews in Cardiovascular Medicine, doi:10.31083/j.rcm.2020.04.264 | Multifaceted highly targeted sequential multidrug treatment of early ambulatory high-risk SARS-CoV-2 infection (COVID-19) |
| Review urging early treatment of COVID-19 with sequential multidrug treatment that has been shown to be safe and effective. Proposed treatment includes zinc, vitamin D & C, quercetin, and depending on age, comorbidities, and symptoms may .. | ||
|
Dec 28
2020 |
et al., Scientific Reports, doi:10.1038/s41598-021-85809-y (date from preprint) | Lack of association of baseline 25-hydroxyvitamin D levels with disease severity and mortality in Indian patients hospitalized for COVID-19 |
| 82% lower mortality (p=0.12), 34% lower ICU admission (p=0.29), and 32% lower need for oxygen therapy (p=0.06). Prospective study of 410 hospitalized patients in India showing lower mortality and ICU admission with cholecalciferol treatment, although not statistically significant with the small number of cases. The median total dose was 60,000IU. N.. | ||
|
Dec 26
2020 |
et al., European Journal of Integrative Medicine, doi:10.1016/j.eujim.2020.101271 | High dose vitamin D improves total serum antioxidant capacity and ICU outcome in critically ill patients – a randomized, double-blind clinical trial |
| 64% lower mortality (p=0.004). RCT of 30 ventilated ICU patients showing lower mortality with vitamin D treatment, RR 0.36, p = 0.004. Authors do not indicate why the patients were hospitalized or if any of the patients were COVID-19 patients. 300,000 IU intramuscular .. | ||
|
Dec 22
2020 |
et al., Aging, doi:10.18632/aging.202307 | Mortality in an Italian nursing home during COVID-19 pandemic: correlation with gender, age, ADL, vitamin D supplementation, and limitations of the diagnostic tests |
| 70% lower mortality (p=0.04). 70% lower mortality with vitamin D supplementation. Analysis of 98 PCR+ nursing home residents in Italy, mean age 90, vitamin D supplementation RR 0.30, p = 0.04. The paper provides the p value for regression but not the effect size. Trea.. | ||
|
Dec 12
2020 |
et al., Journal of Medical Virology, doi:10.1002/jmv.26726 | The Association Between the Level of Serum 25(OH) Vitamin D, Obesity, and underlying Diseases with the risk of Developing COVID-19 Infection: A case-control study of hospitalized patients in Tehran, Iran |
| 54% fewer cases (p=0.001). Case control study with 201 patients and 201 matched controls in Iran showing vitamin D deficiency associated with COVID-19. | ||
|
Dec 11
2020 |
et al., Nutrients, doi:10.3390/nu12123799 | High-Dose Cholecalciferol Booster Therapy is Associated with a Reduced Risk of Mortality in Patients with COVID-19: A Cross-Sectional Multi-Centre Observational Study |
| 80% lower mortality (p=0.001). 80% lower mortality with cholecalciferol booster therapy. Retrospective 986 hospitalized patients in the UK finding that cholecalciferol booster therapy, regardless of baseline serum levels, was associated with a reduced risk of mortality.. | ||
|
Dec 10
2020 |
et al., JAMA Network Open, doi:10.1001/jamanetworkopen.2020.29058 | Risk Factors Associated With In-Hospital Mortality in a US National Sample of Patients With COVID-19 |
| 11% lower mortality (p=0.005). Retrospective database analysis of 64,781 hospitalized patients in the USA, showing lower mortality with vitamin C or vitamin D (authors do not distinguish between the two), and higher mortality with zinc and HCQ, statistically significan.. | ||
|
Dec 10
2020 |
Over 100 Scientists, Doctors, & Leading Authorities Call For Increased Vitamin D Use To Combat COVID-19 | |
| Over 100 scientists and doctors call for efforts to increase vitamin D levels. Recommendations include reaching 75 nmol/L serum levels, 2000-4000IU daily supplementation (in the absence of testing), and measurement and treatment in hospit.. | ||
|
Dec 9
2020 |
et al., Hellenic Journal of Cardiology, doi:10.1016/j.hjc.2020.11.011 | Vitamin D deficiency correlates with a reduced number of natural killer cells in intensive care unit (ICU) and non-ICU patients with COVID-19 pneumonia |
| Observational study of 29 ICU patients and 10 non-ICU patients showing vitamin D levels positively correlated with cytotoxic T cells, natural killer (NK) cells, NK-T cells, and regulatory T cells. | ||
|
Dec 9
2020 |
et al., Nutrients, doi:10.3390/nu12123773 | Low 25-Hydroxyvitamin D Levels on Admission to the Intensive Care Unit May Predispose COVID-19 Pneumonia Patients to a Higher 28-Day Mortality Risk: A Pilot Study on a Greek ICU Cohort |
| 91% lower mortality (p=0.04). Small prospective study of 30 ICU patients, showing higher mortality risk for low vitamin D levels. When divided into two groups at the median level, there was 5 of 15 deaths for the low vitamin D group compared to 0 of 15 in the high vit.. | ||
|
Dec 5
2020 |
et al., Cardiovascular Diabetology, doi:10.1186/s12933-020-01184-4 | Diabetes and Covid-19 among hospitalized patients in Saudi Arabia: a single-centre retrospective study |
| 86% lower mortality (p=0.007). Retrospective 439 diabetic hospitalized patients in Saudi Arabia showing lower mortality with vitamin D >12.5 nmol/L, adjusted hazard ratio aHR 0.14, p = 0.007. | ||
|
Dec 4
2020 |
et al., Nutrition, doi:10.1016/j.nut.2020.111106 | Increased risk for Covid-19 in patients with Vitamin D deficiency |
| 78% fewer cases (p=0.001). Retrospective database analysis showing patients with vitamin D deficiency were 4.6 times more likely to be COVID-19 positive, p<0.001. | ||
|
Nov 30
2020 |
et al., BMJ Nutrition, Prevention & Health, doi:10.1136/bmjnph-2021-000250 (date from preprint) | Modest effects of dietary supplements during the COVID-19 pandemic: insights from 445 850 users of the COVID-19 Symptom Study app |
| 8% fewer cases (p=0.0007). Survey analysis of dietary supplements showing vitamin D usage associated with lower incidence of COVID-19. These results are for PCR+ cases only, they do not reflect potential benefits for reducing the severity of cases. A number of bias.. | ||
|
Nov 25
2020 |
et al., American Journal of Clinical Pathology, doi:10.1093/ajcp/aqaa252 | Serum 25(OH)D Level on Hospital Admission Associated With COVID-19 Stage and Mortality |
| 70% lower mortality (p=0.02). Retrospective 186 hospitalized patients in Belgium showing that 59% of patients were vitamin D deficient, and that non-vitamin D deficient patients had significantly lower mortality risk, RR 0.26, p = 0.015. | ||
|
Nov 19
2020 |
et al., Nature, doi:10.1038/s41598-020-77093-z | Analysis of vitamin D level among asymptomatic and critically ill COVID-19 patients and its correlation with inflammatory markers |
| 85% lower mortality (p=0.001) and 95% lower ICU admission (p<0.0001). Prospective study of 91 asymptomatic and 63 ICU patients showing significantly higher vitamin D deficiency in the ICU patients (97% vs. 33%). | ||
|
Nov 17
2020 |
et al., JAMA, doi:10.1001/jama.2020.26848 (date from preprint) | Effect of a Single High Dose of Vitamin D3 on Hospital Length of Stay in Patients With Moderate to Severe COVID-19: A Randomized Clinical Trial |
| 49% higher mortality (p=0.43), 48% lower ventilation (p=0.09), 25% lower ICU admission (p=0.3), and 7% higher hospital discharge (p=0.63). Very late stage (mean 10 days from symptom onset, 90% on oxygen at baseline) vitamin D supplementation RCT not showing significant differences. Ethnicity was poorly matched between arms, and diabetes was 41% in the treatment arm vs. 29% i.. | ||
|
Nov 13
2020 |
et al., The Journal of Nutrition, doi:10.1093/jn/nxaa332 | Vitamin D Deficiency Is Associated with COVID-19 Incidence and Disease Severity in Chinese People |
| 63% lower progression (p=0.01). Retrospective 335 patients in China compared to 560 matched controls showing significanlty lower risk of severe COVID-19 with vitamin D sufficiency (>=30 nmol/L) OR 0.37, p = 0.014. | ||
|
Nov 12
2020 |
et al., medRxiv, doi:10.1101/2020.11.08.20222638 | Mathematical analysis of Córdoba calcifediol trial suggests strong role for Vitamin D in reducing ICU admissions of hospitalized COVID-19 patients |
| Analysis of Castillo et al. confirming efficacy of calcifediol treatment. Authors find that issues related to imperfect blinding and comorbidities can not explain the result found. See [compbio.mit.edu] for a response to issues raised on .. | ||
|
Nov 12
2020 |
et al., Postgraduate Medical Journal, doi:10.1136/postgradmedj-2020-139065 | Short term, high-dose vitamin D supplementation for COVID-19 disease: a randomised, placebo-controlled, study (SHADE study) |
| 53% improved viral clearance (p=0.02). 53% reduction in PCR+ with high-dose cholecalciferol supplementation. RCT with 16 treatment patients and 24 control patients. 25(OH)D levels at day 14 were 52 ng/ml vs. 15 ng/ml in the intervention and control group. | ||
|
Nov 11
2020 |
et al., Nutrition, doi:10.1016/j.nut.2020.111055 | Vitamin D supplementation and outcomes in coronavirus disease 2019 (COVID-19) patients from the outbreak area of Lombardy, Italy |
| 73% higher mortality (p=0.14) and 17% higher hospitalization (p=0.68). Retrospective 105 Parkinson’s disease patients, 92 caregivers, and 127 hospital inpatients, showing higher, but not statistically significant mortality and hospitalization with treatment. Supplementation was defined as >=25,000IU/month fo.. | ||
|
Nov 9
2020 |
et al., medRxiv, doi:10.1101/2020.11.07.20227512 | Vitamin D – contrary to vitamin K – does not associate with clinical outcome in hospitalized COVID-19 patients |
| no change in combined mortality/intubation (p=1). Small retrospective study of 135 patients not finding a significant difference in vitamin D status. Patients with good outcomes had a median of 45.0 nmol/L versus 37.7 nmol/L for bad outcomes, p = 0.85. Authors found that vitamin D suffic.. | ||
|
Nov 2
2020 |
et al., Nutrients, doi:10.3390/nu12113377 | Vitamin D Supplementation Associated to Better Survival in Hospitalized Frail Elderly COVID-19 Patients: The GERIA-COVID Quasi-Experimental Study |
| 93% lower mortality (p=0.02). Retrospective study finding that regular bolus vitamin D supplementation was associated with less severe COVID-19 and better survival in frail elderly. For those receiving regular supplementation: Adjusted mortality hazard ratio with supp.. | ||
|
Nov 1
2020 |
et al., Clinical Nutrition (Edinburgh, Scotland), doi:10.1016/j.clnu.2020.10.055 | Vitamin D 25OH deficiency in COVID-19 patients admitted to a tertiary referral hospital |
| 120% higher mortality (p=0.04). Prospective cohort study of 129 adult hospitalized COVID-19 patients finding patients with vitamin D levels >20ng/mL had increased mortality after adjustment. This study does not account for the risk of having a serious enough case to be.. | ||
|
Oct 31
2020 |
et al., American Journal of Therapeutics, doi:10.1097/MJT.0000000000001222 | Vitamin D Supplementation in COVID-19 Patients: A Clinical Case Series |
| Small case study of 4 vitamin D deficient patients with 2 patients treated with cholecalciferol 1,000 IU daily and two patients treated with ergocalciferol 50,000 IU daily for 5 days (high dose), showing that patients receiving high dose .. | ||
|
Oct 31
2020 |
et al., Nutrients 2020, 12:11, 3361, doi:10.3390/nu12113361 | Evidence Regarding Vitamin D and Risk of COVID-19 and Its Severity |
| Review of vitamin D and COVID-19 concluding that the evidence seems strong enough that people and physicians can use or recommend vitamin D supplements to prevent or treat COVID-19 in light of their safety and wide therapeutic window. | ||
|
Oct 30
2020 |
et al., European Journal of Nutrition, doi:10.1007/s00394-020-02411-0 | Possible association of vitamin D status with lung involvement and outcome in patients with COVID-19: a retrospective study |
| 76% lower mortality (p=0.04). Retrospective 73 hospitalized patients showing the probability of death in patients with vitamin D deficiency (< 25ng/mL) was 34.6% compared with 6.4% in patients with sufficient vitamin D levels. | ||
|
Oct 27
2020 |
et al., The Journal of Clinical Endocrinology & Metabolism, doi:10.1210/clinem/dgaa733 | Vitamin D Status in Hospitalized Patients with SARS-CoV-2 Infection |
| 83% lower combined mortality/ICU admission (p=0.0001), 81% lower hospitalization (p=0.0001), 76% lower ventilation (p=0.13), and 79% lower ICU admission (p=0.05). Retrospective 216 COVID-19 patients and 197 population controls, showing vitamin D deficiency in 82.2% of COVID-19 cases and 47.2% of population-based controls (P < .0001). Authors note: “We did not find any relationship between vita.. | ||
|
Oct 26
2020 |
et al., Metabolites, doi:10.3390/metabo11090565 (date from preprint) | Low Levels of Few Micronutrients May Impact COVID-19 Disease Progression: An Observational Study on the First Wave |
| 35% lower ventilation (p=0.21) and 17% lower ICU admission (p=0.58). Retrospective 120 hospitalized patients in Spain showing no significant differences for vitamin D deficiency. | ||
|
Oct 24
2020 |
et al., Journal of Neurology, doi:10.1007/s00415-020-10272-0 | COVID-19 in Parkinson’s disease: what holds the key? |
| 33% lower severe cases (p=0.45) and 44% fewer cases (p=0.23). Case control study with 39 COVID+ and 172 COVID- Parkinson’s disease patients in Spain, showing positive and severe cases being less likely to use vitamin D supplementation compared to negative or mild/negative cases respectively. These d.. | ||
|
Oct 21
2020 |
et al., Clinical Epidemiology and Global Health, doi:10.1016/j.cegh.2020.10.005 | Is the shielding effect of cholecalciferol in SARS CoV-2 infection dependable? An evidence based unraveling |
| Review of vitamin D for COVID-19, concluding that the available evidence is very suggestive of protective and preventive effect of vitamin D. Authors note that strict lockdown (longer time indoors and home quarantine) may increase the ris.. | ||
|
Oct 21
2020 |
et al., Nutr. Hosp., doi:10.20960/nh.03193 | Interaction between age and vitamin D deficiency in severe COVID-19 infection |
| 55% lower severe cases (p=0.07). Retrospective 80 hospitalized patients in Spain showing higher risk of severe COVID-19 with vitamin D deficiency. | ||
|
Oct 20
2020 |
et al., Aging, doi:10.18632/aging.104117 | Influence of anti-osteoporosis treatments on the incidence of COVID-19 in patients with non-inflammatory rheumatic conditions |
| 8% fewer cases (p=0.68). Retrospective 2,102 rheumatology patients in Spain showing no significant difference in cases with vitamin D supplementation. Details of vitamin D supplementation are not providied – other patients may have also independently taken vitami.. | ||
|
Oct 13
2020 |
et al., The Journal of Steroid Biochemistry and Molecular Biology, doi:10.1016/j.jsbmb.2020.105771 | Vitamin D and survival in COVID-19 patients: A quasi-experimental study |
| 89% lower mortality (p=0.002). Vitamin D3 supplementation during or just before COVID-19 was associated with 68% lower mortality and less severe COVID-19 in frail elderly. Retrospective 66 French nursing home residents, mean age 87.7, 9 control patients, and 57 that re.. | ||
|
Oct 13
2020 |
et al., Journal of the American College of Nutrition, doi:10.1080/07315724.2020.182600 | Does Serum Vitamin D Level Affect COVID-19 Infection and Its Severity? A Case-Control Study |
| 93% lower hospitalization (p=0.03). Case control study in China comparing 62 patients with 80 healthy controls showing vitamin D deficiency is a risk factor for COVID-19, especially for severe/critical cases. | ||
|
Oct 6
2020 |
et al., medRxiv, doi:10.1101/2020.10.05.20206706 | Vitamin D status and seroconversion for COVID-19 in UK healthcare workers who isolated for COVID-19 like symptoms during the 2020 pandemic |
| 29% lower seropositivity (p=0.003). Analysis of vitamin D status and anti-SARS-Cov-2 antibodies in UK healthcare workers finding that Vitamin D deficiency is a risk factor for COVID-19 seroconversion. | ||
|
Oct 5
2020 |
et al., Pediatric Pulmonology, doi:10.1002/ppul.25106 | Is vitamin D deficiency a risk factor for COVID-19 in children? |
| 73% lower severe cases (p=1). Retrospective 40 hospitalized pediatric COVID-19 patients and 45 healthy controls showing significantly lower vitamin D levels for COVID-19 patients (13.1 vs. 34.8µg/L), and that, within the hospitalized patients, there was more moderate .. | ||
|
Oct 5
2020 |
et al., J. Nutr. Health Aging, doi:10.1007/s12603-020-1479-0 | Impact of Serum 25(OH) Vitamin D Level on Mortality in Patients with COVID-19 in Turkey |
| 83% lower mortality (p<0.0001). Retrospective 149 COVID-19 patients, 69.1% with vitamin D deficiency, showing lower vitamin D levels associated with higher mortality. | ||
|
Sep 30
2020 |
et al., Tuberk Toraks, doi:10.5578/tt.70027 | Evaluation of the relationship of serum vitamin D levels in COVID-19 patients with clinical course and prognosis |
| Prospective study of 88 hospitalized PCR+ COVID-19 patients and 20 asymptomatic PCR- medical personnel, showing lower vitamin D levels correlated with COVID-19 and with the development of ARDS and MAS. | ||
|
Sep 29
2020 |
et al., Research Square, doi:10.21203/rs.3.rs-83262/v1 | Vitamin D Deficiency is Associated with Increased COVID-19 Severity: Prospective Screening of At-Risk Groups is Medically Indicated |
| 56% lower ICU admission (p=0.01). Retrospective 37 hospitalized patients in the USA, showing higher risk of ICU admission with vitamin D deficiency. | ||
|
Sep 25
2020 |
et al., PLOS One, doi:10.1371/journal.pone.0239799 | Vitamin D sufficiency, a serum 25-hydroxyvitamin D at least 30 ng/mL reduced risk for adverse clinical outcomes in patients with COVID-19 infection |
| 52% lower mortality (p=0.08), 32% lower ventilation (p=0.49), and 32% lower ICU admission (p=0.33). Retrospective 235 hospitalized patients showing a significant association between vitamin D sufficiency and reduction in clinical severity. For patients over 40, mortality was 9.7% with 25(OH)D levels >30ng/mL, versus 20% for <30ng/mL. A .. | ||
|
Sep 23
2020 |
et al., MDPI AG, doi:10.20944/preprints202009.0555.v1 | Up to 40% of COVID-19 Critically Ill Patients Have Vitamin D Deficiency |
| Retrospective 35 ICU patients in Spain showing 71% of patients had vitamin D levels <20 ng/mL, and 40% <10 ng/mL. | ||
|
Sep 17
2020 |
et al., PLOS One, doi:10.1371/journal.pone.0239252 | SARS-CoV-2 positivity rates associated with circulating 25-hydroxyvitamin D levels |
| 53% fewer cases (p=0.001). Analysis of 191,779 patients in the US finding COVID-19 positivity strongly and inversely associated with circulating 25(OH)D levels. The relationship persists across latitudes, races/ethnicities, gender, and age ranges. COVID-19 adjusted.. | ||
|
Sep 10
2020 |
et al., Nutrients 2020, 12:9, 2757, doi:10.3390/nu12092757 | Vitamin D Deficiency and Outcome of COVID-19 Patients |
| 93% lower mortality (p=0.001) and 84% lower combined mortality/intubation (p=0.001). Observational study 185 patients in Germany shows an association between vitamin D status and severity and mortality. Adjusted hazard ratio of vitamin D sufficiency for combined mechanical ventilation and death was HR 0.16, p < 0.001, and.. | ||
|
Sep 8
2020 |
et al., Nutrients, doi:10.3390/nu12092738 | Current State of Evidence: Influence of Nutritional and Nutrigenetic Factors on Immunity in the COVID-19 Pandemic Framework |
| Ecological study of European countries analyzing 10 vitamins and minerals endorsed by the European Food Safety Authority as having sufficient evidence for a causal relationship between intake and optimal immune system function: vitamins D.. | ||
|
Sep 3
2020 |
et al., JAMA network open, 3:9, doi:10.1001/jamanetworkopen.2020.19722 | Association of Vitamin D Status and Other Clinical Characteristics With COVID-19 Test Results |
| 44% fewer cases (p=0.02). Retrospective 489 patients showing 44% lower risk for COVID-19 with vitamin D sufficiency, relative risk RR = 0.56, p = 0.02. | ||
|
Aug 29
2020 |
et al., Journal of Steroid Biochemistry and Molecular Biology, 203, October 2020, doi:10.1016/j.jsbmb.2020.105751 | Effect of calcifediol treatment and best available therapy versus best available therapy on intensive care unit admission and mortality among patients hospitalized for COVID-19: A pilot randomized clinical study |
| 85% lower mortality (p=0.11) and 94% lower ICU admission (p=0.008). RCT on calcifediol (25-hydroxyvitamin D) treatment for hospitalized COVID-19 patients showing significantly reduced intensive care unit admissions. All patients received standard care including HCQ+AZ. Significantly lower ICU admission wi.. | ||
|
Aug 28
2020 |
et al., Virus Research, doi:10.1016/j.virusres.2020.198148 | Association of vitamin D with the modulation of the disease severity in COVID-19 |
| Prospective study of 123 outpatients in Iran, showing mortality associated with significantly lower vitamin D levels. IR.SBMU.RETECH.REC.1399.131. | ||
|
Aug 27
2020 |
et al., Postgraduate Medical Journal, doi:10.1136/postgradmedj-2020-138712 | Vitamin D status and outcomes for hospitalised older patients with COVID-19 |
| 29% lower mortality (p=0.5). Prospective study of 105 hospitalized patients, showing lower vitamin D levels in the COVID-19 positive group (27.0 nmol/L vs 52.0 nmol/L, p=0.0008), and non-statistically significant higher mortality with vitamin D deficiency. | ||
|
Aug 26
2020 |
et al., Journal of Translational Medicine, doi:10.1186/s12967-020-02488-5 | The importance of vitamin d metabolism as a potential prophylactic, immunoregulatory and neuroprotective treatment for COVID-19 |
| Review of vitamin D for the prevention and treatment of COVID-19, focusing on preventing SARS-CoV-2 infection, acting as an immunosuppressant inhibiting cytokine release syndrome, and preventing loss of neural sensation by stimulating exp.. | ||
|
Aug 26
2020 |
et al., Journal of Contemporary Medical Sciences, 10.22317/jcms.v6i4.822 | Suggested role of Vitamin D supplementation in COVID-19 severity |
| Brief report noting that there was a dramatic and complete resolution of ICU admissions after adding routine vitamin D supplementation to standard of care. | ||
|
Aug 26
2020 |
et al., Diabetes and Metabolic Syndrome: Clinical Research and Reviews, 14:4, 561–565, doi:10.1016/j.dsx.2020.04.050 | Vitamin D concentrations and COVID-19 infection in UK Biobank |
| 17% lower mortality (p=0.31) and 9% lower hospitalization (p=0.4). Database analysis of 341,484 patients in the UK with 656 hospitalized confirmed COVID-19 patients and 203 deaths, not showing a statistically significant difference after adjustment. Since adjustment factors may be correlated with vitamin.. | ||
|
Aug 15
2020 |
et al., Biomedical Research, 31:5 | Effects of Ivermectin-azithromycin-cholecalciferol combined therapy on COVID-19 infected patients: A proof of concept study |
| 70% faster recovery (p=0.0001) and 97% improved viral clearance (p<0.0001). Small study with 28 patients treated with ivermectin + AZ + cholecalciferol and 7 control patients. All treated patients were PCR- at day 10 while all control patients remained PCR+. The mean duration of symptoms was 3 days in the treatme.. | ||
|
Aug 11
2020 |
et al., Int. J. Infect. Dis., doi:10.1016/j.ijid.2020.08.018 | Nutritional status of patients with COVID-19 |
| 73% fewer cases (p=0.0003). Analysis of 50 hospitalized COVID-19 patients in South Korea showing that 76% of patients were vitamin D deficient. Comparison with 150 matched controls showed a higher probability of cases with vitamin D deficiency. | ||
|
Aug 9
2020 |
et al., J. Endocrinol. Invest., 2020, Aug 9, 1-7, doi:10.1007/s40618-020-01370-x | Vitamin D deficiency as a predictor of poor prognosis in patients with acute respiratory failure due to COVID-19 |
| 71% lower mortality (p=0.05). Retrospective study 42 patients with acute respiratory failure, 81% with low vitamin D levels. After 10 days, patients with severe vitamin D deficiency had a 50% probability of dying, while those with vitamin D ≥ 10 ng/mL had a 5% mortali.. | ||
|
Jul 31
2020 |
et al., Pakistan J. Med. Heal. Sci., 14:3 | Examine the association between severe vitamin D deficiency and mortality in patients with Covid-19 |
| 62% lower mortality (p=0.02). Prospective study of 140 COVID-19 patients in Pakistan, showing significantly higher mortality with vitamin D deficiency. | ||
|
Jul 23
2020 |
et al., The FEBS Journal, doi:doi.org/10.1111/febs.15495 | Low plasma 25(OH) vitamin D level is associated with increased risk of COVID-19 infection: an Israeli population-based study |
| 46% lower hospitalization (p=0.06) and 28% fewer cases (p=0.001). Analysis of 7,807 patients finding that low vitamin D levels are correlated with increased risk of cases and hospitalization. Adjusted odds ratio OR for sufficient vitamin D level for cases 0.69, p < 0.001, and for hospitalization 0.51, p.. | ||
|
Jul 23
2020 |
et al., Spat. Spatiotemporal Epidemiol, doi:10.1016/j.sste.2020.100362 | Covid-19 and vit-d: Disease mortality negatively correlates with sunlight exposure |
| Analysis of COVID-19 mortality and sunlight exposure in continental metropolitan France, showing that average annual sunlight hours were significantly correlated with COVID-19 mortality, with a Pearson coefficient of -0.636. Also see the .. | ||
|
Jul 20
2020 |
et al., J Clin Anesth., doi:10.1016/j.jclinane.2020.110005 | Clinical comorbidities, characteristics, and outcomes of mechanically ventilated patients in the State of Michigan with SARS-CoV-2 pneumonia |
| 19% lower mortality (p=0.42). Retrospective 152 mechanically ventilated patients in the USA showing unadjusted lower mortality with vitamin C, vitamin D, HCQ, and zinc treatment, statistically significant only for vitamin C. | ||
|
Jul 17
2020 |
et al., medRxiv, doi:10.1101/2020.07.14.20152728 | Vitamin D supplementation to prevent acute respiratory infections: systematic review and meta-analysis of aggregate data from randomised controlled trials |
| Meta analysis of 40 RCTs showing that vitamin D supplementation is safe and reduced risk of acute respiratory infections, odds ratio OR 0.89 [0.81-0.98]. | ||
|
Jun 30
2020 |
et al., Pakistan Journal of Medical & Health Sciences | Role of Vitamin D in Pathogenesis and Severity of Coronavirus Disease 2019 (COVID-19) Infection |
| Prospective study of 168 patients in Pakistan reporting an association between vitamin D deficiency and symptomatic cases. Details of the association are not provided. | ||
|
Jun 30
2020 |
et al., Irish Medical Journal, 113:5, 84 | Vitamin D Deficiency and ARDS after SARS-CoV-2 Infection |
| 69% lower ventilation (p=0.03). Analysis of 33 hospitalized COVID-19 patients with respiratory failure requiring FiO2 greater than 0.4. Intubation hazard ratio for vitamin D sufficiency HR 0.31, p = 0.03. | ||
|
Jun 30
2020 |
et al., medRxiv, doi:10.1101/2020.06.21.20136903 | Low serum 25-hydroxyvitamin D (25[OH]D) levels in patients hospitalised with COVID-19 are associated with greater disease severity: results of a local audit of practice |
| 52% lower ICU admission (p=0.02). Retrospective analysis 134 hospitalized patients. 19% of ICU patients had 25(OH)D levels > 50 nmol/L vs. 39.1% of non-ICU patients, p=0.02 | ||
|
Jun 27
2020 |
et al., medRxiv, doi:10.1101/2020.06.25.20137323 | Factors Associated with Hospitalization and Disease Severity in a Racially and Ethnically Diverse Population of COVID-19 Patients |
| 7% lower mortality (p=0.89), 17% lower combined mortality/ICU admission (p=0.001), 55% lower ICU admission (p=0.008), and 15% lower hospitalization (p=0.001). Retrospective 689 patients showing vitamin D deficiency associated with hospitalization and disease severity. | ||
|
Jun 26
2020 |
et al., American Journal of Infection Control, doi:10.1016/j.ajic.2020.06.193 | COVID-19 fatalities, latitude, sunlight, and vitamin D |
| Analysis of 88 countries, showing a significant correlation between death rates and latitude, suggesting that sunlight exposure and vitamin D levels influence mortality. | ||
|
Jun 24
2020 |
et al., SciELO preprints, doi:10.1590/SciELOPreprints.839 | Vitamin A and D deficiencies in the prognosis of respiratory tract infections: A systematic review with perspectives for COVID-19 and a critical analysis on supplementation |
| Systematic review showing deficiencies of vitamins A and D negatively affecting the prognosis of respiratory tract infections. | ||
|
Jun 22
2020 |
et al., bioRxiv, doi:10.1101/2020.06.21.162396 | Calcitriol, the active form of vitamin D, is a promising candidate for COVID-19 prophylaxis |
| In Vitro study showing that the active form of Vitamin D, calcitriol, exhibits significant potent activity against SARS-CoV-2. | ||
|
Jun 19
2020 |
et al., J. Public Health, doi:10.1093/pubmed/fdaa095 | Greater risk of severe COVID-19 in Black, Asian and Minority Ethnic populations is not explained by cardiometabolic, socioeconomic or behavioural factors, or by 25(OH)-vitamin D status: study of 1326 cases from the UK Biobank |
| UK Biobank retrospective not finding a significant association between vitamin D levels and the risk of PCR+ after adjustment. Since adjustment factors may be correlated with vitamin D deficiency, the extent of any causal contribution of .. | ||
|
Jun 14
2020 |
et al., BMJ Nutr. Prev. Health, doi:10.1136/bmjnph-2020-000110 | COVID-19 mortality increases with northerly latitude after adjustment for age suggesting a link with ultraviolet and vitamin D |
| Analysis of COVID-19 mortality and latitude as of May 18, 2020, showing that latitude was significantly associated with mortality (p=0.031), with an estimated 4.4% [0.4%-8.5%] increase in mortality for each 1° further north. | ||
|
Jun 13
2020 |
et al., medRxiv, doi:10.1101/2020.05.01.20087965 | Evidence Supports a Causal Role for Vitamin D Status in Global COVID-19 Outcomes |
| Causal inference analysis of COVID-19 severity and latitude concluding that vitamin D status plays a key role in COVID-19 outcome. | ||
|
Jun 10
2020 |
et al., Nutrition, doi:10.1016/j.nut.2020.111017 (date from preprint) | Cohort study to evaluate the effect of combination Vitamin D, Magnesium and Vitamin B12 (DMB) on progression to severe outcome in older COVID-19 patients |
| 80% lower need for oxygen therapy (p=0.04) and 81% lower ICU admission (p=0.07). Observational study of 43 patients >= 50 years old, with 17 patients receiving vitamin D, magnesium, and vitamin B12 (DMB); and 26 control patients, showing a significantly lower need for oxygen therapy and ICU admission with treatment. D.. | ||
|
Jun 2
2020 |
et al., Research Square, doi:10.21203/rs.3.rs-32499/v1 | Sunlight and vitamin D in the prevention of coronavirus disease (COVID-19) infection and mortality in the United States |
| Analysis of COVID-19 cases in the USA reporting a potential relationship between latitude and the number of COVID-19 cases (p = 0.08) and deaths (p=0.06). Authors note that sunlight and vitamin D may reduce risk for COVID-19 cases and dea.. | ||
|
May 27
2020 |
et al., medRxiv, doi:10.1101/2020.05.25.20112805 | The association of UV with rates of COVID-19 transmission and deaths in Mexico: the possible mediating role of vitamin D |
| Analysis of UV, temperature, humidity and COVID-19 in 45 Mexican cities, showing that UV was negatively correlated with rates of transmission (statistically significant) and mortality (not statistically significant). | ||
|
May 14
2020 |
et al., Journal of Travel Medicine, doi:10.1093/jtm/taaa069 | Angiotensin-converting enzyme inhibitors and angiotensin-receptor blockers are not associated with increased risk of SARS-CoV-2 infection |
| Retrospective 14,520 patients in Israel, 1,317 testing positive, showing no significant difference in vitamin D levels (23.6ng/mL and 24.1ng/mL for positive and negative cases respectively). | ||
|
May 9
2020 |
et al., Nutrients, 12:5, 1–7, doi:10.3390/nu12051359 | 25-hydroxyvitamin D concentrations are lower in patients with positive PCR for SARS-CoV-2 |
| Retrospective 107 patients in Switzerland showing lower vitamin D levels (11.1 ng/mL) in PCR positive patients compared with negative patients (24.6 ng/mL), p = 0.004. | ||
|
Apr 30
2020 |
et al., Revista de Sanidad Militar, doi:10.35366/93773 | Deficiency of vitamin D is a risk factor of mortality in patients with COVID-19 |
| 62% lower mortality (p=0.006). Retrospective 172 hospitalized COVID-19 patients in Mexico, reporting a very high prevalence of vitamin D deficiency, and significantly higher mortality with low vitamin D levels in unadjusted results. | ||
|
Apr 28
2020 |
et al., Med Drug Discov., doi:10.1016/j.medidd.2020.100041 | Does vitamin D status impact mortality from SARS-CoV-2 infection? |
| Analysis of case fatality rates showing that the CFR was significantly greater for Northern states (>40° latitude) compared to Southern States (6.0% vs. 3.5%, p < 0 .001), although there were some exceptions with individual states. | ||
|
Apr 28
2020 |
et al., medRxiv, doi:10.1101/2020.04.24.20075838 | Vitamin D Insufficiency is Prevalent in Severe COVID-19 |
| 45% lower ICU admission (p=0.29). Analysis of 20 hospitalized COVID-19 patients, 13 requiring ICU admission. 84.6% of the ICU patients had low vitamin D levels versus 57.1% of the non-ICU patients. | ||
|
Apr 2
2020 |
et al., Nutrients, 12:4, 988, doi:10.3390/nu12040988 | Evidence that Vitamin D Supplementation Could Reduce Risk of Influenza and COVID-19 Infections and Deaths |
| Review of the evidence that vitamin D supplementation could reduce COVID-19 risk. | ||
|
Jan 4
2019 |
et al., The Journal of Steroid Biochemistry and Molecular Biology, doi:10.1016/j.jsbmb.2018.12.010 | Daily oral dosing of vitamin D3 using 5000 TO 50,000 international units a day in long-term hospitalized patients: Insights from a seven year experience |
| Report on the long-term use of vitamin D in hospitalized patients with daily dosing from 5,000 to 50,000IU over 7 years. There were no cases of hypercalcemia or any adverse events related to vitamin D supplementation. Authors conclude tha.. | ||
|
Jan 6
2018 |
et al., The Journal of Steroid Biochemistry and Molecular Biology, doi:10.1016/j.jsbmb.2018.01.002 | In vivo response of the human epigenome to vitamin D: A Proof-of-principle study |
| Epigenome-wide chromatin accessibility study before and after vitamin D supplementation (calcitriol), showing significant changes at hundreds of sites within the epigenome of human leukocytes (part of the immune system). | ||
|
Feb 15
2017 |
et al., BMJ 2017, 356, doi:10.1136/bmj.i6583 | Vitamin D supplementation to prevent acute respiratory tract infections: systematic review and meta-analysis of individual participant data |
| 7% fewer cases (p=0.003). Meta analysis of 25 RCTs showing vitamin D supplementation was safe and it protected against acute respiratory tract infection overall. Patients who were very vitamin D deficient and those not receiving bolus doses experienced the most be.. | ||
|
Feb 1
2014 |
et al., JAMA Surgery, doi:10.1001/jamasurg.2013.3176 | Association Between Preoperative 25-Hydroxyvitamin D Level and Hospital-Acquired Infections Following Roux-en-Y Gastric Bypass Surgery |
| Retrospective 770 gastric bypass surgery patients showing a strong relationship between pre-operative vitamin D levels and the risk of hospital acquired infections. | ||
|
Oct 1
2014 |
et al., J Steroid Biochem Mol Biol., 2014, 144PA, 138–145, doi:10.1016/j.jsbmb.2013.11.003 | Is vitamin D deficiency a major global public health problem? |
| Review showing vitamin D deficiency is common worldwide in all age groups. | ||
|
Jun 19
2013 |
et al., PLoS ONE, 2013, 8:6, doi:10.1371/journal.pone.0065835 | Vitamin D and Respiratory Tract Infections: A Systematic Review and Meta-Analysis of Randomized Controlled Trials |
| Meta analysis of 11 placebo-controlled studies of 5660 patients. Vitamin D showed a protective effect against RTI (OR 0.64 [0.49-0.84]). The protective effect was larger in studies using once-daily dosing compared to bolus doses (OR = 0.5.. | ||
|
Nov 1
2012 |
et al., Endocr. Pract., 2012, 18:6, 914–923, doi:10.4158/EP12072.OR | Prevalence and predictors of vitamin D deficiency in healthy adults |
| Study of 634 healthy volunteers showing 64% had 25(OH)D ≤ 30 ng/mL. Gender, ethnicity, and multivitamin use were significantly associated with 25(OH)D levels. | ||
|
Mar 10
2010 |
et al., Am. J. Clin. Nutr. 2010, 91:5, 1255-60, doi:10.3945/ajcn.2009.29094 | Randomized trial of vitamin D supplementation to prevent seasonal influenza A in schoolchildren |
| RCT for vitamin D supplementation and seasonal influenza A in schoolchildren, showing 10.8% incidence in children in the vitamin D3 group compared with 18.6% in the placebo group, relative risk RR 0.58 [0.34-0.99], p = 0.04. The reduction.. | ||
|
Jul 31
2009 |
et al., Dermato-Endocrinology, doi:10.4161/derm.1.4.9063 | The possible roles of solar ultraviolet-B radiation and vitamin D in reducing case-fatality rates from the 1918–1919 influenza pandemic in the United States |
| Analysis of the 1918–1919 influenza pandemic for 12 US states, showing estimated UVB dose correlated with case fatality rates (p = 0.009) and with pneumonia as a complication of influenza (p = 0.005). | ||
|
Sep 7
2006 |
et al., Epidemiol Infect., 2006, 134:6. 1129-40, doi:10.1017/S0950268806007175 | Epidemic influenza and vitamin D |
| Review article on the mechanisms of action and seasonality of vitamin D levels, concluding that varying vitamin D levels may be the reason for the seasonality of epidemic influenza. | ||
